Form 10-Q - Quarterly report [Sections 13 or 15(d)]

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE QUARTERLY PERIOD ENDED NOVEMBER 30, 2024

 

OR

 

☐ TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE TRANSITION PERIOD FROM _______________ TO _______________

 

COMMISSION FILE NUMBER: 000-55079

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

(Exact name of registrant as specified in its charter)

 

Nevada		27-2343603
(State or other jurisdiction of Incorporation or organization)		(I.R.S. Employer Identification Number)
10800 Galaxie Avenue Ferndale, MI		48220
(Address of principal executive offices)		(Zip code)

 

[phone]

(Registrant’s telephone number, including area code)

 

not applicable

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

	Large accelerated filer	☐	Accelerated filer	☐
	Non-accelerated filer	☒	Smaller reporting company	☒
			Emerging growth company	☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 13,308,594,118 shares of common stock were issued and outstanding as of January 13, 2025.

 

 

 

 

Table of Contents

 

		PAGE
PART I	FINANCIAL INFORMATION
ITEM 1.	Financial Statements	3
	Condensed Consolidated Balance Sheets as of November 30, 2024 and February 28, 2024 (Unaudited)	3
	Condensed Consolidated Statements of Operations for the Three Months and Nine Months Ended November 30, 2024 and 2023 (Unaudited)	4
	Condensed Consolidated Statements of Stockholders’ Deficit for the Nine Months Ended November 30, 2024 and 2023 (Unaudited)	5-6
	Condensed Consolidated Statements of Cash Flows for the Nine Months Ended November 30, 2024 and 2023 (Unaudited)	7
	Notes to the Consolidated Financial Statements (Unaudited)	8-27
ITEM 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	28
ITEM 3.	Quantitative and Qualitative Disclosures About Market Risk	33
ITEM 4.	Controls and Procedures	33
PART II	OTHER INFORMATION
ITEM 1.	Legal Proceedings	34
ITEM 1A.	Risk Factors	34
ITEM 2.	Unregistered Sales of Equity Securities and Use of Proceeds	34
ITEM 3.	Defaults Upon Senior Securities	34
ITEM 4.	Mine Safety Disclosures	34
ITEM 5.	Other Information	34
ITEM 6.	Exhibits	35
SIGNATURES		36

 

-2-

Table of Contents

 

PART I – FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

 

		November 30, 2024 (unaudited)				February 29, 2024*
ASSETS
Current assets:
Cash		$	84,231			$	105,926
Accounts receivable, net			1,249,792				756,084
Share proceeds receivable			352,701				—
Device parts inventory, net			1,883,530				2,131,599
Prepaid expenses and deposits			430,159				622,957
Total current assets			4,000,413				3,616,566
Operating lease asset			1,040,862				1,139,188
Revenue earning devices, net of accumulated depreciation of $1,881,451 and $952,844, respectively			4,351,750				2,480,002
Fixed assets, net of accumulated depreciation of $460,641 and $349,878, respectively			257,189				268,075
Trademarks			31,224				27,080
Convertible note receivable			50,000				—
Investment at cost			50,000				50,000
Security deposit			15,880				15,880
Total assets		$	9,797,318			$	7,596,791
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current liabilities:
Accounts payable and accrued expenses		$	2,495,455			$	2,034,301
Customer deposits			102,321				73,702
Current operating lease liability			225,348				237,653
Current portion of deferred variable payment obligation			1,599,971				904,377
Loan payable - related party			297,414				257,438
Deferred compensation for CEO			598,635				538,767
Current portion of loans payable, net of discount of $58,620 and $688,598			25,053,991				13,190,882
Vehicle loan - current portion			38,522				38,522
Current portion of accrued interest payable			10,882,807				4,440,009
Total current liabilities			41,294,464				21,715,651
Non-current operating lease liability			810,513				889,360
Loans payable, net of discount of $374,081 and $4,118,332, respectively			7,676,654				14,798,532
Deferred variable payment obligation			2,525,000				2,525,000
Incentive compensation plan payable			2,500,000				2,500,000
Accrued interest payable			2,008,308				5,367,805
Total liabilities			56,814,939				47,796,348
Commitments and Contingencies
Redeemable Preferred Stock (Temporary Equity):
Series B Convertible, Redeemable Preferred Stock. $0.001 par value; 8% cumulative dividend payable quarterly, $1,200 stated value, 5,000 shares authorized, 0 and 0 shares issued and outstanding at November 30, 2024 and February 29, 2024, respectively			—				—
Stockholders’ deficit:
Preferred Stock, undesignated; 15,535,000 shares authorized; no shares issued and outstanding at November 30, 2024 and February 29, 2024, respectively			—				—
Series G Redeemable Preferred Stock. $0.001 par value; 100,000 shares authorized, no shares issued and outstanding at November 30, 2024 and February 29, 2024, respectively			—				—
Series E Preferred Stock, $0.001 par value; 4,350,000 shares authorized; 3,350,000 and 3,350,000 shares issued and outstanding, respectively			3,350				3,350
Series F Convertible Preferred Stock, $1.00 par value; 10,000 shares authorized; 2,513 and 2,533 shares issued and outstanding, respectively			2,513				2,533
Common Stock, $0.00001 par value; 15,000,000,000 shares authorized 12,581,671,042 and 9,238,750,958 shares issued, issuable and outstanding, respectively			125,817				92,388
Additional paid-in capital			102,141,607				92,565,513
Preferred stock to be issued			99,086				99,086
Accumulated deficit			(149,389,994	)			(132,962,427	)
Total stockholders’ deficit			(47,017,621	)			(40,199,557	)
Total liabilities and stockholders’ deficit		$	9,797,318			$	7,596,791

 

*	Derived from audited information

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

-3-

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

 

		Three Months Ended November 30, 2024				Three Months Ended November 30, 2023				Nine Months Ended November 30, 2024				Nine Months Ended November 30, 2023
Revenues		$	1,750,968			$	596,980			$	4,277,951			$	1,368,551
Cost of Goods Sold			289,339				135,914				688,024				316,439
Depreciation and amortization			287,799				113,830				729,672				322,369
Total Cost of Goods Sold			577,138				249,744				1,417,696				638,808
Gross Profit			1,173,830				347,236				2,860,255				729,743
Operating expenses:
Research and development (Note 9)			579,045				557,126				1,897,165				2,243,431
General and administrative			2,733,547				2,009,047				8,220,564				6,423,951
Depreciation and amortization			106,261				101,933				309,699				252,377
Operating lease cost and rent			57,875				64,081				182,855				189,164
Total operating expenses			3,476,728				2,732,187				10,610,283				9,108,923
Loss from operations			(2,302,898	)			(2,384,951	)			(7,750,028	)			(8,379,180	)
Other income (expense), net:
Interest expense			(1,401,076	)			(1,581,533	)			(4,072,108	)			(4,940,965	)
Gain (loss) on settlement of debt			—				—				(6,520	)			38,740
Total other income (expense), net			(1,401,076	)			(1,581,533	)			(4,078,628	)			(4,902,225	)
Net Loss		$	(3,703,974	)		$	(3,966,484	)		$	(11,828,656	)		$	(13,281,405	)
Net income (loss) per share - basic		$	(0.00	)		$	(0.00	)		$	(0.00	)		$	(0.00	)
Net income (loss) per share - diluted		$	(0.00	)		$	(0.00	)		$	(0.00	)		$	(0.00	)
Weighted average common share outstanding - basic			12,161,286,427				7,294,775,879				11,071,139,695				6,606,988,956
Weighted average common share outstanding - diluted			12,161,286,427				7,294,775,879				11,071,139,695				6,606,988,956

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

-4-

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS’ DEFICIT

(Unaudited)

 

		Series E								Series F																Additional								Total
		Preferred Stock								Preferred Stock								Common Stock								Paid-In				Accumulated				Stockholders’
		Shares				Amount				Shares				Amount				Shares				Amount				Capital				Deficit				Deficit
Balance at February 28, 2023			3,350,000			$	3,350				2,533			$	101,619				5,848,741,599			$	58,489			$	80,247,252			$	(112,253,711	)		$	(31,843,001	)
Issuance of shares, net of $81,285 issuance costs			—				—				—				—				280,929,190				2,809				1,316,100				—				1,318,909
Relative fair value of Series F warrants issued with loans payable			—				—				—				—				—				—				947,447								947,447
Stock based compensation			—				—				—				—				—				—				52,721				—				52,721
Net income			—				—				—				—				—				—				—				(4,555,193	)			(4,555,193	)
Balance at May 31, 2023			3,350,000			$	3,350				2,533			$	101,619				6,129,670,789			$	61,298			$	82,563,520			$	(116,808,904	)		$	(34,079,117	)
Issuance of shares, net of $176,672 issuance costs			—				—				—				—				903,636,004				9,036				4,787,087				—				4,796,123
Shares as payment for services			—				—				—				—				6,500,000				65				44,395				—				44,460
Stock based compensation			—				—				—				—				—				—				50,713				—				50,713
Net income			—				—				—				—				—				—				—				(4,759,728	)			(4,759,728	)
Balance at August 31, 2023			3,350,000			$	3,350				2,533			$	101,619				7,039,806,793			$	70,399			$	87,445,715			$	(121,568,632	)		$	(33,947,549	)
Issuance of shares, net of $56,320 issuance costs			—				—				—				—				675,336,434				6,753				1,405,405				—				1,412,158
Relative fair value of Series F warrants issued with debt			—				—				—				—				—				—				261,759								261,759
Stock based compensation			—				—				—				—				—				—				47,462				—				47,462
Net income			—				—				—				—				—				—				—				(3,966,484	)			(3,966,484	)
Balance at November 30, 2023			3,350,000			$	3,350				2,533			$	101,619				7,715,143,227			$	77,152			$	89,160,341			$	(125,535,116	)		$	(36,192,654	)

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

-5-

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS’ DEFICIT

(Unaudited)

 

		Temporary Equity								Shareholder’s Deficit
		Series B								Series E								Series F																Additional								Total
		Preferred Stock								Preferred Stock								Preferred Stock								Common Stock								Paid-In				Accumulated				Shareholders’
		Shares				Amount				Shares				Amount				Shares				Amount				Shares				Amount				Capital				Deficit				Deficit
Balance at February 29, 2024			—				—				3,350,000			$	3,350				2,533			$	101,619				9,238,750,958			$	92,388			$	92,565,513			$	(132,962,427	)		$	(40,199,557	)
Cumulative Effect Adjustment RFV discount per adoption of ASU 2020-06 at March 1, 2024			—				—				—				—				—				—				—				—				—				(4,175,535	)			(4,175,535	)
Issuance of shares, net of $116,046 issuance costs			—				—				—				—				—				—				1,080,166,425				10,802				2,671,791				—				2,682,593
Issuance of Series B Preferred Shares			300				360,000				—				—				—				—				—				—				(82,000	)			—				(82,000	)
Series B Preferred Shares issued as commitment fee			20				24,000				—				—				—				—				—				—				(24,000	)			—				(24,000	)
Series B Preferred shares issued as dividend			2				2,568				—				—				—				—				—				—				(2,568	)			—				(2,568	)
Redemption of Series B Preferred shares			(107	)			(128,856	)			—				—				—				—				—				—				28,856				(28,856	)			—
Stock based compensation			—				—				—				—				—				—				—				—				83,323				—				83,323
Net income			—				—				—				—				—				—				—				—				—				(4,194,359	)			(4,194,359	)
Balance at May 31, 2024			215			$	257,712				3,350,000			$	3,350				2,533			$	101,619				10,318,917,383			$	103,190			$	95,240,915			$	(141,361,177	)		$	(45,912,103	)
Issuance of shares, net of $195,656 issuance costs			—				—				—				—				—				—				1,330,610,802				13,306				4,478,054				—				4,491,360
Debt exchanged for common stock			—				—				—				—				—				—				57,142,857				571				199,429				—				200,000
Series F Preferred Shares exchanged for debt			—				—				—				—				(20	)			(20	)			—				—				(65,793	)			(334,187	)			(400,000	)
Series B Preferred shares issued as dividend			2				2,620				—				—				—				—				—				—				(2,620	)			—				(2,620	)
Redemption of Series B Preferred shares			(217	)			(260,332	)			—				—				—				—				—				—				60,333				(60,333	)			—
Stock based compensation			—				—				—				—				—				—				—				—				83,323				—				83,323
Net income			—				—				—				—				—				—				—				—				—				(3,930,323	)			(3,930,323	)
Balance at August 31, 2024			—			$	—				3,350,000			$	3,350				2,513			$	101,599				11,706,671,042			$	117,067			$	99,993,641			$	(145,686,020	)		$	(45,470,363	)
Issuance of shares, net of $93,885 issuance costs			—				—				—				—				—				—				875,000,000				8,750				2,064,643				—				2,073,393
Stock based compensation			—				—				—				—				—				—				—				—				83,323				—				83,323
Net income			—				—				—				—				—				—				—				—				—				(3,703,974	)			(3,703,974	)
Balance at November 30, 2024			—			$	—				3,350,000			$	3,350				2,513			$	101,599				12,581,671,042			$	125,817			$	102,141,607			$	(149,389,994	)		$	(47,017,621	)

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

-6-

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

 

		Nine Months Ended November 30, 2024				Nine Months Ended November 30, 2023
CASH FLOWS USED IN OPERATING ACTIVITIES:
Net loss		$	(11,828,656	)		$	(13,281,405	)
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization			1,039,371				574,746
Bad debts expense			37,995				26,730
Inventory provision			150,000				—
Reduction of right of use asset			91,152				88,378
Accretion of lease liability			90,165				99,248
Stock based compensation			249,969				337,896
Change in fair value of derivative liabilities			—				—
Amortization of debt discounts			198,696				1,755,897
(Gain) loss on settlement of debt			6,520				(38,740	)
Increase in related party accrued payroll and interest			39,976				92,770
Changes in operating assets and liabilities:
Accounts receivable			(531,703	)			(267,144	)
Prepaid expenses			199,972				(90,315	)
Device parts inventory			(2,778,439	)			(2,004,189	)
Accounts payable and accrued expenses			700,082				266,666
Deferred compensation for CEO			(195,000	)			—
Customer deposits			28,619				68,567
Operating lease liabilities			(171,898	)			(174,874	)
Current portion of deferred variable payment obligation for payments			695,594				222,525
Accrued interest payable			3,083,301				2,944,817
Net cash used in operating activities			(8,894,284	)			(9,378,427	)
CASH FLOWS USED IN INVESTING ACTIVITIES:
Purchase of fixed assets			(23,724	)			(13,903	)
Acquisition of trademarks			(4,144	)			—
Convertible note receivable			(50,000	)			—
Reimbursement of security deposit			—				3,859
Net cash used in investing activities			(77,868	)			(10,044	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Share proceeds net of issuance costs			8,894,645				7,527,190
Proceeds from loans payable			350,000				1,400,000
Repayment of loans payable			(183,000	)			(381,000	)
Proceeds on issuance of Series B Preferred shares			278,000				—
Redemption of Series B Preferred shares			(389,188	)			—
Proceeds from convertible debt and warrants issued			—				—
Net cash provided by financing activities			8,950,457				8,546,190
Net change in cash			(21,695	)			(842,281	)
Cash, beginning of period			105,926				939,759
Cash, end of period		$	84,231			$	97,478
Supplemental disclosure of cash and non-cash transactions:
Cash paid for interest		$	81,040			$	17,726
Cash paid for income taxes		$	—			$	—
Noncash investing and financing activities:
Share proceeds receivable		$	352,701			$	—
Transfer from device parts inventory to revenue earning devices		$	2,876,508			$	1,421,979
Cumulative Effect Adjustment RFV discount per adoption of ASU 2020-06 at March 1, 2024		$	4,175,535			$	—
Exchange of Series F preferred stock for note payable		$	400,000			$	—
Exchange of note payable for common stock		$	200,000			$	—
Series B preferred shares issued as dividend		$	5,188			$	—
Shares issued for services		$	—			$	44,460
Discount applied to face value of loans		$	—			$	200,000
Warrants issued as part of debt		$	—			$	1,209,206

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

-7-

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

1. GENERAL INFORMATION

 

Artificial Intelligence Technology Solutions Inc. (“AITX” or the “Company”) was incorporated in Florida on March 25, 2010 and reincorporated in Nevada on February 17, 2015. On August 24, 2018, Artificial Intelligence Technology Solutions Inc., changed its name from On the Move Systems Corp (“OMVS”).

 

Robotic Assistance Devices, LLC (“RAD”), was incorporated in the State of Nevada on July 26, 2016 as a Limited Liability Company. On July 25, 2017, Robotic Assistance Devices LLC converted to a C Corporation, Robotic Assistance Devices, Inc., through the issuance of 10,000 common shares to its sole shareholder.

 

On August 28, 2017, AITX completed the acquisition of RAD (the “Acquisition”), whereby AITX acquired all the ownership and equity interest in RAD for 3,350,000 shares of AITX Series E Preferred Stock and 2,450 shares of Series F Convertible Preferred Stock. AITX’s prior business focus was transportation services, and was exploring the on-demand logistics market by developing a network of logistics partnerships. As a result of the closing of the Acquisition, AITX has succeeded to the business of RAD, and AITX’s business going forward will consist of one segment activity, which is the delivery of artificial intelligence and robotic solutions for operational, security and monitoring needs.

 

The Acquisition was treated as a reverse recapitalization effected by a share exchange for financial accounting and reporting purposes since substantially all of AITX’s operations were disposed of as part of the consummation of the transaction. Therefore, no goodwill or other intangible assets were recorded by AITX as a result of the Acquisition. RAD is treated as the accounting acquirer as its stockholders control the Company after the Acquisition, even though AITX was the legal acquirer. As a result, the assets and liabilities and the historical operations that are reflected in these financial statements are those of RAD as if RAD had always been the reporting company.

 

2. GOING CONCERN

 

The accompanying unaudited consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the possible inability of the Company to continue as a going concern.

 

For the nine months ended November 30, 2024, the Company had negative cash flow from operating activities of $8,894,284. As of November 30, 2024, the Company has an accumulated deficit of $149,389,994, and negative working capital of $37,294,051. Management does not anticipate having positive cash flow from operations in the near future. These factors raise substantial doubt about the Company’s ability to continue as a going concern for the twelve months following the issuance of these financial statements.

 

The Company does not have the resources at this time to repay all its credit and debt obligations, make any payments in the form of dividends to its shareholders or fully implement its business plan. Without additional capital, the Company will not be able to remain in business. At the same time management points to its successful history with maintaining Company operations and reminds all with reasonable confidence this will continue. Management has plans to address the Company’s financial situation as follows:

 

Management is committed to raise either non-dilutive funds or minimally dilutive funds. There is no assurance that these funds will be able to be raised nor can we provide assurance that these possible raises may not have dilutive effects. In July 2024, the Company entered into an equity financing agreement whereby an investor will purchase up to $30,000,000 of the Company’s common stock at a discount over a two-year period. There remains approximately $26 million left to issue under this arrangement. Management believes that it has the necessary support to continue operations by continuing its funding methods in the following ways: growing revenues, through equity proceeds, and issuing non-convertible debt. Management has had many recent conversations with the Company’s primary debt holder and believes that the non-convertible debt on the balance sheet will be extended. Management notes that non-convertible debt on the books has been extended by this debt holder twice in the past and notes that this debt holder has been a strong supporter of the Company.

 

-8-

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

3. ACCOUNTING POLICIES

 

Basis of Presentation and Consolidation

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and in conformity with the condensing instructions on Form 10-Q and Rule 8-03 of Regulation S-X and the related rules and regulations of the Securities and Exchange Commission (“SEC”) and should be read in conjunction with the audited financial statements and notes thereto in the Company’s latest Annual Report filed with the SEC on Form 10-K as filed on May 29, 2024. The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Robotic Assistance Devices, Inc., Robotic Assistance Devices Group , Inc, Robotic Assistance Devices Mobile, Inc., On the Move Experience, LLC and On the OMV Transports, LLC. All significant intercompany accounts and transactions have been eliminated in consolidation. The unaudited consolidated financial statements reflect all adjustments, consisting of normal recurring accruals, which are, in the opinion of management, necessary for a fair presentation of such statements. The results of operations for the nine months ended November 30, 2024 are not necessarily indicative of the results that may be expected for the entire year.

 

Use of Estimates

 

In order to prepare financial statements in conformity with accounting principles generally accepted in the United States, management must make estimates, judgements and assumptions that affect the amounts reported in the financial statements and determine whether contingent assets and liabilities, if any, are disclosed in the financial statements. The ultimate resolution of issues requiring these estimates and assumptions could differ significantly from resolution currently anticipated by management and on which the financial statements are based. The most significant estimates included in these consolidated financial statements are those associated with the assumptions used to value preferred stock and derivative liabilities.

 

Reclassifications

 

Certain amounts in the Company’s consolidated financial statements for prior periods have been reclassified to conform to the current period presentation. These reclassifications have not changed the results of operations of prior periods.

 

Concentrations

 

Loans payable

 

At November 30, 2024 there were $33,163,345 of loans payable, $28,743,506 or 87% of these loans to companies controlled by one individual. At February 29, 2024 there were $32,796,345 of loans payable, $28,540,506 or 87% of these loans to companies controlled by the same individual.

 

Cash

 

The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Cash and cash equivalents consist of cash on deposit with banks and money market instruments. The Company places its cash and cash equivalents with high-quality, U.S. financial institutions and, to date has not experienced losses on any of its balances.

 

Accounts Receivable

 

Accounts receivable are comprised of balances due from customers, net of estimated allowances for uncollectible accounts. In determining collectability, historical trends are evaluated, and specific customer issues are reviewed on a periodic basis to arrive at appropriate allowances. There was an allowance of $74,000 and $68,000 provided as of November 30, 2024 and February 29, 2024, respectively. For the three months ended November 30, 2024, one customer accounted for 61% of total accounts receivable. For the three months ended November 30, 2023, two customers account for 61% of total accounts receivable.

 

Device Parts Inventory

 

Device parts inventory is stated at the lower of cost or net realizable value using the weighted average cost method. The Company records a valuation reserve for obsolete and slow-moving inventory, relying principally on specific identification of such inventory. The Company uses these device parts in the assembly of revenue earning devices (and demo devices) as well as research and development. Depending on use, the Company will transfer the parts to the corresponding asset or expense if used in research and development. A charge to income is taken when factors that would result in a need for an increase in the valuation, such as excess or obsolete inventory, are noted. As of November 30, 2024 and February 29, 2024 there was a valuation reserve of $1,109,000 and $959,000, respectively.

 

-9-

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

Revenue Earning Devices

 

Revenue earning devices are stated at cost. Depreciation is provided on a straight-line basis over the estimated useful life of 48 months. The Company continually evaluates revenue earning devices to determine whether events or changes in circumstances have occurred that may warrant revision of the estimated useful life or whether the devices should be evaluated for possible impairment. The Company uses a combination of undiscounted cash flows and market approaches in assessing whether an asset has been impaired. The Company measures impairment losses based upon the amount by which the carrying amount of the asset exceeds the fair value.

 

Fixed Assets

 

Fixed assets are stated at cost. Depreciation is provided on the straight-line method based on the estimated useful lives of the respective assets which range from two to five years. Major repairs or improvements are capitalized. Minor replacements and maintenance and repairs which do not improve or extend asset lives are expensed currently.

  

Computer equipment and software		2 or 3 years
Office equipment		4 years
Manufacturing equipment		7 years
Warehouse equipment		5 years
Tooling		2 years
Demo Devices		4 years
Vehicles		3 years
Leasehold improvements		5 years, the life of the lease

 

The Company periodically evaluates the fair value of fixed assets whenever events or changes in circumstances indicate that its carrying amounts may not be recoverable. Upon retirement or other disposition of fixed assets, the cost and related accumulated depreciation are removed from the accounts and the resulting gain or loss, if any, is recognized in income.

 

Research and Development

 

Research and development costs are expensed in the period they are incurred in accordance with ASC 730, Research and Development unless they meet specific criteria related to technical, market and financial feasibility, as determined by Management, including but not limited to the establishment of a clearly defined future market for the product, and the availability of adequate resources to complete the project. If all criteria are met, the costs are deferred and amortized over the expected useful life or written off if a product is abandoned. At November 30, 2024 and February 29, 2024, the Company had no deferred development costs.

 

Contingencies

 

Occasionally, the Company may be involved in claims and legal proceedings arising from the ordinary course of its business. The Company records a provision for a liability when it believes that it is both probable that a liability has been incurred, and the amount can be reasonably estimated. If these estimates and assumptions change or prove to be incorrect, it could have a material impact on the Company’s consolidated financial statements. Contingencies are inherently unpredictable, and the assessments of the value can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions.

 

Sales of Future Revenues

 

The Company has entered into transactions, as more fully described in footnote 8, in which it has received funding from investors in exchange for which it will make payments to those investors based on the level of sales of certain revenue categories, generally based on a percentage of sales for those certain revenues. The Company determines whether these agreements constitute sales of future revenues or are in substance debt based on the facts and circumstances of each agreement, with the following primary criteria determinative of whether the agreement constitutes a sale of future revenues or debt:

 

-10-

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

	●	Does the agreement purport, in substance, to be a sale
	●	Does the Company have continuing involvement in the generation of cash flows due the investor
	●	Is the transaction cancellable by either party through payment of a lump sum or other transfer of assets
	●	Is the investors rate of return is implicitly limited by the terms of the agreement
	●	Does the Company’s revenue for a reporting period underlying the agreement have only a minimal impact on the investor’s rate of return
	●	Does the investor have recourse relating to payments due

 

In the event a transaction is determined to be a sale of future revenues, it is recorded as deferred revenue and amortized using the sum-of-the-revenue method. In the event a transaction is determined to be debt, it is recorded as debt and amortized using the effective interest method. As of the date of these financial statements, the Company has determined that all such agreements are debt.

 

Revenue Recognition

 

ASU 2014-09, “Revenue from Contracts with Customers (Topic 606)”, supersedes the revenue recognition requirements and industry specific guidance under Revenue Recognition (Topic 605). Topic 606 requires an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration the entity expects to be entitled to in exchange for those goods or services. Topic 606 defines a five-step process that must be evaluated and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing accounting principles generally accepted in the United States of America (“U.S. GAAP”) including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. The Company adopted Topic 606 on March 1, 2018, using the modified retrospective method. Under the modified retrospective method, prior period financial positions and results will not be adjusted. There was no cumulative effect adjustment recognized as a result of this adoption. Refer to Note 4 – Revenue from Contracts with Customers for additional information. For the nine months ended November 30, 2024, one customer accounted for 57% of total revenue and for the nine months ended November 30, 2023, four customers accounted for 58% of total revenue.

 

Income Taxes

 

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized when items of income and expense are recognized in the financial statements in different periods than when recognized in the tax return. Deferred tax assets arise when expenses are recognized in the financial statements before the tax returns or when income items are recognized in the tax return prior to the financial statements. Deferred tax assets also arise when operating losses or tax credits are available to offset tax payments due in future years. Deferred tax liabilities arise when income items are recognized in the financial statements before the tax returns or when expenses are recognized in the tax return prior to the financial statements. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

 

On December 22, 2017, the Tax Cuts and Jobs Act (“Tax Act”) was signed into law. ASC 740, Accounting for Income Taxes requires companies to recognize the effects of changes in tax laws and rates on deferred tax assets and liabilities and the retroactive effects of changes in tax laws in the period in which the new legislation is enacted. The Company’s gross deferred tax assets were revalued based on the reduction in the federal statutory tax rate from 35% to 21%. A corresponding offset has been made to the valuation allowance, and any potential other taxes arising due to the Tax Act will result in reductions to the Company’s net operating loss carryforward and valuation allowance. The Company will continue to analyze the Tax Act to assess its full effects on the Company’s financial results, including disclosures, for the Company’s fiscal year ending February 28, 2024, but the Company does not expect the Tax Act to have a material impact on the Company’s consolidated financial statements.

 

Leases

 

Lease agreements are evaluated to determine if they are sales/finance leases meeting any of the following criteria at inception: (a) transfer of ownership of the underlying asset; (b) purchase option that is reasonably certain of being exercised; (c) the lease term is greater than a major part of the remaining estimated economic life of the underlying asset; or (d) if the present value of the sum of lease payments and any residual value guaranteed by the lessee that has not already been included in lease payments in accordance with ASC 842-10-30-5(f) equals or exceeds substantially all of the fair value of the underlying asset.

 

-11-

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

If at its inception, a lease meets any of the four lease criteria above, the lease is classified by the Company as a sales/finance; and if none of the four criteria are met, the lease is classified by the Company as an operating lease.

 

Operating lease payments are recognized as an expense in the income statement on a straight-line basis over the lease term, whereby an equal amount of rent expense is attributed to each period during the term of the lease, regardless of when actual payments are made. This generally results in rent expense in excess of cash payments during the early years of a lease and rent expense less than cash payments in the later years. The difference between rent expense recognized and actual rental payments is recorded as deferred rent and included in liabilities.

 

Distinguishing Liabilities from Equity

 

The Company relies on the guidance provided by ASC Topic 480, Distinguishing Liabilities from Equity, to classify certain redeemable and/or convertible instruments. The Company first determines whether a financial instrument should be classified as a liability. The Company will determine the liability classification if the financial instrument is mandatorily redeemable, or if the financial instrument, other than outstanding shares, embodies a conditional obligation that the Company must or may settle by issuing a variable number of its equity shares.

 

Once the Company determines that a financial instrument should not be classified as a liability, the Company determines whether the financial instrument should be presented between the liability section and the equity section of the balance sheet (“temporary equity”). The Company will determine temporary equity classification if the redemption of the financial instrument is outside the control of the Company (i.e. at the option of the holder). Otherwise, the Company accounts for the financial instrument as permanent equity.

 

Our Chief Executive Officer/ Chairman holds sufficient shares of the Company’s voting preferred stock that give sufficient voting rights under the articles of incorporation and bylaws of the Company such that the CEO/ Chairman can at any time unilaterally vote to increase the number of authorized shares of common stock of the Company, without the need to call a general meeting of common shareholders of the Company.

 

Initial Measurement

 

The Company records its financial instruments classified as liability, temporary equity or permanent equity at issuance at the fair value, or cash received.

 

Subsequent Measurement – Financial Instruments Classified as Liabilities

 

The Company records the fair value of its financial instruments classified as liabilities at each subsequent measurement date. The changes in fair value of its financial instruments classified as liabilities are recorded as other income (expenses).

 

Fair Value of Financial Instruments

 

ASC Topic 820, Fair Value Measurements and Disclosures (“ASC Topic 820”) provides a framework for measuring fair value in accordance with generally accepted accounting principles.

 

ASC Topic 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs).

 

The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy under ASC Topic 820 are described as follows:

 

-12-

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

	●	Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities that are accessible at the measurement date.
	●	Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data by correlation or other means.
	●	Level 3 – Inputs that are unobservable for the asset or liability.

 

Measured on a Recurring Basis

 

The following table presents information about our liabilities measured at fair value on a recurring basis, aggregated by the level in the fair value hierarchy within which those measurements fell:

 

		Amount at				Fair Value Measurement Using
		Fair Value				Level 1				Level 2				Level 3
November 30, 2024
Liabilities
Incentive compensation plan payable- revaluation of equity awards payable in Series G shares		$	2,500,000			$	—			$	—			$	2,500,000
February 29, 2024
Liabilities
Incentive compensation plan payable- revaluation of equity awards payable in Series G shares		$	2,500,000			$	—			$	—			$	2,500,000

 

The carrying amounts of the Company’s financial assets and liabilities, such as cash, accounts receivable, prepaid expenses

and advances, accounts payable and accrued expenses, approximate their fair values because of the short maturity of these instruments.

 

Earnings (Loss) per Share

 

Basic earnings (loss) per share (“EPS”) is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS give effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used to determine the number of shares assumed to be purchased from the exercise of stock options and/or warrants. Diluted EPS excluded all dilutive potential shares if their effect is anti-dilutive.

 

Basic loss per common share is computed based on the weighted average number of shares outstanding during the period. Diluted loss per share is computed in a manner similar to the basic loss per share, except the weighted-average number of shares outstanding is increased to include all common shares, including those with the potential to be issued by virtue of convertible debt and other such convertible instruments. Diluted loss per share contemplates a complete conversion to common shares of all convertible instruments only if they are dilutive in nature with regards to earnings per share.

 

-13-

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

Recently Issued Accounting Pronouncements

 

Recently Issued Accounting Standards During the Year

 

In August 2020, the FASB issued ASU 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. Under ASU 2020-06, the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives under Topic 815, or that do not result in substantial premiums accounted for as paid-in capital. Consequently, a convertible debt instrument will be accounted for as a single liability measured at its amortized cost, as long as no other features require bifurcation and recognition as derivatives. The new guidance also requires the if-converted method to be applied for all convertible instruments. The amendments in ASU 2020-06 are effective for public entities, excluding smaller reporting companies as defined, for fiscal years beginning after December 15, 2021. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023. Early adoption is permitted. A reporting entity is not permitted to adopt the guidance in an interim period, other than the first interim period of its fiscal year. The Company adopted the standard using a modified retrospective approach. The adjustment to the Company’s accumulated deficit at March 1, 2024 was $4,175,535 with a corresponding adjustment to loans payable.

 

4. REVENUE FROM CONTRACTS WITH CUSTOMERS

 

Revenue is earned primarily from two sources: 1) direct sales of goods or services and 2) short-term rentals. Direct sales of goods or services are accounted for under Topic 606, and short-term rentals are accounted for under Topic 842 (which addresses lease accounting and was adopted on March 1, 2019).

 

As disclosed in the revenue recognition section of Note 3 – Accounting Polices, the Company adopted Topic 606 in accordance with the effective date on March 1, 2018. Note 3 includes disclosures regarding the Company’s method of adoption and the impact on the Company’s financial statements. Revenue is recognized on direct sales of goods or services when it transfers promised goods or services to customers in an amount that reflects the consideration the entity expects to be entitled to in exchange for those goods or services.

 

After adopting Topic 842, also referred to above in Note 3, the Company is accounting for revenue earned from rental activities where an identified asset is transferred to the customer and the customer has the ability to control that asset. The Company recognizes revenue from its device rental activities when persuasive evidence of a contract exists, the performance obligations have been satisfied, the transaction price is fixed or determinable and collection is reasonably assured. Performance obligations associated with device rental transactions are satisfied over the rental period. Rental periods are short-term in nature. Therefore, the Company has elected to apply the practical expedient which eliminates the requirement to disclose information about remaining performance obligations. Payments are due from customers at the completion of the rental, except for customers with negotiated payment terms, generally net 30 days or less, which are invoiced and remain as accounts receivable until collected.

 

The following table presents revenues from contracts with customers disaggregated by product/service:

 

		Three Months Ended November 30, 2024				Three Months Ended November 30, 2023				Nine Months Ended November 30, 2024				Nine Months Ended November 30, 2023
Device rental activities		$	1,429,112			$	416,062			$	3,475,546			$	997,754
Direct sales of goods and services			321,856				180,918				802,405				370,797
		$	1,750,968			$	596,980			$	4,277,951			$	1,368,551

 

-14-

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

5. LEASES

 

We lease certain warehouses, and office space. Leases with an initial term of 12 months or less are not recorded on the balance sheet; we recognize lease expense for these leases on a straight-line basis over the lease term. For lease agreements entered into or reassessed after the adoption of Topic 842, we did not combine lease and non-lease components.

 

There is no lease renewal. The depreciable life of assets and leasehold improvements are limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise.

 

Below is a summary of our lease assets and liabilities at November 30, 2024 and February 29, 2024.

 

Leases		Classification		November 30, 2024				February 29, 2024
Assets
Operating		Operating Lease Assets		$	1,040,862			$	1,139,188
Liabilities
Current
Operating		Current Operating Lease Liability		$	225,348			$	237,653
Noncurrent
Operating		Noncurrent Operating Lease Liabilities			810,513				889,360
Total lease liabilities				$	1,035,861			$	1,127,013

 

Note: As most of our leases do not provide an implicit rate, we use our incremental borrowing rate of 10% which for the leases noted above was based on the information available at commencement date in determining the present value of lease payments. We compare against loans we obtain to acquire physical assets and not loans we obtain for financing. The loans we obtain for financing are generally at significantly higher rates and we believe that physical space or vehicle rental agreements are in line with physical asset financing agreements. CAM charges were not included in operating lease expense and were expensed in general and administrative expenses as incurred.

 

Rent expense and operating lease cost was $57,875 and $182,855 for the three and nine months ended November 30, 2024, respectively, and $64,081 and $189,164 for the three and nine months ended November 30, 2023, respectively.

 

6. REVENUE EARNING DEVICES

 

Revenue earning devices consisted of the following:

 

		November 30, 2024				February 29, 2024
Revenue earning devices		$	6,233,201			$	3,432,846
Less: Accumulated depreciation			(1,881,451	)			(952,844	)
		$	4,351,750			$	2,480,002

 

During the three and nine months ended November 30, 2024 the Company made total additions to revenue earning devices of $1,069,822 and $2,800,355 respectively, which were transfers from inventory. During the three and nine months ended November 30, 2023 the Company made total additions to revenue earning devices of $521,037 and $1,306,501, respectively, which were transfers from inventory.

 

Depreciation and amortization for the three and nine months ended November 30, 2024 and 2023 are as follows:

 

Depreciation and Amortization		Three Months Ended November 30, 2024				Three Months Ended November 30, 2023				Nine Months Ended November 30, 2024				Nine Months Ended November 30, 2023
Cost of Goods Sold		$	287,799			$	113,830			$	729,672			$	322,369
Operating expenses			79,662				51,540				198,935				107,456
Total Depreciation and Amortization		$	367,461			$	165,370			$	928,607			$	429,825

 

-15-

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

7. FIXED ASSETS

 

Fixed assets consisted of the following:

 

		November 30, 2024				February 29, 2024
Automobile		$	74,237			$	74,237
Demo devices			270,502				194,352
Tooling			107,020				107,020
Machinery and equipment			8,825				8,825
Computer equipment			157,448				150,387
Office equipment			15,312				15,312
Furniture and fixtures			21,225				21,225
Warehouse equipment			36,305				19,639
Leasehold improvements			26,956				26,956
			717,830				617,953
Less: Accumulated depreciation			(460,641	)			(349,878	)
		$	257,189			$	268,075

 

During the three months ended November 30, 2024, the Company made additions of $25,603, all of which were transfers from inventory. During the nine months ended November 30, 2024, the Company made additions of $99,877 of which $76,153 were transfers from inventory with remaining additions of $23,724. During the three months ended November 30, 2023, the Company made additions of $22,101, $11,661 which were transfers from inventory with remaining additions of $ 10,440. During the nine months ended November 30, 2023, the Company made additions of $129,331 of which $115,428 were transfers from inventory with remaining additions of $13,903.

 

Depreciation and Amortization		Three Months Ended November 30, 2024				Three Months Ended November 30, 2023				Nine Months Ended November 30, 2024				Nine Months Ended November 30, 2023
Fixed assets		$	26,599			$	50,393			$	110,764			$	144,921
Revenue earning devices			79,662				51,540				198,935				107,456
Total Depreciation and Amortization included in operating expenses		$	106,261			$	101,933			$	309,699			$	252,377

 

 

8. DEFERRED VARIABLE PAYMENT OBLIGATION

 

On February 1, 2019, the Company entered into an agreement with an investor whereby the investor would pay up to $900,000 in exchange for a perpetual 9% rate payment (Payments) on the Company’s reported quarterly revenue from operations excluding any gains or losses from financial instruments (Revenues). At February 29, 2020 the investor has advanced the full $900,000.

 

On May 9, 2019, the Company entered into two similar arrangements with two investors:

 

	(1)	The investor would pay up to $400,000 in exchange for a perpetual 4% rate Payment on the Company’s reported quarterly Revenues. At February 29, 2020, $400,000 has been paid to the Company.
	(2)	The investor would pay up to $50,000 in exchange for a perpetual 1.11% rate Payment on the Company’s reported quarterly Revenues. At February 29, 2020, $50,000 has been paid to the Company.

 

These variable payments (Payments) are to be made 30 days after the end of each fiscal quarter. If the Payments would deplete RAD’s available cash by more than 30%, the Payments may be deferred for up to 12 months after the quarterly report at an interest rate of 6% per annum on the unpaid amount.

 

-16-

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

In the event that at least 10% of the assets of the Company are sold by the Company, the investors would be entitled to the fair market value (FMV) of all future Payments associated with the assets sold as determined by an independent valuator to be chosen by the investors. The FMV cannot exceed 30% of the total asset disposition price defined as the total price paid for the assets plus all future Payments associated with the assets sold. In the event that the common or preferred shares are sold by the Company to a third party as to effect a change in control, then the investors must be paid the FMV of all future Payments in one lump payment. The FMV cannot exceed 30% of the share disposition price defined as the total price the third party paid for the shares plus the total value of all future Payments.

 

On November 18, 2019, the Company entered into another similar arrangement with the (February 1, 2019) investor above whereby the investor would advance up to $225,000 in exchange for a perpetual 2.25% rate Payment on the Company’s quarterly Revenues (commencing on quarter ending May 31, 2020). At February 29, 2020, the investor has advanced $109,000 and the investor advanced the $116,000 remainder as of May 2020.

 

On December 30, 2019, the Company entered into another similar arrangement with a new investor whereby the investor would advance up to $100,000 in exchange for a perpetual 1.00% rate Payment on the Company’s quarterly Revenues (commencing quarter ended November 30, 2020). At February 29, 2020, the investor has advanced $50,000 with the remainder to be advanced no later than June 30, 2020. If the total investor advances turns out to be less than $100,000, this would not constitute a breach of the agreement, rather the 1.00% rate would be adjusted on a pro-rata basis.

 

On April 22, 2020, the Company entered into another similar arrangement with the (first May 9, 2019) investor above whereby the investor would advance up to $100,000 in exchange for a perpetual 1.00% rate Payment on the Company’s quarterly Revenues. At May 31, 2020, the investor has fully funded this commitment.

 

On July 1, 2020, the Company entered into a similar agreement with the first investor whereby the investor would pay up to $800,000 in exchange for a perpetual 2.75% rate payment (Payment) on the Company’s reported quarterly revenue. These Payments are to be made 90 days after the fiscal quarter with the first payment being due no later than May 31, 2021. If the Payments would deplete RAD’s available cash by more than 20%, the payment may be deferred. The investor had agreed to pay $100,000 per month over an 8 month period with the first payment due July 2020 and the final payment no later than February 28, 2021. As at August 31, 2020 the investor had fully funded the $800,000 commitment.

 

On August 27, 2020, the Company and the first investor referred to above consolidated the three separate agreements of February 1, 2019, for $900,000, November 18, 2019 for $225,000 and July 1, 2020 for $800,000 into a new agreement for a total of $1,925,000. This new agreement is for similar terms as the above agreements save for the following: the rate payment is revised to 14.25% payable on revenues commencing the quarter ended August 31, 2020. Upon an event of default that we are unable to cure in the time allotted under the agreements, these Payments may be secured with a priority lien by UCC filing against all of our assets but is subordinated to equipment financing or leasing agreements on the products the Company leases to its customers.

 

In summary of all agreements mentioned above if in the event that at least 10% of the assets of the Company are sold by the Company, the investors would be entitled to the fair market value (FMV) of all future Payments associated with the assets sold as determined by an independent valuator to be chosen by the investors. The FMV cannot exceed 43.77% of the total asset disposition price defined as the total price paid for the assets plus all future Payments associated with the assets sold. In the event that the common or preferred shares are sold by the Company to a third party as to effect a change in control, then the investors must be paid the FMV of all future Payments in one lump payment. The FMV cannot exceed 43.77% of the share disposition price defined as the total price the third party paid for the shares plus the total value of all future Payments. As of March 1, 2021, as a result of the amendment with the first investor noted below. This aggregate asset disposition % was reduced from 43.77 % to 33.77%.

 

The Payments first become payable on June 30, 2019 (unless otherwise indicated) based on the quarterly Revenues for the quarter ended May 31, 2019, and accrue every quarter thereafter. As of November 30, 2024, the Company has accrued $1,599,971 in Payments of which $764,702 are in arrears. As of February 29, 2024, the Company has accrued approximately $904,377 in Payments, of which $542,176 is in arrears. No notices have been sent to the Company.

 

On March 1, 2021, the first investor referred to above whose aggregate investment is $1,925,000 revised his agreements as follows:

 

	1)	The rate payment was reduced from 14.25 % to 9.65 %
	2)	The asset disposition % (see below) was reduced from 31 % to 21%

 

-17-

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

In consideration for the above changes, the investor received 40 Series F Convertible Preferred Stock and a warrant to purchase 367 shares of its Series F Convertible Preferred Stock with a five-year term and an exercise price of $1.00. During the three months ended May 31, 2021, the warrant holder exercised warrants to acquire 38 shares of Series F Convertible Preferred Stock. The Company attributed a fair value based on recent transactions for the Series F Preferred stock and warrants of $33,015,214 and recorded a loss on settlement of debt with a corresponding adjustment to paid in capital.

 

The Company retains total involvement in the generation of cash flows from these revenue streams that form the basis of the payments to be made to the investors under this agreement. Because of this, the Company has determined that the agreements constitute debt agreements. As of November 30, 2024, and February 29, 2024, the long-term balances other than Payments already owed is the cash received of $2,525,000 and $2,525,000, respectively.

 

For both the three months and nine months ended November 30, 2024 and year ended February 29, 2024, the Company has received $0 related to the deferred payment obligation since there were no new agreements during this period. The balance remains $2,525,000 at both November 30, 2024 and February 29, 2024.

 

9. RELATED PARTY TRANSACTIONS

 

For both the three months ended November 30, 2024 and November 30, 2023, the Company had no repayments of net advances from its loan payable-related party. At November 30, 2024, the loan payable-related party was $297,414 and $257,438 at February 29, 2024. Included in the balance due to the related party at November 30, 2024 is $222,754 of deferred salary and interest, $183,625 of which bears interest at 12%. As of February 29, 2024, included in the balance due to the related party is $140,013 of deferred salary all of which bears interest at 12%. The accrued interest included in loan at November 30, 2024 and February 29, 2024 was $28,267 and $32,468 respectively.

 

Pursuant to the amended Employment Agreement with its Chief Executive Officer, for the three months and six ended November 30, 2024, the Company accrued $0 (2023-$62,000) and $0 (2023-$187,000) of incentive compensation plan payable with a corresponding recognition of stock based compensation due to the expectation of additional awards being met. This will be payable in Series G Preferred Shares which are redeemable at the Company’s option at $1,000 per share. At November 31, 2024 and February 29, 2024 there was $2,500,000 and $2,500,000 of incentive compensation payable.

 

At November 30, 2024 deferred compensation for CEO was $598,635. For the nine months ended November 30, 2024, the net change was an increase of $59,868 comprising of net cash repayments and adjustments of $195,000offset by accruals of $700,082. At February 29, 2024 deferred compensation for CEO was $538,767.

 

During the three months ended November 30, 2024, and 2023, the Company was charged $556,175 and $526,723, respectively for fees for research and development from a company partially owned by a principal shareholder.

 

During the nine months ended November 30, 2024, and 2023, the Company was charged $1,846,005 and $2,185,998, respectively for fees for research and development from a company partially owned by a principal shareholder.

 

10. OTHER DEBT – VEHICLE LOAN

 

In December 2016, RAD entered into a vehicle loan for $47,704 secured by the vehicle. The loan is repayable over 5 years maturing November 9, 2021, and repayable $1,019 per month including interest and principal. In November 2017, RAD entered into another vehicle loan secured by the vehicle for $47,661. The loan is repayable over 5 years, maturing October 24, 2022 and repayable at $923 per month including interest and principal. The principal repayments made were $0 for both the year ended February 28, 2022 and February 28, 2021. Regarding the second vehicle loan, the vehicle was returned at the end of fiscal 2019 and the car was subsequently sold by the lender for proceeds of $21,907 which went to reduce the outstanding balance of the loan. A loss of $3,257 was recorded as well. A balance of $21,578 remains on this vehicle loan at both February 28, 2021 and February 29, 2020. For the first vehicle loan, the vehicle was retired in 2020, the proceeds of the disposal of $18,766 was applied against the balance of the loan with a $5,515 gain on the remaining asset value of $13,251. A balance of $16,944 remains on this vehicle loan at both February 28, 2022 and February 28, 2021. The remaining total balances of the amounts owed on the vehicle loans were $38,522 and $38,522 as of November 30, 2024 and February 29, 2024, respectively, of which all were classified as current.

 

-18-

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

11. LOANS PAYABLE

 

Loans payable at November 30, 2024 consisted of the following:

  

												Annual
Date		Maturity		Description				Principal				Interest Rate
July 18, 2016		July 18, 2017		Promissory note		(1)*		$	3,500				22	%
December 10, 2020		March 1, 2025		Promissory note		(2)			3,921,168				12	%
December 10, 2020		March 1, 2025		Promissory note		(3)			2,754,338				12	%
December 10, 2020		December 10, 2024		Promissory note		(4)			165,605				12	%
December 14, 2020		March 1, 2027		Promissory note		(5)			310,375				12	%
December 30, 2020		March 1, 2025		Promissory note		(6)			350,000				12	%
January 1, 2021		March 1, 2025		Promissory note		(7)			25,000				12	%
January 1, 2021		March 1, 2025		Promissory note		(8)			145,000				12	%
January 14, 2021		March 1, 2025		Promissory note		(9)			550,000				12	%
February 22, 2021		March 1, 2025		Promissory note		(10)			1,650,000				12	%
March 1, 2021		March 1, 2025		Promissory note		(11)			6,000,000				12	%
June 8, 2021		June 8, 2025		Promissory note		(12)			2,750,000				12	%
July 12, 2021		July 26, 2026		Promissory note		(13)			3,740,360				7	%
September 14, 2021		September 14, 2025		Promissory note		(14)			1,650,000				12	%
July 28, 2022		March 1, 2025		Promissory note		(15)			170,000				15	%
August 30, 2022		August 30,2025		Promissory note		(16)			3,000,000				15	%
September 7, 2022		March 1, 2025		Promissory note		(17)			400,000				15	%
September 8, 2022		March 1, 2025		Promissory note		(18)			475,000				15	%
October 13, 2022		March 1, 2025		Promissory note		(19)			350,000				15	%
October 28, 2022		October 31, 2026		Promissory note		(20)			400,000				15	%
November 9, 2022		October 31, 2026		Promissory note		(20)			400,000				15	%
November 10, 2022		October 31, 2026		Promissory note		(20)			400,000				15	%
November 15, 2022		October 31, 2026		Promissory note		(20)			400,000				15	%
January 11, 2023		October 31, 2026		Promissory note		(20)			400,000				15	%
February 6, 2023		October 31, 2026		Promissory note		(20)			400,000				15	%
April 5. 2023		October 31, 2026		Promissory note		(20)			400,000				15	%
April 20, 23		October 31, 2026		Promissory note		(20)			400,000				15	%
May 11, 2023		October 31, 2026		Promissory note		(20)			400,000				15	%
October 27, 2023		October 31, 2026		Promissory note		(20)			400,000				15	%
November 30, 2023		April 30, 2025		Purchase Agreement		(21)			203,000				35	%
March 8, 2024		August 8, 2025		Purchase Agreement		(22)			350,000				35	%
August 8, 2024		August 8, 2025		Exchange Agreement		(23)			200,000				12	%
								$	33,163,346
Less: current portion of loans payable									(25,112,611	)
Less: discount on non-current loans payable									(374,081	)
Non-current loans payable, net of discount								$	7,676,654
Current portion of loans payable								$	25,112,611
Less: discount on current portion of loans payable									(58,620	)
Current portion of loans payable, net of discount								$	25,053,991

 

*	In default

 

-19-

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

(1)	This note was transferred from convertible notes payable because in August 2022 it was no longer convertible due to restrictions placed on the lender.
(2)	This promissory note was issued as part of a debt settlement whereby $2,683,357 in convertible notes and associated accrued interest of $1,237,811 totaling $3,921,168 was exchanged for this promissory note of $3,921,168, and a warrant to purchase 450,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a relative fair value of $990,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from December 10, 2023 to March 1, 2025 with all other terms and conditions remaining the same.
(3)	This promissory note was issued as part of a debt settlement whereby $1,460,794 in convertible notes and associated accrued interest of $1,593,544 totaling $3,054,338 was exchanged for this promissory note of $3,054,338, and a warrant to purchase 250,000,000 shares at an exercise price of $0.002 per share and a three-year maturity having a relative fair value of $550,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. $300,000 has been repaid during the year ended February 29, 2024. On November 28, 2023, the parties extended the maturity date from December 10, 2023 to March 1, 2025 with all other terms and conditions remaining the same.
(4)	This promissory note was issued as part of a debt settlement whereby $103,180 in convertible notes and associated accrued interest of $62,425 totaling $165,605 was exchanged for this promissory note of $165,605, and a warrant to purchase 80,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a fair value of $176,000.The maturity date was extended from December 10, 2023 to December 10, 2024 on February 29, 2024 and a fee of $22,958 was paid and charged to interest expense.
(5)	This promissory note was issued as part of a debt settlement whereby $235,000 in convertible notes and associated accrued interest of $75,375 totaling $310,375 was exchanged for this promissory note of $310,375, and a warrant to purchase 25,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a fair value of $182,500.
(6)	The note, with an original principal amount of $350,000, may be pre-payable at any time. The note balance includes an original issue discount of $35,000 and was issued with a warrant to purchase 50,000,000 shares at an exercise price of $0.025 per share with a 3-year term and having a relative fair value of $271,250. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $271,250 with a corresponding adjustment to paid in capital for the relative fair value of the warrant. On March 1, 2024, the unamortized relative fair value discount of $65,092 was removed with a corresponding adjustment to accumulated deficit. A $8,399 unamortized discount remained. On November 28, 2023, the parties extended the maturity date from December 10, 2023 to March 1, 2025 with all other terms and conditions remaining the same. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $2,115 and $6,069, respectively, with an unamortized discount of $2,330 at November 30, 2024.
(7)	This promissory note was issued as part of a debt settlement whereby $9,200 in convertible notes and associated accrued interest of $6,944 totaling $16,144 was exchanged for this promissory note of $25,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from January 1, 2024 to March 1, 2025 with all other terms and conditions remaining the same.
(8)	This promissory note was issued as part of a debt settlement whereby $79,500 in convertible notes and associated accrued interest of $28,925 totaling $108,425 was exchanged for this promissory note of $145,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from January 1, 2024 to March 1, 2025 with all other terms and conditions remaining the same.
(9)	The note, with an original principal amount of $550,000, may be pre-payable at any time. The note balance includes an original issue discount of $250,000 and was issued with a warrant to purchase 50,000,000 shares at an exercise price of $0.025 per share with a 3-year term and having a relative fair value of $380,174. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $380,174 with a corresponding adjustment to paid in capital. On March 1, 2024, the unamortized relative fair value discount of $80,284 was removed with a corresponding adjustment to accumulated deficit. A $10,559 unamortized discount remained. On November 28, 2023, the parties extended the maturity date from January 14, 2024 to March 1, 2025 with all other terms and Conditions remaining the same. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $2,649 and $7,702, respectively, with an unamortized discount of $2,857 at November 30, 2024

 

-20-

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

(10)	The note, with an original principal balance of $1,650,000, may be pre-payable at any time. The note balance includes an original issue discount of $150,000 and was issued with a warrant to purchase 100,000,000 shares at an exercise price of $0.135 per share with a 3-year term and having a relative fair value of $1,342,857. The discount and warrant are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $1,342,857 with a corresponding adjustment to paid in capital for the relative fair value of the warrant. The maturity date was extended from February 22, 2022 to February 22, 2024 on February 28, 2022 in exchange for warrants to purchase 50,000,000 at an exercise price of $.0164 and a 3-year term. These warrants have a fair value of $950,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. On November 28, 2023, the parties extended the maturity date from February 22, 2024 to March 1, 2025 with all other terms and conditions remaining the same. On March 1, 2024, the unamortized relative fair value discount of $497,614 was removed with a corresponding adjustment to accumulated deficit. A $55,585 unamortized discount remained. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $14,046 and $40,289 respectively, with an unamortized discount of $15,296 at November 30, 2024.
(11)	The unsecured note may be pre-payable at any time. Cash proceeds of $5,400,000 were received. The note balance of $6,000,000 includes an original issue discount of $600,000 and was issued with a warrant to purchase 300,000,000 shares at an exercise price of $0.135 per share with a 3-year term and having a relative fair value of $4,749,005 using Black-Scholes with assumptions described in note 13. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $4,749,005 with a corresponding adjustment to paid in capital for the relative value of the warrant. The maturity was extended from March 1, 2022 to March 1, 2024 on February 28, 2022 in exchange for warrants to purchase 150,000,000 shares of common stock at an exercise price of $.0164 and a 3 year term. These warrants have a fair value of $2,850,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. This note has been fully amortized. This note was again extended to March 1, 2025.
(12)	The note, with an original principal balance of $2,750,000, may be pre-payable at any time. The note balance includes an original issue discount of $50,000 and was issued with a warrant to purchase 170,000,000 shares at an exercise price of $0.064 per share with a 3-year term and having a relative fair value of $2,035,033. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $2,035,033 with a corresponding adjustment to paid in capital. The maturity date was extended from June 8, 2022 to June 8, 2024 on February 28, 2022 in exchange for warrants to purchase 85,000,000 at an exercise price of $.0164 and a 3 year term. These warrants have a fair value of $1,615,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. This note was extended to June 8, 2025. On March 1, 2024, the unamortized relative fair value discount of $33,547 was removed with a corresponding adjustment to accumulated deficit. A $4,121 unamortized discount remained. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $895 and $2,234, respectively, with an unamortized discount of $1,887 at November 30, 2024.
(13)	This loan, with an original principal balance of $4,000,160, was in exchange for 184 Series F preferred shares from a former director. The interest and principal are payable at maturity. The loan is unsecured. For the three and nine months ended November 30, 2024 there were repayments of $9,000 and $36,000 , respectively on the note.
(14)	The note, with an original principal balance of $1,650,000, may be pre-payable at any time. The note balance includes an original issue discount of $150,000 and was issued with a warrant to purchase 250,000,000 shares at an exercise price of $0.037 per share with a 3-year term and having a relative fair value of $1,284,783, The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $1,284,783 with a corresponding adjustment to paid in capital. On March 1, 2024, the unamortized relative fair value discount of $572,549 was removed with a corresponding adjustment to accumulated deficit. A $66,846 unamortized discount remained. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $10,668 and $30,659 respectively, with an unamortized discount of 36,250 at November 30, 2024. This note was extended to September 14, 2025.
(15)	Original $170,000 note may be pre-payable at any time. The note balance includes an original issue discount of $20,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from July 28, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized..

 

-21-

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

(16)	A warrant holder exchanged 955,000,000 warrants for a promissory note of $3,000,000, bearing interest at 15% with a two year maturity. The fair value of the warrants was determined to be $2,960,500 with a corresponding adjustment to paid-in capital and a debt discount of $39,500 which will be amortized over the term of the loan. Principal and interest due at maturity. On March 1, 2024, the unamortized relative fair value discount of $11,535 was removed with a corresponding adjustment to accumulated deficit. This note has been fully amortized. This note was extended to August 30, 2025.
(17)	Original $400,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from September 7, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized.
(18)	Original $475,000 note may be pre-payable at any time. The note balance includes an original issue discount of $75,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from September 8, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized.
(19)	Original $350,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of the Company’s s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from October 13, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized.

 

(20)	On October 28, 2022 the Company entered into an loan facility with a lender for up to $4,000,000 including an original issue discount of $500,000. In exchange the Company will issue one series F Preferred Share, extended 329 series F warrants with a March 1, 2026 maturity to a new October 31, 2033 maturity, and issue up to 10 tranches with each tranche of $400,000, with cash proceeds of $350,000 an original issue discount of $50,000, October 31, 2026 maturity, and 61 Series F warrants with a October 31, 2033 maturity. Secured by a general security charging all of the Company’s present and after-acquired property. At February 29, 2024 the Company has issued all 10 tranches totaling $ 4,000,000 as follows:
	October 28, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants and 1 Series F Preferred Share having a relative fair value of $299,399. On March 1, 2024, the unamortized relative fair value discount of $286,775 was removed with a corresponding adjustment to accumulated deficit. A $47,892 unamortized discount remained. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $3,857 and $10,922, respectively, with an unamortized discount of $36,970 at November 30, 2024.

 

-22-

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

(20)

November 9, 2022, $400,000 loan, original issue discount of $50,000 , 61 Series F Preferred Share warrants having a relative fair value of $299,750. On March 1, 2024, the unamortized relative fair value discount of $288,513 was removed with a corresponding adjustment to accumulated deficit. A $48,126 unamortized discount remained. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $3,875 and $10,972, respectively, with an unamortized discount of $37,154 at November 30, 2024.

 

November 10, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $302,020. On March 1, 2024, the unamortized relative fair value discount of $291,694 was removed with a corresponding adjustment to accumulated deficit. A $48,290 unamortized discount remained. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $3,887 and $11,006, respectively, with an unamortized discount of $37,284 at November 30, 2024.

 

November 15, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. On March 1, 2024, the unamortized relative fair value discount of $287,814 was removed with a corresponding adjustment to accumulated deficit. A $47,976 unamortized discount remained. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $3,863 and $10,939, respectively, with an unamortized discount of $37,037 at November 30, 2024.

 

January 11, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. On March 1, 2024, the unamortized relative fair value discount of $286,813 was removed with a corresponding adjustment to accumulated deficit. A $48,124 unamortized discount remained. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $3,874 and $10,970, respectively, with an unamortized discount of $37,154 at November 30, 2024.

 

February 6, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. On March 1, 2024, the unamortized relative fair value discount of $288,342 was removed with a corresponding adjustment to accumulated deficit. A $48,294 unamortized discount remained. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $3,887 and $11,007, respectively, with an unamortized discount of $37,287 at November 30, 2024.

 

April 5, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $296,245. On March 1, 2024, the unamortized relative fair value discount of $286,821 was removed with a corresponding adjustment to accumulated deficit. A $48,409 unamortized discount remained. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $3,896 and $11,031, respectively, with an unamortized discount of $37,378 at November 30, 2024.

 

April 20, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $302,219. On March 1, 2024, the unamortized relative fair value discount of $294,824 was removed with a corresponding adjustment to accumulated deficit. A $48,777 unamortized discount remained. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $3,924 and $11,110, respectively, with an unamortized discount of $37,667 at November 30, 2024.

 

May 11, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $348,983. On March 1, 2024, the unamortized relative fair value discount of $348,831 was removed with a corresponding adjustment to accumulated deficit. A $49,978 unamortized discount remained. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $4,015 and $11,365, respectively, with an unamortized discount of $38,613 at November 30, 2024.

 

October 27 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $261,759. On March 1, 2024, the unamortized relative fair value discount of $254,487 was removed with a corresponding adjustment to accumulated deficit. A $48,611 unamortized discount remained. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $3,912 and $11,075, respectively, with an unamortized discount of $37,536 at November 30, 2024.

 

-23-

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

(21)	On November 30, 2023, the Company entered into an agreement where the lender will pay the Company $350,000 in exchange for thirteen future monthly payments of $36,750 commencing on April 30,2024 through to April 30, 2025 totaling $477,750. The effective interest rate is 35% per annum. Secured by a general security charging all of RAD’s present and after-acquired property. Default rate of 15% per annum calculated daily on any missed monthly payment. The Company has repaid $147,000 and $53,000 in accrued interest in July to account for the missed the April and August 2024 payments not made in agreement with the lender. No notices have been sent.
(22)	On March 8, 2024, the Company entered into another agreement where the lender will pay the Company $350,000 in exchange for thirteen future monthly payments of $36,750 commencing on August 8, 2024 through to August 80, 2025 totaling $477,750. The effective interest rate is 35% per annum. Secured by a general security charging all of RAD’s present and after- acquired property. Default rate of 15% per annum calculated daily on any missed monthly payment. The August 2024 payment has not been made but will be resolved with the lender. No notices have been sent.
(23)	On August 8, 2024, a Series F preferred shareholder exchanged 20 Series F the preferred shares for a $400,000 note payable. On August 22, 2022 the lender exchanged $200,000 of note principal for 57,142,857 common shares. The common shares were issued in September 2024. The note balance at November 30, 2024 is $200,000.

 

12. STOCKHOLDERS’ EQUITY (DEFICIT)

 

Summary or Preferred Stock Activity

 

During the nine months ended November 30, 2024, a Series F preferred shareholder exchanged 20 Series F preferred shares for a $400,000 note payable. (see Note 12). The Company recorded an adjustment to the par value of the shares of $20, paid -in capital for the carrying value of the shares of $65,793 with the remaining amount of $334,187 a deemed dividend.

 

Summary of Preferred Stock Warrant Activity

 

		Number of Series F Preferred Warrants				Weighted Average Exercise Price				Weighted Average Remaining Years
Outstanding at March 1, 2023			939			$	1.00				9.50
Issued			—				—				—
Exercised			—				—				—
Forfeited and cancelled			—				—				—
Outstanding at November 30, 2024			939			$	1.00				9.20

 

Series B Convertible, Redeemable Preferred Stock (Temporary Equity)

 

On April 27, 2024, in connection with a Share Purchase Agreement the Company created a new class Of Series B Convertible Redeemable Preferred Shares with 5,000 authorized shares. The Company received gross proceeds of $300,000 with net proceeds of $278,000 less $10,000 in legal fees and 12,000 in broker fees both charged against paid in capital. In addition, as a commitment fee the Company issued an additional 20 Series B Convertible Redeemable Preferred Shares, with a fair value of $24,000 charged to paid in capital. The shares have a redemption value of $1,200 per share. The Company must redeem one third of these shares in 30, days and each 30 days thereafter until all the shares are redeemed at 90 days. The Company must also pay an 8% dividend from issue date to redemption date. On May 30, June 28 and July 28, 2024 the Company then issued total dividends of 4.32 shares of Series B Convertible Redeemable Preferred Shares having a value of $5,188 and fully redeemed the outstanding 324 Series B shares for $389,189 including deemed dividends of $89,189 which represents the redemption value over the purchase cost of the shares.

 

At November 30, 2024 there are 0 Series B Convertible Redeemable Preferred Shares outstanding.

 

-24-

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

Series F Convertible Preferred Shares

 

During the nine months ended November 30, 2024, a Series F preferred shareholder exchanged 20 Series F preferred shares for a $400,000 note payable. (see Note 12). The Company record an adjustment to the par value of the shares of $20, paid -in capital for the carrying value of the shares of $65,793 with the remaining amount of $334,187 a deemed dividend.

 

Summary of Common Stock Activity

 

The Company increased authorized common shares from 12,500,000,000 to 15,000,000,000 on October 4, 2024.

 

For the three months ended November 30, 2024, the Company issued 875,000,000 common shares with gross proceeds of $2,468,477 and net proceeds of $2,073,393 after issuance costs of $93,885.

 

For the nine months ended November 30, 2024, the Company issued 3,285,777,227 common shares with gross proceeds of 9,652,914 and net proceeds of $9,247,248 after issuance costs of $406,566. Included in the net proceeds are $352,701 in share proceeds receivable received after quarter end. In addition, for the nine months ended November 30, 2024, the Company issued 57,142,857 issuable shares as payment for $200,000 of principle on a note payable. (see Note 12)

 

Summary of Common Stock Warrant Activity

 

For the three months and nine months ended November 30, 2024 and November 30, 2023, the Company recorded a total of $83,323 and $47,462, and $249,969 and $150,896 respectively, to stock-based compensation for options and warrants with a corresponding adjustment to additional paid-in capital.

 

		Number of Warrants				Weighted Average Exercise Price				Weighted Average Remaining Years
Outstanding at March 1, 2024			300,595,661			$	0.003				1.00
Issued			—				—				—
Exercised			—				—				—
Forfeited and cancelled			(253,324,212	)			0.003				—
Outstanding at November 30, 2024			47,271,449			$	0.003				2.68

 

Summary of Common Stock Option Activity -Employee Stock Options

 

		Number of Options				Weighted Average Exercise Price				Weighted Average Remaining Years
Outstanding at March 1, 2024			188,667,035			$	0.02				4.10
Issued			—				—				—
Exercised			—				—				—
Forfeited, extinguished and cancelled			(3,011,029	)		$	0.02				(4.60	)
Outstanding at November 30, 2024			185,656,006			$	0.02				3.75

 

-25-

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED) 

 

13. COMMITMENTS AND CONTINGENCIES

 

Litigation

 

Occasionally, the Company may be involved in claims and legal proceedings arising from the ordinary course of its business. The Company records a provision for a liability when it believes that is both probable that a liability has been incurred, and the amount can be reasonably estimated. If these estimates and assumptions change or prove to be incorrect, it could have a material impact on the Company’s condensed consolidated financial statements. Contingencies are inherently unpredictable, and the assessments of the value can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions.

 

The related legal costs are expensed as incurred.

 

On September 24, 2024 a prospective lender filed a claim against the Company for an alleged breach of a non-binding term sheet made on June 7, 2024. This claim is an example of predatory lending practices for which the Company has filed a notice of dismissal in the relevant jurisdiction. The Company and its counsel believe the claim is without merit and will contest it vigorously. Accordingly, the Company has made no accruals.

 

Operating Lease

 

On March 10, 2021, the Company entered into a 10 year lease agreement for q manufacturing facility at 10800 Galaxie Avenue, Ferndale, Michigan, 48220, commencing on May 1, 2021 through to April 30, 2031 with a minimum base rent of $15,880 per month. The base rent increase by 3% per annum commencing May 1, 2024. The Company paid a security deposit of $15,880.

 

On September 30, 2021, the Company entered into a 3-year lease agreement for a vehicle commencing September 30, 2021 through to April 30, 2031 with a minimum base rent of $1,538 per month. The Company paid a down payment of $18,462.

 

On January 28, 2022, the Company entered into a 2-year lease agreement for office space at 1516 E Edinger, Santa Ana, California, 92705, commencing on February 1, 2022 through to January 31, 2024 with a minimum base rent of $1,500 per month. The Company paid a security deposit of $1,500.

 

On February 5, 2024, the Company entered into a 3-year lease agreement for a vehicle commencing February 5, 2024 through to February 5, 2027 with a minimum base rent of $1,223 per month. The Company paid a down payment of $9,357.

 

The Company’s leases are accounted for as operating leases. Rent expense and operating lease cost are recorded over the lease terms on a straight-line basis. Rent expense and operating lease cost was $57,875 and $182,855 for the three and nine months ended November 30, 2024, respectively, and $64,081 and $189,164 for the three and nine months ended November 30, 2023 respectively.

 

Summary of rent expense and operating lease cost are recorded over the lease terms on a straight-line basis.

 

Maturity of Lease Liabilities		Operating Leases
November 30, 2025		$	225,348
November 30, 2026			225,348
November 30, 2027			210,523
November 30, 2028			207,558
November 30, 2029			207,558
November 30, 2030 and after			294,041
Total lease payments			1,370,376
Less: Interest			(334,514	)
Present value of lease liabilities		$	1,035,861

 

-26-

Table of Contents

 

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

14. EARNINGS (LOSS) PER SHARE

 

The net income (loss) per common share amounts were determined as follows:

 

		For the Three Months Ended								For the Nine Months Ended
		November 30,								November 30,
		2024				2023				2024				2023
Numerator:
Net income (loss) available to common shareholders		$	(3,703,974	)		$	(3,966,484	)		$	(11,828,656	)		$	(13,281,405	)
Effect of common stock equivalents
Deduct : Dividend on Series B shares			—				—				(89,189	)			—
Deduct: Deemed dividend on redemption of Series F shares			—				—				(334,187	)			—
Net income (loss) adjusted for common stock equivalents			(3,703,974	)			(3,966,484	)			(12,252,032	)			(13,281,405	)
Denominator:
Weighted average shares – basic			12,161,286,427				7,294,775,879				11,071,139,695				6,606,988,956
Net income (loss) per share – basic		$	(0.00	)		$	(0.00	)		$	(0.00	)		$	(0.00	)
Dilutive effect of common stock equivalents:
Convertible Debt			—				—				—				—
Preferred shares			—				—				—				—
Warrants			—				—				—				—
			—				—				—				—
Denominator:
Weighted average shares – diluted			12,161,286,427				7,294,775,879				11,071,139,695				6,606,988,956
Net income (loss) per share – diluted		$	(0.00	)		$	(0.00	)		$	(0.00	)		$	(0.00	)

 

The anti-dilutive shares of common stock equivalents for the three and nine months ended November 30, 2024 and 2023 were as follows:

 

		For the Three Months Ended								For the Nine Months Ended
		November 30,								November 30,
		2024				2023				2024				2023
Convertible Series F Preferred Shares*			43,406,765,095				26,617,244,133				43,406,765,095				26,617,244,133
Stock options and warrants			232,927,455				428,667,451				232,927,455				428,667,451
Total			43,639,692,550				27,045,911,584				43,639,692,550				27,045,911,584

 

15. SUBSEQUENT EVENTS

 

Subsequent to November 30, 2024 through to January 14, 2025:

 

— The Company issued 650,000,000 common shares pursuant to a share purchase agreement : 450,000,000 common shares for gross proceeds of $1,026,407, issuance costs of $44,131 and net proceeds of $982,236. The remaining 200,000,000 common shares were issued for estimated gross proceeds of $620,000 as the pricing on these common shares have not yet been determined at time of filing.

 

— The Company repaid the remaining $200,000 on a loan payable through the issuance of 76,923,076 common shares on December 16, 2024.

 

-27-

Table of Contents

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Forward-Looking Statements

 

The following discussion of our financial condition and results of operations for the three and nine months ended November 30, 2024 and November 30, 2023 should be read in conjunction with our unaudited consolidated financial statements and the notes to those statements that are included elsewhere in this report. Our discussion includes forward-looking statements based upon current expectations that involve risks and uncertainties, such as our plans, objectives, expectations and intentions. Actual results and the timing of events could differ materially from those anticipated in these forward-looking statements as a result of a number of factors, including those set forth under Item 1A. Risk Factors appearing in our Annual Report on Form 10-K for the year ended February 29, 2024, as filed on May 29, 2024 with the SEC. We use words such as “anticipate,” “estimate,” “plan,” “project,” “continuing,” “ongoing,” “expect,” “believe,” “intend,” “may,” “will,” “should,” “could,” and similar expressions to identify forward-looking statements.

 

Unless expressly indicated or the context requires otherwise, the terms “AITX”, the “Company”, “we”, “us”, and “our” refer to Artificial Intelligence Technology Solutions Inc.

 

Overview

 

AITX was incorporated in Florida on March 25, 2010. AITX reincorporated into Nevada on February 17, 2015. AITX’s fiscal year end is February 28 (February 29 during leap year). AITX is located at 10800 Galaxie Ave., Ferndale Michigan, 48220, and our telephone number is 877-767-6268.

 

AITX’s mission is to apply Artificial Intelligence (AI) technology to solve enterprise problems categorized as expensive, repetitive, difficult to staff, and outside of the core competencies of the client organization.

 

A short list of basic examples include:

 

	1.	Typical security guard-related functions such as monitoring a parking lot during and after hours and responding appropriately. This scenario applies to perimeters, interior yard areas, and related similar environments.
	2.	Integrated hardware/software with AI-driven responses, simulating and expanding on what legacy or manned solutions could perform.
	3.	Automation of common access control functions through technology utilizing facial recognition and machine vision, leapfrogging most legacy solutions in use today.

 

RAD solutions are unique because they:

 

	1.	Start with an AI-driven autonomous response utilizing cellular-optimized communications, while easily connecting to a human operator for a manned response, as needed.
	2.	Use unique hardware purpose-built by RAD for delivery of these solutions. Various form factors have been customized to deliver this new functionality.
	3.	Deliver services through RAD-developed software and cloud services, allowing enterprise IT groups to focus on core competencies instead of maintenance of complex video and security platforms.

 

We encourage everyone to ensure they have the most up to date news by visiting AITX at AITX News - AITX - Artificial Intelligence Technology Solutions.

 

-28-

Table of Contents

 

Management Discussion and Analysis

 

Results of Operations for the Three Months Ended November 30, 2024, and 2023

 

The following table shows our results of operations for the three months ended November 30, 2024, and 2023. The historical results presented below are not necessarily indicative of the results that may be expected for any future period.

 

		Period								Change
		Three Months Ended November 30, 2024				Three Months Ended November 30, 2023				Dollars				Percentage
Revenues		$	1,750,968			$	596,980			$	1,153,988				193	%
Gross profit			1,173,830				347,236				826,594				238	%
Operating expenses			3,476,728				2,732,187				744,541				27	%
Loss from operations			(2,302,898	)			(2,384,951	)			82,053				(3	)%
Other income (expense), net			(1,401,076	)			(1,581,533	)			180,457				(11	)%
Net loss		$	(3,703,974	)		$	(3,966,484	)		$	262,510				(7	)%

 

Revenue

 

The following table presents revenues from contracts with customers disaggregated by product/service:

 

		Three Months Ended				Three Months Ended				Change
		November 30, 2024				November 30, 2023				Dollars				Percentage
Device rental activities		$	1,429,112			$	416,062			$	1,013,050				243	%
Direct sales of goods and services			321,856				180,918				140,938				78	%
		$	1,750,968			$	596,980			$	1,153,988				193	%

 

Total revenue for the three-month period ended November 30, 2024, was $1,750,968 which represented an increase of $1,153,988 compared to total revenue of $596,980 for the three months ended November 30, 2023. There has been a large increase in revenues as a result of higher rental activities growing each quarter through the deployment of new revenue earning devices.

 

Gross profit

 

Total gross profit for the three-month period ended November 30, 2024, was $1,173,830, which represented an increase of $826,594 compared to gross profit of 347,236 for the three months ended November 30, 2023. The gross profit increased due to the higher sales and higher proportion of rental activities at higher margins than direct sales. The gross profit % of 67% for the three-month period ended November 30, 2023, was higher than the gross profit % of 58% for the prior year’s corresponding period.

 

Operating Expenses

 

		Period								Change
		Three Months Ended November 30, 2024				Three Months Ended November 30, 2023				Dollars				Percentage
Research and development		$	579,045			$	557,126			$	21,919				4	%
General and administrative			2,733,547				2,009,047				724,500				36	%
Depreciation and amortization			106,261				101,933				4,328				4	%
Operating lease cost and rent			57,875				64,081				(6,206	)			(10	)%
			3,476,728				2,732,187				744,541				27	%

 

-29-

Table of Contents

 

Our operating expenses were comprised of general and administrative expenses, research and development, and depreciation. General and administrative expenses consisted primarily of professional services, automobile expenses, advertising, salaries and wages, travel expenses and consultants. Our operating expenses during the three-month period ended November 30, 2024, and November 30, 2023, were $3,476,728 and $2,732,187, respectively. The overall increase of $744,541 was primarily attributable to the following changes in operating expenses of:

 

●	General and administrative expenses increased by $724,500. In comparing the three months ended November 30, 2024, and November 30, 2023, this increase was primarily due to the following increases: wages and salaries $421,996, commissions by $65,064, repairs and maintenance by $158,813 and RMC costs by $108,919. These were partially offset by decreases in other G& A accounts.
●	Research and development increased by $21,919 as the Company continues to develop new hardware and software solutions..
●	Depreciation and amortization increased by $4,328 due to small increases in demo devices, and warehouse equipment.
●	Operating lease cost and rent decreased by $6,206 due to one less lease in the current period.

 

Other Income (Expense)

 

Other income (expense) during the three months ended November 30, 2024, and November 30, 2023, was ($1,401,076) and ($1,581,533), respectively. The $180,457 decrease in other expense was primarily attributable to the application of ASU-2020 06 in the current year which resulted in lower amortization expense.

 

Net loss

 

We had a net loss of $3,703,974 for the three months ended November 30, 2024, compared to a net loss of $3,966,484 for the three months ended November 30, 2023. The decrease in net loss of $262,510 is due to a number of factors: higher gross profit offset and lower other expenses offset by higher general and administrative in the three months ended November 30, 2024.

 

Results of Operations for the Nine Months Ended November 30, 2024, and 2023

 

The following table shows our results of operations for the nine months ended November 30, 2024, and 2023. The historical results presented below are not necessarily indicative of the results that may be expected for any future period.

 

Revenue

 

		Period								Change
		Nine Months Ended November 30, 2024				Nine Months Ended November 30, 2023				Dollars				Percentage
Revenues		$	4,277,951			$	1,368,551			$	2,909,400				213	%
Gross profit			2,860,255				729,743				2,130,512				292	%
Operating expenses			10,610,283				9,108,923				1,501,360				16	%
Loss from operations			(7,750,028	)			(8,379,180	)			629,152				(8	)%
Other income (expense), net			(4,078,628	)			(4,902,225	)			823,597				(17	)%
Net loss		$	(11,828,656	)		$	(13,281,405	)		$	1,452,749				(11	)%

 

The following table presents revenues from contracts with customers disaggregated by product/service:

 

		Nine Months Ended				Nine Months Ended				Change
		November 30, 2024				November 30, 2023				Dollars				Percentage
Device rental activities		$	3,475,546			$	997,754			$	2,477,792				248	%
Direct sales of goods and services			802,405				370,797				431,608				116	%
		$	4,277,951			$	1,368,551			$	2,909,400				213	%

 

-30-

Table of Contents

 

Total revenue for the nine-month period ended November 30, 2024, was $4,277,951 which represented an increase of $2,909,400 compared to total revenue of $1,368,551 for the nine months ended November 30, 2023. This 213% increase was because of higher rental activities due to 272 new deployments year to date November 30, 2023.

 

Gross profit

 

Total gross profit for the nine-month period ended November 30, 2024, was 2,860,255 which represented an increase of $2,130,512, compared to gross profit of $729,743 for the nine months ended November 30, 2023. The gross profit increased due to the 213% higher sales and higher proportion of rental activities at higher margins than direct sales. The gross profit percentage of 67% for the nine-month period ended November 30, 2024, was higher than the gross profit percentage of 53% for the prior year’s corresponding period.

 

Operating Expenses

 

		Period								Change
		Nine Months Ended November 30, 2024				Nine Months Ended November 30, 2023				Dollars				Percentage
Research and development		$	1,897,165			$	2,243,431			$	(346,266	)			(15	)%
General and administrative			8,220,564				6,423,951				1,796,613				28	%
Depreciation and amortization			309,699				252,377				57,322				23	%
Operating lease cost and rent			182,855				189,164				(6,309	)			(3	)%
Operating expenses		$	10,610,283			$	9,108,923				1,501,360				16	%

 

General and administrative expenses consisted primarily of professional services, automobile expenses, advertising, salaries and wages, travel expenses and consultants. Our operating expenses during the six-month period ended November 30, 2024 and November 30, 2023, were $10,610,283 and $9,108,923, respectively. The overall increase of $1,501,360 was primarily attributable to the following changes in operating expenses of:

 

●	General and administrative expenses increased by $1,796,613. In comparing the nine months ended November 30, 2024, and November 30, 2023 the increase may be partially explained by the following increases: wages and salaries by $900,370, subcontractors by $143,935, insurance by $82,352, freight and duty by $117,773, installation expenses by $100,768, repairs and maintenance by $90,355 RMC costs by $273,629, dues and subscriptions by $30,146, and office expenses $38,246. These were partially offset by decreases in the following accounts: professional fees by $84,522, stock-based compensation by $87,927 and other G& A decreases.
●	Research and development decreased by $346,266 due to a reduction in funding on development of future products especially in the first two quarters of the current year.
●	Depreciation and amortization increased by $57,322 due to the acquisition of demo devices, computer equipment and warehouse equipment.
●	Operating lease cost and rent decreased by $6,309 due to one less lease in the current period.

 

Other Income (Expense)

 

Other income (expense) during the nine months ended November 30, 2024, and November 30, 2023, was ($4,078,628) and (4,902,225), respectively. The $823,597 decrease in other expense was primarily attributable to the application of ASU-2020 06 in the current year which resulted in lower amortization expense.

Net loss

 

We had a net loss of $11,828,656 for the nine months ended November 30, 2024, compared to a net loss of $13,281,405 for the nine months ended November 30, 2023. The decrease in net loss of $1,452,749 is due to a number of factors: higher gross profit offset and lower other expenses offset by higher general and administrative in the nine months ended November 30, 2024.

 

-31-

Table of Contents

 

Liquidity, Capital Resources and Cash Flows

 

Management believes that we will continue to incur losses for the immediate future. Therefore, we will need additional equity or debt financing until we can achieve profitability and positive cash flows from operating activities, if ever. These conditions raise substantial doubt about our ability to continue as a going concern. Our unaudited condensed consolidated financial statements do not include and adjustments relating to the recovery of assets or the classification of liabilities that may be necessary should we be unable to continue as a going concern.

 

As of November 30, 2024, we had a cash balance of $84,231, accounts receivable of $1,249,792, device parts inventory of $1,883,530 and $41,294,464 in current liabilities. At the current cash consumption rate, we will need to consider additional funding sources going forward. We are taking proactive measures to reduce operating expenses and drive growth in revenue.

 

The successful outcome of future activities cannot be determined at this time and there is no assurance that, if achieved, we will have sufficient funds to execute our intended business plan or generate positive operating results.

 

Capital Resources

 

The following table summarizes total current assets, liabilities and working capital (deficit) for the periods indicated:

 

		November 30, 2024				February 29, 2024
Current assets		$	4,000,413			$	3,616,566
Current liabilities			41,294,464				21,715,651
Working capital		$	(37,294,051	)		$	(18,099,085	)

 

As of November 30, 2024 and February 29, 2024, we had a cash balance of $84,231 and $105,926, respectively.

 

Summary of Cash Flows

 

Summary of Cash Flows		Nine Months Ended November 30, 2024				Nine Months Ended November 30, 2023
Net cash used in operating activities		$	(8,894,284	)		$	(9,378,427	)
Net cash used in investing activities		$	(77,868	)		$	(10,044	)
Net cash provided by financing activities		$	8,950,457			$	8,546,190

 

Net cash used in operating activities.

 

Net cash used in operating activities for the nine months ended November 30, 2024, was $8,894,284 which included a net loss of $11,828,656, non-cash activity such as the bad debts expense of $37,995, inventory provision of $150,000, reduction of right of use asset of $91,152, accretion of lease liability $90,165, stock based compensation of $249,868, loss on settlement of debt of $6,520, change in operating assets and liabilities of $1,030,529, amortization of debt discount of $198,696, increase in related party accrued payroll and interest of $39,976 and depreciation and amortization of $1,039,371 to derive the uses of cash in operations.

 

Net cash used in investing activities.

 

Net cash used in investing activities for the nine months ended November 30, 2024, was $77,868 which was the purchase of fixed assets of $23,724, $4,144 for acquisition of trademarks and $50,000 for a convertible note receivable.

 

Net cash provided by financing activities.

 

Net cash provided by financing activities was $8,950,457 for the nine months ended November 30, 2024. This consisted of share proceeds net of issuance costs of 8,894,645, proceeds from loans payable of $350,000, reduced by repayments on loans payable of $183,000, proceeds on the issuance of Series B redeemable convertible preferred shares of $278,000 reduced by redemption of those same Series B redeemable convertible preferred shares of $389,188.

 

Off-Balance Sheet Arrangements

 

None.

 

-32-

Table of Contents

 

Critical Accounting Policies and Estimates

 

Critical accounting policies and estimates are further discussed in our Annual Report on Form 10-K for the year ended February 29, 2024, as filed on May 29, 2024.

 

Related Party Transactions

 

For both the three months ended November 30, 2024 and November 30, 2023 , the Company had no repayments of net advances from its loan payable-related party. At November 30, 2024, the loan payable-related party was $297,414 and $257,438 at February 29, 2024. Included in the balance due to the related party at November 30, 2024 is $222,754 of deferred salary and interest, $183,625 of which bears interest at 12%. As of February 29, 2024, included in the balance due to the related party is $140,013 of deferred salary all of which bears interest at 12%. The accrued interest included in loan at November 30, 2024 and February 29, 2024 was $28,267 and $32,468 respectively.

 

Pursuant to the amended Employment Agreement with its Chief Executive Officer, for the three months and six ended November 30, 2024, the Company accrued $0 (2023-$62,000) and $0 (2023-$187,000) of incentive compensation plan payable with a corresponding recognition of stock based compensation due to the expectation of additional awards being met. This will be payable in Series G Preferred Shares which are redeemable at the Company’s option at $1,000 per share. At November 31, 2024 and February 29, 2024 there was $2,500,000 and $2,500,000 of incentive compensation payable.

 

At November 30, 2024 deferred compensation for CEO was $598,635. For the nine months ended November 30, 2024, the net change was an increase of $59,868 comprising of net cash repayments and adjustments of $195,000 offset by accruals of $700,082. At February 29, 2024 deferred compensation for CEO was $538,767.

 

During the three months ended November 30, 2024 and 2023, the Company was charged $556,175 and $526,723, respectively for fees for research and development from a company partially owned by a principal shareholder.

 

During the nine months ended November 30, 2024 and 2023, the Company was charged $1,846,005 and $2,185,998, respectively for fees for research and development from a company partially owned by a principal shareholder.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not applicable for a smaller reporting company.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Management’s Report on Internal Control over Financial Reporting

 

We carried out an evaluation, under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, of the effectiveness of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of November 30, 2024. Based upon that evaluation, our principal executive officer and principal financial officer concluded that, as of November 30, 2024, our disclosure controls and procedures were not effective to ensure that information required to be disclosed in reports filed by us under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the required time periods and is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

 

	1.	As of November 30, 2024, we did not maintain effective controls over our control environment. Specifically, we have not developed and effectively communicated to our employees our accounting policies and procedures. This has resulted in inconsistent practices. Further, the Board of Directors does not currently have any independent members and no director qualifies as an audit committee financial expert as defined in Item 407(d)(5)(ii) of Regulation S-K. Since these entity level programs have a pervasive effect across the organization, management has determined that these circumstances constitute a material weakness.
	2.	As of November 30, 2024, we did not maintain effective controls over financial statement disclosure. Specifically, controls were not designed and in place to ensure that all disclosures required were originally addressed in our financial statements. Accordingly, management has determined that this control deficiency constitutes a material weakness.

 

Our management, including our principal executive officer and principal financial officer, do not expect that our disclosure controls and procedures or our internal controls will prevent all error or fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Due to the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected.

 

-33-

Table of Contents

 

PART II — OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

None.

 

ITEM 1A. RISK FACTORS

 

This item is not applicable to smaller reporting companies.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

Each issuance of securities was issued without registration in reliance of the exemption from registration Section 3(a)9 of the Securities Act of 1933.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

The Company has not defaulted upon senior securities.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable to the Company.

 

ITEM 5. OTHER INFORMATION

 

None.

 

-34-

Table of Contents

 

ITEM 6. EXHIBITS

 

Exhibit No.		Description of Document
3.1		Articles of Incorporation (1)
3.2		Bylaws (2)
14		Code of Ethics (2)
21		Subsidiaries of the Registrant (3)
31.1		Rule 13(a)-14(a)/15(d)-14(a) Certification of principal executive officer. (3)
31.2		Rule 13(a)-14(a)/15(d)-14(a) Certification of principal financial and accounting officer. (3)
32.1		Section 1350 Certification of principal executive officer. (3)
32.2		Section 1350 Certification of principal financial accounting officer. (3)
101.INS		Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document. (3)
101.SCH		Inline XBRL Taxonomy Extension Schema Document (3)
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document (3)
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document (3)
101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document (3)
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document (3)
104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) (3)

 

 

(1)	Incorporated by reference to our Form 10-KT file with the Securities and Exchange Commission on March 12, 2018.
(2)	Incorporated by reference to our Form S-1 filed with the Securities and Exchange Commission on August 4, 2010.
(3)	Filed or furnished herewith.

 

-35-

Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

	Artificial Intelligence Technology Solutions Inc.
Date: January 14, 2025	BY:	/s/ Steven Reinharz
	Steven Reinharz
	President, Chief Executive Officer (principal executive officer)
Date: January 14, 2025	BY:	/s/ Anthony Brenz
	Anthony Brenz
	Chief Financial Officer (principal financial officer)

 

-36-

 

 

Exhibit 21.1

 

Artificial Intelligence Technology Solutions Inc.

 

Subsidiaries

 

Name		Jurisdiction of Incorporation
Robotic Assistance Devices, Inc.		Nevada
Robotic Assistance Devices Group, Inc.		Nevada
Robotic Assistance Devices Mobile, Inc.		Nevada
Robotic Assistance Devices Residential, Inc		Nevada

 

 

 

Exhibit 31.1

 

RULE 13A-14(A)/15D-14(A) CERTIFICATION

 

I, Steven Reinharz, certify that:

 

1. I have reviewed this Form 10-Q for the period ended November 30, 2024 of Artificial Intelligence Technology Solutions Inc.

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15-d-15(f)) for the registrant and have:

 

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: January 14, 2025	BY:	/s/ Steven Reinharz
	Steven Reinharz
	President, Chief Executive Officer (principal executive officer)

 

 

 

Exhibit 31.2

 

RULE 13A-14(A)/15D-14(A) CERTIFICATION

 

I, Anthony Brenz, certify that:

 

1. I have reviewed this Form 10-Q for the period ended November 30, 2024 of Artificial Intelligence Technology Solutions Inc.

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15-d-15(f)) for the registrant and have:

 

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: January 14, 2025	BY:	/s/ Anthony Brenz
	Anthony Brenz
	Chief Financial Officer (principal financial officer)

 

 

 

Exhibit 32.1

 

SECTION 1350 CERTIFICATION

 

In connection with the quarterly report of Artificial Intelligence Technology Solutions Inc. (the “Company”) on Form 10-Q for the period ended November 30, 2024 as filed with the Securities and Exchange Commission (the “Report”), I, Steven Reinharz, President of the Company, certify, pursuant to 18 U.S.C. SS. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

1.	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.	The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

Date: January 14, 2025	BY:	/s/ Steven Reinharz
	Steven Reinharz
	President, Chief Executive Officer (principal executive officer)

 

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

 

 

Exhibit 32.2

 

SECTION 1350 CERTIFICATION

 

In connection with the quarterly report of Artificial Intelligence Technology Solutions Inc. (the “Company”) on Form 10-Q for the period ended November 30, 2024 as filed with the Securities and Exchange Commission (the “Report”), I, Anthony Brenz, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. SS. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

1.	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.	The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

Date: January 14, 2025	BY:	/s/ Anthony Brenz
	Anthony Brenz
	Chief Financial Officer (principal financial officer)

 

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

 

Cover - shares	9 Months Ended
	Nov. 30, 2024	Jan. 13, 2025
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Nov. 30, 2024
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2025
Current Fiscal Year End Date	--02-28
Entity File Number	000-55079
Entity Registrant Name	ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.
Entity Central Index Key	0001498148
Entity Tax Identification Number	27-2343603
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	10800 Galaxie Avenue
Entity Address, City or Town	Ferndale
Entity Address, State or Province	MI
Entity Address, Postal Zip Code	48220
City Area Code	(877)
Local Phone Number	787-6268
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		13,308,594,118

Condensed Consolidated Balance Sheets - USD ($)	Nov. 30, 2024	Feb. 29, 2024	[1]
Current assets:
Cash	$ 84,231	$ 105,926
Accounts receivable, net	1,249,792	756,084
Share proceeds receivable	352,701
Device parts inventory, net	1,883,530	2,131,599
Prepaid expenses and deposits	430,159	622,957
Total current assets	4,000,413	3,616,566
Operating lease asset	1,040,862	1,139,188
Revenue earning devices, net of accumulated depreciation of $1,881,451 and $952,844, respectively	4,351,750	2,480,002
Fixed assets, net of accumulated depreciation of $460,641 and $349,878, respectively	257,189	268,075
Trademarks	31,224	27,080
Convertible note receivable	50,000
Investment at cost	50,000	50,000
Security deposit	15,880	15,880
Total assets	9,797,318	7,596,791
Current liabilities:
Accounts payable and accrued expenses	2,495,455	2,034,301
Customer deposits	102,321	73,702
Current operating lease liability	225,348	237,653
Current portion of deferred variable payment obligation	1,599,971	904,377
Loan payable - related party	297,414	257,438
Deferred compensation for CEO	598,635	538,767
Current portion of loans payable, net of discount of $58,620 and $688,598	25,053,991	13,190,882
Vehicle loan - current portion	38,522	38,522
Current portion of accrued interest payable	10,882,807	4,440,009
Total current liabilities	41,294,464	21,715,651
Non-current operating lease liability	810,513	889,360
Loans payable, net of discount of $374,081 and $4,118,332, respectively	7,676,654	14,798,532
Deferred variable payment obligation	2,525,000	2,525,000
Incentive compensation plan payable	2,500,000	2,500,000
Accrued interest payable	2,008,308	5,367,805
Total liabilities	56,814,939	47,796,348
Commitments and Contingencies
Redeemable Preferred Stock (Temporary Equity):
Series B Convertible, Redeemable Preferred Stock. $0.001 par value; 8% cumulative dividend payable quarterly, $1,200 stated value, 5,000 shares authorized, 0 and 0 shares issued and outstanding at November 30, 2024 and February 29, 2024, respectively
Stockholders’ deficit:
Preferred Stock, value
Common Stock, $0.00001 par value; 15,000,000,000 shares authorized 12,581,671,042 and 9,238,750,958 shares issued, issuable and outstanding, respectively	125,817	92,388
Additional paid-in capital	102,141,607	92,565,513
Preferred stock to be issued	99,086	99,086
Accumulated deficit	(149,389,994)	(132,962,427)
Total stockholders’ deficit	(47,017,621)	(40,199,557)
Total liabilities and stockholders’ deficit	9,797,318	7,596,791
Series G Preferred Stock [Member]
Stockholders’ deficit:
Preferred Stock, value
Series E Preferred Stock [Member]
Stockholders’ deficit:
Preferred Stock, value	3,350	3,350
Series F Preferred Stock [Member]
Stockholders’ deficit:
Preferred Stock, value	$ 2,513	$ 2,533
[1] Derived from audited information

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Nov. 30, 2024	Feb. 29, 2024
Accumulated depreciation, revenue earning devices	$ 1,881,451	$ 952,844
Accumulated depreciation, fixed assets	460,641	349,878
Discount of current portion of loans payable	58,620	688,598
Discount of loans payable	$ 374,081	$ 4,118,332
Preferred stock, shares authorized	15,535,000	15,535,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.00001	$ 0.00001
Common stock, shares authorized	15,000,000,000	15,000,000,000
Common stock, shares issued	12,581,671,042	9,238,750,958
Common stock, shares outstanding	12,581,671,042	9,238,750,958
Redeemable Preferred Stock [Member]
Temporary equity, par value	$ 0.001	$ 0.001
Cumulative dividend payable, percentage	8.00%	8.00%
Cumulative dividend payable, stated value	$ 1,200	$ 1,200
Temporary equity, shares authorized	5,000	5,000
Temporary equity, shares issued	0	0
Temporary equity, shares outstanding	0	0
Series G Preferred Stock [Member]
Preferred stock, shares authorized	100,000	100,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Preferred stock, par value	$ 0.001	$ 0.001
Series E Preferred Stock [Member]
Preferred stock, shares authorized	4,350,000	4,350,000
Preferred stock, shares issued	3,350,000	3,350,000
Preferred stock, shares outstanding	3,350,000	3,350,000
Preferred stock, par value	$ 0.001	$ 0.001
Series F Preferred Stock [Member]
Preferred stock, shares authorized	10,000	10,000
Preferred stock, shares issued	2,513	2,533
Preferred stock, shares outstanding	2,513	2,533
Preferred stock, par value	$ 1.00	$ 1.00

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Nov. 30, 2024	Nov. 30, 2023	Nov. 30, 2024	Nov. 30, 2023
Revenues	$ 1,750,968	$ 596,980	$ 4,277,951	$ 1,368,551
Total Cost of Goods Sold	577,138	249,744	1,417,696	638,808
Gross Profit	1,173,830	347,236	2,860,255	729,743
Operating expenses:
Research and development (Note 9)	579,045	557,126	1,897,165	2,243,431
General and administrative	2,733,547	2,009,047	8,220,564	6,423,951
Depreciation and amortization	106,261	101,933	309,699	252,377
Operating lease cost and rent	57,875	64,081	182,855	189,164
Total operating expenses	3,476,728	2,732,187	10,610,283	9,108,923
Loss from operations	(2,302,898)	(2,384,951)	(7,750,028)	(8,379,180)
Other income (expense), net:
Interest expense	(1,401,076)	(1,581,533)	(4,072,108)	(4,940,965)
Gain (loss) on settlement of debt			(6,520)	38,740
Total other income (expense), net	(1,401,076)	(1,581,533)	(4,078,628)	(4,902,225)
Net Loss	$ (3,703,974)	$ (3,966,484)	$ (11,828,656)	$ (13,281,405)
Net income (loss) per share - basic	$ (0.00)	$ (0.00)	$ (0.00)	$ (0.00)
Net income (loss) per share - diluted	$ (0.00)	$ (0.00)	$ (0.00)	$ (0.00)
Weighted average common share outstanding - basic	12,161,286,427	7,294,775,879	11,071,139,695	6,606,988,956
Weighted average common share outstanding - diluted	12,161,286,427	7,294,775,879	11,071,139,695	6,606,988,956
Cost Of Goods Sold [Member]
Total Cost of Goods Sold	$ 289,339	$ 135,914	$ 688,024	$ 316,439
Depreciation And Amortization [Member]
Total Cost of Goods Sold	$ 287,799	$ 113,830	$ 729,672	$ 322,369

Condensed Consolidated Statement of Shareholders' Deficit (Unaudited) - USD ($)	Temporary Equity [Member] Series B Preferred Stock [Member]	Preferred Stock [Member] Series E Preferred Stock [Member]	Preferred Stock [Member] Series F Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance at Feb. 28, 2023		$ 3,350	$ 101,619	$ 58,489	$ 80,247,252	$ (112,253,711)	$ (31,843,001)
Balance, shares at Feb. 28, 2023		3,350,000	2,533	5,848,741,599
Issuance of shares, net of issuance costs				$ 2,809	1,316,100		1,318,909
Issuance of shares, net of issuance costs, shares				280,929,190
Relative fair value of Series F warrants issued with debt					947,447		947,447
Stock based compensation					52,721		52,721
Net income						(4,555,193)	(4,555,193)
Balance at May. 31, 2023		$ 3,350	$ 101,619	$ 61,298	82,563,520	(116,808,904)	(34,079,117)
Balance, shares at May. 31, 2023		3,350,000	2,533	6,129,670,789
Balance at Feb. 28, 2023		$ 3,350	$ 101,619	$ 58,489	80,247,252	(112,253,711)	(31,843,001)
Balance, shares at Feb. 28, 2023		3,350,000	2,533	5,848,741,599
Net income							(13,281,405)
Balance at Nov. 30, 2023		$ 3,350	$ 101,619	$ 77,152	89,160,341	(125,535,116)	(36,192,654)
Balance, shares at Nov. 30, 2023		3,350,000	2,533	7,715,143,227
Balance at May. 31, 2023		$ 3,350	$ 101,619	$ 61,298	82,563,520	(116,808,904)	(34,079,117)
Balance, shares at May. 31, 2023		3,350,000	2,533	6,129,670,789
Issuance of shares, net of issuance costs				$ 9,036	4,787,087		4,796,123
Issuance of shares, net of issuance costs, shares				903,636,004
Stock based compensation					50,713		50,713
Net income						(4,759,728)	(4,759,728)
Shares as payment for services				$ 65	44,395		44,460
Shares as payment for servises, shares				6,500,000
Balance at Aug. 31, 2023		$ 3,350	$ 101,619	$ 70,399	87,445,715	(121,568,632)	(33,947,549)
Balance, shares at Aug. 31, 2023		3,350,000	2,533	7,039,806,793
Issuance of shares, net of issuance costs				$ 6,753	1,405,405		1,412,158
Issuance of shares, net of issuance costs, shares				675,336,434
Relative fair value of Series F warrants issued with debt					261,759		261,759
Stock based compensation					47,462		47,462
Net income						(3,966,484)	(3,966,484)
Balance at Nov. 30, 2023		$ 3,350	$ 101,619	$ 77,152	89,160,341	(125,535,116)	(36,192,654)
Balance, shares at Nov. 30, 2023		3,350,000	2,533	7,715,143,227
Balance at Feb. 29, 2024		$ 3,350	$ 101,619	$ 92,388	92,565,513	(132,962,427)	(40,199,557)	[1]
Balance, shares at Feb. 29, 2024		3,350,000	2,533	9,238,750,958
Issuance of shares, net of issuance costs				$ 10,802	2,671,791		2,682,593
Issuance of shares, net of issuance costs, shares				1,080,166,425
Stock based compensation					83,323		83,323
Net income						(4,194,359)	(4,194,359)
Cumulative Effect Adjustment RFV discount per adoption of ASU 2020-06 at March 1, 2024						(4,175,535)	(4,175,535)
Issuance of Series B Preferred Shares	$ 360,000				(82,000)		(82,000)
Issuance of Series B Preferred Shares,shares	300
Series B Preferred Shares issued as commitment fee	$ 24,000				(24,000)		(24,000)
Series B Preferred Shares issued as commitment fee, shares	20
Series B Preferred shares issued as dividend	$ 2,568				(2,568)		(2,568)
Series B Preferred shares issued as dividend,shares	2
Redemption of Series B Preferred shares	$ (128,856)				28,856	(28,856)
Redemption of Series B Preferred shares,shares	(107)
Balance at May. 31, 2024	$ 257,712	$ 3,350	$ 101,619	$ 103,190	95,240,915	(141,361,177)	(45,912,103)
Balance, shares at May. 31, 2024	215	3,350,000	2,533	10,318,917,383
Balance at Feb. 29, 2024		$ 3,350	$ 101,619	$ 92,388	92,565,513	(132,962,427)	(40,199,557)	[1]
Balance, shares at Feb. 29, 2024		3,350,000	2,533	9,238,750,958
Issuance of shares, net of issuance costs, shares				3,285,777,227
Net income							(11,828,656)
Balance at Nov. 30, 2024		$ 3,350	$ 101,599	$ 125,817	102,141,607	(149,389,994)	(47,017,621)
Balance, shares at Nov. 30, 2024		3,350,000	2,513	12,581,671,042
Balance at May. 31, 2024	$ 257,712	$ 3,350	$ 101,619	$ 103,190	95,240,915	(141,361,177)	(45,912,103)
Balance, shares at May. 31, 2024	215	3,350,000	2,533	10,318,917,383
Issuance of shares, net of issuance costs				$ 13,306	4,478,054		4,491,360
Issuance of shares, net of issuance costs, shares				1,330,610,802
Stock based compensation					83,323		83,323
Net income						(3,930,323)	(3,930,323)
Series B Preferred shares issued as dividend	$ 2,620				(2,620)		(2,620)
Series B Preferred shares issued as dividend,shares	2
Redemption of Series B Preferred shares	$ (260,332)				60,333	(60,333)
Redemption of Series B Preferred shares,shares	(217)
Debt exchanged for common stock				$ 571	199,429		200,000
Debt exchanged for common stock, shares				57,142,857
Series F Preferred Shares exchanged for debt			(20)		(65,793)	(334,187)	(400,000)
Balance at Aug. 31, 2024		$ 3,350	$ 101,599	$ 117,067	99,993,641	(145,686,020)	(45,470,363)
Balance, shares at Aug. 31, 2024		3,350,000	2,513	11,706,671,042
Series F Preferred Shares exchanged for debt, shares			(20)
Issuance of shares, net of issuance costs				$ 8,750	2,064,643		2,073,393
Issuance of shares, net of issuance costs, shares				875,000,000
Stock based compensation					83,323		83,323
Net income						(3,703,974)	(3,703,974)
Balance at Nov. 30, 2024		$ 3,350	$ 101,599	$ 125,817	$ 102,141,607	$ (149,389,994)	$ (47,017,621)
Balance, shares at Nov. 30, 2024		3,350,000	2,513	12,581,671,042
[1] Derived from audited information

Condensed Consolidated Statement of Shareholders' Deficit (Unaudited) (Parenthetical) - USD ($)	3 Months Ended
	Nov. 30, 2024	Aug. 31, 2024	May 31, 2024	Nov. 30, 2023	Aug. 31, 2023	May 31, 2023
Statement of Stockholders' Equity [Abstract]
Issuance cost of shares	$ 93,885	$ 195,656	$ 116,046	$ 56,320	$ 176,672	$ 81,285

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended				9 Months Ended		12 Months Ended
	Nov. 30, 2024	May 31, 2024	Nov. 30, 2023	May 31, 2023	Nov. 30, 2024	Nov. 30, 2023	Feb. 29, 2024
CASH FLOWS USED IN OPERATING ACTIVITIES:
Net loss	$ (3,703,974)	$ (4,194,359)	$ (3,966,484)	$ (4,555,193)	$ (11,828,656)	$ (13,281,405)
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization					1,039,371	574,746
Bad debts expense					37,995	26,730
Inventory provision					150,000
Reduction of right of use asset					91,152	88,378
Accretion of lease liability					90,165	99,248
Stock based compensation					249,969	337,896
Change in fair value of derivative liabilities
Amortization of debt discounts					198,696	1,755,897
(Gain) loss on settlement of debt					6,520	(38,740)
Increase in related party accrued payroll and interest					39,976	92,770
Changes in operating assets and liabilities:
Accounts receivable					(531,703)	(267,144)
Prepaid expenses					199,972	(90,315)
Device parts inventory					(2,778,439)	(2,004,189)
Accounts payable and accrued expenses					700,082	266,666
Deferred compensation for CEO					(195,000)
Customer deposits					28,619	68,567
Operating lease liabilities					(171,898)	(174,874)
Current portion of deferred variable payment obligation for payments					695,594	222,525
Accrued interest payable					3,083,301	2,944,817
Net cash used in operating activities					(8,894,284)	(9,378,427)
CASH FLOWS USED IN INVESTING ACTIVITIES:
Purchase of fixed assets					(23,724)	(13,903)
Acquisition of trademarks					(4,144)
Convertible note receivable					(50,000)
Reimbursement of security deposit						3,859
Net cash used in investing activities					(77,868)	(10,044)
CASH FLOWS FROM FINANCING ACTIVITIES:
Share proceeds net of issuance costs					8,894,645	7,527,190
Proceeds from loans payable					350,000	1,400,000
Repayment of loans payable					(183,000)	(381,000)
Proceeds on issuance of Series B Preferred shares					278,000
Redemption of Series B Preferred shares					(389,188)
Proceeds from convertible debt and warrants issued
Net cash provided by financing activities					8,950,457	8,546,190
Net change in cash					(21,695)	(842,281)
Cash, beginning of period		$ 105,926		$ 939,759	105,926	939,759	$ 939,759
Cash, end of period	$ 84,231		$ 97,478		84,231	97,478	$ 105,926
Supplemental disclosure of cash and non-cash transactions:
Cash paid for interest					81,040	17,726
Cash paid for income taxes
Noncash investing and financing activities:
Share proceeds receivable					352,701
Transfer from device parts inventory to revenue earning devices					2,876,508	1,421,979
Cumulative Effect Adjustment RFV discount per adoption of ASU 2020-06 at March 1, 2024					4,175,535
Exchange of Series F preferred stock for note payable					400,000
Exchange of note payable for common stock					200,000
Series B preferred shares issued as dividend					5,188
Shares issued for services						44,460
Discount applied to face value of loans						200,000
Warrants issued as part of debt						$ 1,209,206

GENERAL INFORMATION	9 Months Ended
	Nov. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
GENERAL INFORMATION	1. GENERAL INFORMATION   Artificial Intelligence Technology Solutions Inc. (“AITX” or the “Company”) was incorporated in Florida on March 25, 2010 and reincorporated in Nevada on February 17, 2015. On August 24, 2018, Artificial Intelligence Technology Solutions Inc., changed its name from On the Move Systems Corp (“OMVS”).   Robotic Assistance Devices, LLC (“RAD”), was incorporated in the State of Nevada on July 26, 2016 as a Limited Liability Company. On July 25, 2017, Robotic Assistance Devices LLC converted to a C Corporation, Robotic Assistance Devices, Inc., through the issuance of 10,000 common shares to its sole shareholder.   On August 28, 2017, AITX completed the acquisition of RAD (the “Acquisition”), whereby AITX acquired all the ownership and equity interest in RAD for 3,350,000 shares of AITX Series E Preferred Stock and 2,450 shares of Series F Convertible Preferred Stock. AITX’s prior business focus was transportation services, and was exploring the on-demand logistics market by developing a network of logistics partnerships. As a result of the closing of the Acquisition, AITX has succeeded to the business of RAD, and AITX’s business going forward will consist of one segment activity, which is the delivery of artificial intelligence and robotic solutions for operational, security and monitoring needs.   The Acquisition was treated as a reverse recapitalization effected by a share exchange for financial accounting and reporting purposes since substantially all of AITX’s operations were disposed of as part of the consummation of the transaction. Therefore, no goodwill or other intangible assets were recorded by AITX as a result of the Acquisition. RAD is treated as the accounting acquirer as its stockholders control the Company after the Acquisition, even though AITX was the legal acquirer. As a result, the assets and liabilities and the historical operations that are reflected in these financial statements are those of RAD as if RAD had always been the reporting company.

GOING CONCERN	9 Months Ended
	Nov. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
GOING CONCERN	2. GOING CONCERN   The accompanying unaudited consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the possible inability of the Company to continue as a going concern.   For the nine months ended November 30, 2024, the Company had negative cash flow from operating activities of $8,894,284. As of November 30, 2024, the Company has an accumulated deficit of $149,389,994, and negative working capital of $37,294,051. Management does not anticipate having positive cash flow from operations in the near future. These factors raise substantial doubt about the Company’s ability to continue as a going concern for the twelve months following the issuance of these financial statements.   The Company does not have the resources at this time to repay all its credit and debt obligations, make any payments in the form of dividends to its shareholders or fully implement its business plan. Without additional capital, the Company will not be able to remain in business. At the same time management points to its successful history with maintaining Company operations and reminds all with reasonable confidence this will continue. Management has plans to address the Company’s financial situation as follows:   Management is committed to raise either non-dilutive funds or minimally dilutive funds. There is no assurance that these funds will be able to be raised nor can we provide assurance that these possible raises may not have dilutive effects. In July 2024, the Company entered into an equity financing agreement whereby an investor will purchase up to $30,000,000 of the Company’s common stock at a discount over a two-year period. There remains approximately $26 million left to issue under this arrangement. Management believes that it has the necessary support to continue operations by continuing its funding methods in the following ways: growing revenues, through equity proceeds, and issuing non-convertible debt. Management has had many recent conversations with the Company’s primary debt holder and believes that the non-convertible debt on the balance sheet will be extended. Management notes that non-convertible debt on the books has been extended by this debt holder twice in the past and notes that this debt holder has been a strong supporter of the Company.     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

ACCOUNTING POLICIES	9 Months Ended
	Nov. 30, 2024
Accounting Policies [Abstract]
ACCOUNTING POLICIES	3. ACCOUNTING POLICIES   Basis of Presentation and Consolidation   The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and in conformity with the condensing instructions on Form 10-Q and Rule 8-03 of Regulation S-X and the related rules and regulations of the Securities and Exchange Commission (“SEC”) and should be read in conjunction with the audited financial statements and notes thereto in the Company’s latest Annual Report filed with the SEC on Form 10-K as filed on May 29, 2024. The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Robotic Assistance Devices, Inc., Robotic Assistance Devices Group , Inc, Robotic Assistance Devices Mobile, Inc., On the Move Experience, LLC and On the OMV Transports, LLC. All significant intercompany accounts and transactions have been eliminated in consolidation. The unaudited consolidated financial statements reflect all adjustments, consisting of normal recurring accruals, which are, in the opinion of management, necessary for a fair presentation of such statements. The results of operations for the nine months ended November 30, 2024 are not necessarily indicative of the results that may be expected for the entire year.   Use of Estimates   In order to prepare financial statements in conformity with accounting principles generally accepted in the United States, management must make estimates, judgements and assumptions that affect the amounts reported in the financial statements and determine whether contingent assets and liabilities, if any, are disclosed in the financial statements. The ultimate resolution of issues requiring these estimates and assumptions could differ significantly from resolution currently anticipated by management and on which the financial statements are based. The most significant estimates included in these consolidated financial statements are those associated with the assumptions used to value preferred stock and derivative liabilities.   Reclassifications   Certain amounts in the Company’s consolidated financial statements for prior periods have been reclassified to conform to the current period presentation. These reclassifications have not changed the results of operations of prior periods.   Concentrations   Loans payable   At November 30, 2024 there were $33,163,345 of loans payable, $28,743,506 or 87% of these loans to companies controlled by one individual. At February 29, 2024 there were $32,796,345 of loans payable, $28,540,506 or 87% of these loans to companies controlled by the same individual.   Cash   The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Cash and cash equivalents consist of cash on deposit with banks and money market instruments. The Company places its cash and cash equivalents with high-quality, U.S. financial institutions and, to date has not experienced losses on any of its balances.   Accounts Receivable   Accounts receivable are comprised of balances due from customers, net of estimated allowances for uncollectible accounts. In determining collectability, historical trends are evaluated, and specific customer issues are reviewed on a periodic basis to arrive at appropriate allowances. There was an allowance of $74,000 and $68,000 provided as of November 30, 2024 and February 29, 2024, respectively. For the three months ended November 30, 2024, one customer accounted for 61% of total accounts receivable. For the three months ended November 30, 2023, two customers account for 61% of total accounts receivable.   Device Parts Inventory   Device parts inventory is stated at the lower of cost or net realizable value using the weighted average cost method. The Company records a valuation reserve for obsolete and slow-moving inventory, relying principally on specific identification of such inventory. The Company uses these device parts in the assembly of revenue earning devices (and demo devices) as well as research and development. Depending on use, the Company will transfer the parts to the corresponding asset or expense if used in research and development. A charge to income is taken when factors that would result in a need for an increase in the valuation, such as excess or obsolete inventory, are noted. As of November 30, 2024 and February 29, 2024 there was a valuation reserve of $1,109,000 and $959,000, respectively.     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)   Revenue Earning Devices   Revenue earning devices are stated at cost. Depreciation is provided on a straight-line basis over the estimated useful life of 48 months. The Company continually evaluates revenue earning devices to determine whether events or changes in circumstances have occurred that may warrant revision of the estimated useful life or whether the devices should be evaluated for possible impairment. The Company uses a combination of undiscounted cash flows and market approaches in assessing whether an asset has been impaired. The Company measures impairment losses based upon the amount by which the carrying amount of the asset exceeds the fair value.   Fixed Assets   Fixed assets are stated at cost. Depreciation is provided on the straight-line method based on the estimated useful lives of the respective assets which range from two to five years. Major repairs or improvements are capitalized. Minor replacements and maintenance and repairs which do not improve or extend asset lives are expensed currently.    Computer equipment and software   2 or 3 years Office equipment   4 years Manufacturing equipment   7 years Warehouse equipment   5 years Tooling   2 years Demo Devices   4 years Vehicles   3 years Leasehold improvements   5 years, the life of the lease   The Company periodically evaluates the fair value of fixed assets whenever events or changes in circumstances indicate that its carrying amounts may not be recoverable. Upon retirement or other disposition of fixed assets, the cost and related accumulated depreciation are removed from the accounts and the resulting gain or loss, if any, is recognized in income.   Research and Development   Research and development costs are expensed in the period they are incurred in accordance with ASC 730, Research and Development unless they meet specific criteria related to technical, market and financial feasibility, as determined by Management, including but not limited to the establishment of a clearly defined future market for the product, and the availability of adequate resources to complete the project. If all criteria are met, the costs are deferred and amortized over the expected useful life or written off if a product is abandoned. At November 30, 2024 and February 29, 2024, the Company had no deferred development costs.   Contingencies   Occasionally, the Company may be involved in claims and legal proceedings arising from the ordinary course of its business. The Company records a provision for a liability when it believes that it is both probable that a liability has been incurred, and the amount can be reasonably estimated. If these estimates and assumptions change or prove to be incorrect, it could have a material impact on the Company’s consolidated financial statements. Contingencies are inherently unpredictable, and the assessments of the value can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions.   Sales of Future Revenues   The Company has entered into transactions, as more fully described in footnote 8, in which it has received funding from investors in exchange for which it will make payments to those investors based on the level of sales of certain revenue categories, generally based on a percentage of sales for those certain revenues. The Company determines whether these agreements constitute sales of future revenues or are in substance debt based on the facts and circumstances of each agreement, with the following primary criteria determinative of whether the agreement constitutes a sale of future revenues or debt:     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)     ● Does the agreement purport, in substance, to be a sale   ● Does the Company have continuing involvement in the generation of cash flows due the investor   ● Is the transaction cancellable by either party through payment of a lump sum or other transfer of assets   ● Is the investors rate of return is implicitly limited by the terms of the agreement   ● Does the Company’s revenue for a reporting period underlying the agreement have only a minimal impact on the investor’s rate of return   ● Does the investor have recourse relating to payments due   In the event a transaction is determined to be a sale of future revenues, it is recorded as deferred revenue and amortized using the sum-of-the-revenue method. In the event a transaction is determined to be debt, it is recorded as debt and amortized using the effective interest method. As of the date of these financial statements, the Company has determined that all such agreements are debt.   Revenue Recognition   ASU 2014-09, “Revenue from Contracts with Customers (Topic 606)”, supersedes the revenue recognition requirements and industry specific guidance under Revenue Recognition (Topic 605). Topic 606 requires an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration the entity expects to be entitled to in exchange for those goods or services. Topic 606 defines a five-step process that must be evaluated and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing accounting principles generally accepted in the United States of America (“U.S. GAAP”) including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. The Company adopted Topic 606 on March 1, 2018, using the modified retrospective method. Under the modified retrospective method, prior period financial positions and results will not be adjusted. There was no cumulative effect adjustment recognized as a result of this adoption. Refer to Note 4 – Revenue from Contracts with Customers for additional information. For the nine months ended November 30, 2024, one customer accounted for 57% of total revenue and for the nine months ended November 30, 2023, four customers accounted for 58% of total revenue.   Income Taxes   Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized when items of income and expense are recognized in the financial statements in different periods than when recognized in the tax return. Deferred tax assets arise when expenses are recognized in the financial statements before the tax returns or when income items are recognized in the tax return prior to the financial statements. Deferred tax assets also arise when operating losses or tax credits are available to offset tax payments due in future years. Deferred tax liabilities arise when income items are recognized in the financial statements before the tax returns or when expenses are recognized in the tax return prior to the financial statements. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.   On December 22, 2017, the Tax Cuts and Jobs Act (“Tax Act”) was signed into law. ASC 740, Accounting for Income Taxes requires companies to recognize the effects of changes in tax laws and rates on deferred tax assets and liabilities and the retroactive effects of changes in tax laws in the period in which the new legislation is enacted. The Company’s gross deferred tax assets were revalued based on the reduction in the federal statutory tax rate from 35% to 21%. A corresponding offset has been made to the valuation allowance, and any potential other taxes arising due to the Tax Act will result in reductions to the Company’s net operating loss carryforward and valuation allowance. The Company will continue to analyze the Tax Act to assess its full effects on the Company’s financial results, including disclosures, for the Company’s fiscal year ending February 28, 2024, but the Company does not expect the Tax Act to have a material impact on the Company’s consolidated financial statements.   Leases   Lease agreements are evaluated to determine if they are sales/finance leases meeting any of the following criteria at inception: (a) transfer of ownership of the underlying asset; (b) purchase option that is reasonably certain of being exercised; (c) the lease term is greater than a major part of the remaining estimated economic life of the underlying asset; or (d) if the present value of the sum of lease payments and any residual value guaranteed by the lessee that has not already been included in lease payments in accordance with ASC 842-10-30-5(f) equals or exceeds substantially all of the fair value of the underlying asset.     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)   If at its inception, a lease meets any of the four lease criteria above, the lease is classified by the Company as a sales/finance; and if none of the four criteria are met, the lease is classified by the Company as an operating lease.   Operating lease payments are recognized as an expense in the income statement on a straight-line basis over the lease term, whereby an equal amount of rent expense is attributed to each period during the term of the lease, regardless of when actual payments are made. This generally results in rent expense in excess of cash payments during the early years of a lease and rent expense less than cash payments in the later years. The difference between rent expense recognized and actual rental payments is recorded as deferred rent and included in liabilities.   Distinguishing Liabilities from Equity   The Company relies on the guidance provided by ASC Topic 480, Distinguishing Liabilities from Equity, to classify certain redeemable and/or convertible instruments. The Company first determines whether a financial instrument should be classified as a liability. The Company will determine the liability classification if the financial instrument is mandatorily redeemable, or if the financial instrument, other than outstanding shares, embodies a conditional obligation that the Company must or may settle by issuing a variable number of its equity shares.   Once the Company determines that a financial instrument should not be classified as a liability, the Company determines whether the financial instrument should be presented between the liability section and the equity section of the balance sheet (“temporary equity”). The Company will determine temporary equity classification if the redemption of the financial instrument is outside the control of the Company (i.e. at the option of the holder). Otherwise, the Company accounts for the financial instrument as permanent equity.   Our Chief Executive Officer/ Chairman holds sufficient shares of the Company’s voting preferred stock that give sufficient voting rights under the articles of incorporation and bylaws of the Company such that the CEO/ Chairman can at any time unilaterally vote to increase the number of authorized shares of common stock of the Company, without the need to call a general meeting of common shareholders of the Company.   Initial Measurement   The Company records its financial instruments classified as liability, temporary equity or permanent equity at issuance at the fair value, or cash received.   Subsequent Measurement – Financial Instruments Classified as Liabilities   The Company records the fair value of its financial instruments classified as liabilities at each subsequent measurement date. The changes in fair value of its financial instruments classified as liabilities are recorded as other income (expenses).   Fair Value of Financial Instruments   ASC Topic 820, Fair Value Measurements and Disclosures (“ASC Topic 820”) provides a framework for measuring fair value in accordance with generally accepted accounting principles.   ASC Topic 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs).   The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy under ASC Topic 820 are described as follows:     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)     ● Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities that are accessible at the measurement date.         ● Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data by correlation or other means.         ● Level 3 – Inputs that are unobservable for the asset or liability.   Measured on a Recurring Basis   The following table presents information about our liabilities measured at fair value on a recurring basis, aggregated by the level in the fair value hierarchy within which those measurements fell:       Amount at     Fair Value Measurement Using       Fair Value     Level 1     Level 2     Level 3   November 30, 2024                                 Liabilities                                 Incentive compensation plan payable- revaluation of equity awards payable in Series G shares   $ 2,500,000     $ —     $ —     $ 2,500,000                                     February 29, 2024                                 Liabilities                                 Incentive compensation plan payable- revaluation of equity awards payable in Series G shares   $ 2,500,000     $ —     $ —     $ 2,500,000     The carrying amounts of the Company’s financial assets and liabilities, such as cash, accounts receivable, prepaid expenses and advances, accounts payable and accrued expenses, approximate their fair values because of the short maturity of these instruments.   Earnings (Loss) per Share   Basic earnings (loss) per share (“EPS”) is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS give effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used to determine the number of shares assumed to be purchased from the exercise of stock options and/or warrants. Diluted EPS excluded all dilutive potential shares if their effect is anti-dilutive.   Basic loss per common share is computed based on the weighted average number of shares outstanding during the period. Diluted loss per share is computed in a manner similar to the basic loss per share, except the weighted-average number of shares outstanding is increased to include all common shares, including those with the potential to be issued by virtue of convertible debt and other such convertible instruments. Diluted loss per share contemplates a complete conversion to common shares of all convertible instruments only if they are dilutive in nature with regards to earnings per share.     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)   Recently Issued Accounting Pronouncements   Recently Issued Accounting Standards During the Year   In August 2020, the FASB issued ASU 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. Under ASU 2020-06, the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives under Topic 815, or that do not result in substantial premiums accounted for as paid-in capital. Consequently, a convertible debt instrument will be accounted for as a single liability measured at its amortized cost, as long as no other features require bifurcation and recognition as derivatives. The new guidance also requires the if-converted method to be applied for all convertible instruments. The amendments in ASU 2020-06 are effective for public entities, excluding smaller reporting companies as defined, for fiscal years beginning after December 15, 2021. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023. Early adoption is permitted. A reporting entity is not permitted to adopt the guidance in an interim period, other than the first interim period of its fiscal year. The Company adopted the standard using a modified retrospective approach. The adjustment to the Company’s accumulated deficit at March 1, 2024 was $4,175,535 with a corresponding adjustment to loans payable.

REVENUE FROM CONTRACTS WITH CUSTOMERS	9 Months Ended
	Nov. 30, 2024
Revenue from Contract with Customer [Abstract]
REVENUE FROM CONTRACTS WITH CUSTOMERS	4. REVENUE FROM CONTRACTS WITH CUSTOMERS   Revenue is earned primarily from two sources: 1) direct sales of goods or services and 2) short-term rentals. Direct sales of goods or services are accounted for under Topic 606, and short-term rentals are accounted for under Topic 842 (which addresses lease accounting and was adopted on March 1, 2019).   As disclosed in the revenue recognition section of Note 3 – Accounting Polices, the Company adopted Topic 606 in accordance with the effective date on March 1, 2018. Note 3 includes disclosures regarding the Company’s method of adoption and the impact on the Company’s financial statements. Revenue is recognized on direct sales of goods or services when it transfers promised goods or services to customers in an amount that reflects the consideration the entity expects to be entitled to in exchange for those goods or services.   After adopting Topic 842, also referred to above in Note 3, the Company is accounting for revenue earned from rental activities where an identified asset is transferred to the customer and the customer has the ability to control that asset. The Company recognizes revenue from its device rental activities when persuasive evidence of a contract exists, the performance obligations have been satisfied, the transaction price is fixed or determinable and collection is reasonably assured. Performance obligations associated with device rental transactions are satisfied over the rental period. Rental periods are short-term in nature. Therefore, the Company has elected to apply the practical expedient which eliminates the requirement to disclose information about remaining performance obligations. Payments are due from customers at the completion of the rental, except for customers with negotiated payment terms, generally net 30 days or less, which are invoiced and remain as accounts receivable until collected.   The following table presents revenues from contracts with customers disaggregated by product/service:       Three Months Ended November 30, 2024     Three Months Ended November 30, 2023     Nine Months Ended November 30, 2024     Nine Months Ended November 30, 2023   Device rental activities   $ 1,429,112     $ 416,062     $ 3,475,546     $ 997,754   Direct sales of goods and services     321,856       180,918       802,405       370,797     $ 1,750,968     $ 596,980     $ 4,277,951     $ 1,368,551       ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

LEASES	9 Months Ended
	Nov. 30, 2024
Leases [Abstract]
LEASES	5. LEASES   We lease certain warehouses, and office space. Leases with an initial term of 12 months or less are not recorded on the balance sheet; we recognize lease expense for these leases on a straight-line basis over the lease term. For lease agreements entered into or reassessed after the adoption of Topic 842, we did not combine lease and non-lease components.   There is no lease renewal. The depreciable life of assets and leasehold improvements are limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise.   Below is a summary of our lease assets and liabilities at November 30, 2024 and February 29, 2024.   Leases   Classification   November 30, 2024     February 29, 2024   Assets                     Operating   Operating Lease Assets   $ 1,040,862     $ 1,139,188   Liabilities                     Current                     Operating   Current Operating Lease Liability   $ 225,348     $ 237,653   Noncurrent                     Operating   Noncurrent Operating Lease Liabilities     810,513       889,360   Total lease liabilities       $ 1,035,861     $ 1,127,013     Note: As most of our leases do not provide an implicit rate, we use our incremental borrowing rate of 10% which for the leases noted above was based on the information available at commencement date in determining the present value of lease payments. We compare against loans we obtain to acquire physical assets and not loans we obtain for financing. The loans we obtain for financing are generally at significantly higher rates and we believe that physical space or vehicle rental agreements are in line with physical asset financing agreements. CAM charges were not included in operating lease expense and were expensed in general and administrative expenses as incurred.   Rent expense and operating lease cost was $57,875 and $182,855 for the three and nine months ended November 30, 2024, respectively, and $64,081 and $189,164 for the three and nine months ended November 30, 2023, respectively.

REVENUE EARNING DEVICES	9 Months Ended
	Nov. 30, 2024
Revenue Earning Devices
REVENUE EARNING DEVICES	6. REVENUE EARNING DEVICES   Revenue earning devices consisted of the following:       November 30, 2024     February 29, 2024   Revenue earning devices   $ 6,233,201     $ 3,432,846   Less: Accumulated depreciation     (1,881,451 )     (952,844 )   $ 4,351,750     $ 2,480,002     During the three and nine months ended November 30, 2024 the Company made total additions to revenue earning devices of $1,069,822 and $2,800,355 respectively, which were transfers from inventory. During the three and nine months ended November 30, 2023 the Company made total additions to revenue earning devices of $521,037 and $1,306,501, respectively, which were transfers from inventory.   Depreciation and amortization for the three and nine months ended November 30, 2024 and 2023 are as follows:   Depreciation and Amortization   Three Months Ended November 30, 2024     Three Months Ended November 30, 2023     Nine Months Ended November 30, 2024     Nine Months Ended November 30, 2023                             Cost of Goods Sold   $ 287,799     $ 113,830     $ 729,672     $ 322,369   Operating expenses     79,662       51,540       198,935       107,456   Total Depreciation and Amortization   $ 367,461     $ 165,370     $ 928,607     $ 429,825       ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

FIXED ASSETS	9 Months Ended
	Nov. 30, 2024
Property, Plant and Equipment [Abstract]
FIXED ASSETS	7. FIXED ASSETS   Fixed assets consisted of the following:       November 30, 2024     February 29, 2024   Automobile   $ 74,237     $ 74,237   Demo devices     270,502       194,352   Tooling     107,020       107,020   Machinery and equipment     8,825       8,825   Computer equipment     157,448       150,387   Office equipment     15,312       15,312   Furniture and fixtures     21,225       21,225   Warehouse equipment     36,305       19,639   Leasehold improvements     26,956       26,956       717,830       617,953   Less: Accumulated depreciation     (460,641 )     (349,878 )   $ 257,189     $ 268,075     During the three months ended November 30, 2024, the Company made additions of $25,603, all of which were transfers from inventory. During the nine months ended November 30, 2024, the Company made additions of $99,877 of which $76,153 were transfers from inventory with remaining additions of $23,724. During the three months ended November 30, 2023, the Company made additions of $22,101, $11,661 which were transfers from inventory with remaining additions of $ 10,440. During the nine months ended November 30, 2023, the Company made additions of $129,331 of which $115,428 were transfers from inventory with remaining additions of $13,903.   Depreciation and Amortization   Three Months Ended November 30, 2024     Three Months Ended November 30, 2023     Nine Months Ended November 30, 2024     Nine Months Ended November 30, 2023                             Fixed assets   $ 26,599     $ 50,393     $ 110,764     $ 144,921   Revenue earning devices     79,662       51,540       198,935       107,456   Total Depreciation and Amortization included in operating expenses   $ 106,261     $ 101,933     $ 309,699     $ 252,377

DEFERRED VARIABLE PAYMENT OBLIGATION	9 Months Ended
	Nov. 30, 2024
Deferred Variable Payment Obligation
DEFERRED VARIABLE PAYMENT OBLIGATION	8. DEFERRED VARIABLE PAYMENT OBLIGATION   On February 1, 2019, the Company entered into an agreement with an investor whereby the investor would pay up to $900,000 in exchange for a perpetual 9% rate payment (Payments) on the Company’s reported quarterly revenue from operations excluding any gains or losses from financial instruments (Revenues). At February 29, 2020 the investor has advanced the full $900,000.   On May 9, 2019, the Company entered into two similar arrangements with two investors:     (1) The investor would pay up to $400,000 in exchange for a perpetual 4% rate Payment on the Company’s reported quarterly Revenues. At February 29, 2020, $400,000 has been paid to the Company.         (2) The investor would pay up to $50,000 in exchange for a perpetual 1.11% rate Payment on the Company’s reported quarterly Revenues. At February 29, 2020, $50,000 has been paid to the Company.   These variable payments (Payments) are to be made 30 days after the end of each fiscal quarter. If the Payments would deplete RAD’s available cash by more than 30%, the Payments may be deferred for up to 12 months after the quarterly report at an interest rate of 6% per annum on the unpaid amount.     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)   In the event that at least 10% of the assets of the Company are sold by the Company, the investors would be entitled to the fair market value (FMV) of all future Payments associated with the assets sold as determined by an independent valuator to be chosen by the investors. The FMV cannot exceed 30% of the total asset disposition price defined as the total price paid for the assets plus all future Payments associated with the assets sold. In the event that the common or preferred shares are sold by the Company to a third party as to effect a change in control, then the investors must be paid the FMV of all future Payments in one lump payment. The FMV cannot exceed 30% of the share disposition price defined as the total price the third party paid for the shares plus the total value of all future Payments.   On November 18, 2019, the Company entered into another similar arrangement with the (February 1, 2019) investor above whereby the investor would advance up to $225,000 in exchange for a perpetual 2.25% rate Payment on the Company’s quarterly Revenues (commencing on quarter ending May 31, 2020). At February 29, 2020, the investor has advanced $109,000 and the investor advanced the $116,000 remainder as of May 2020.   On December 30, 2019, the Company entered into another similar arrangement with a new investor whereby the investor would advance up to $100,000 in exchange for a perpetual 1.00% rate Payment on the Company’s quarterly Revenues (commencing quarter ended November 30, 2020). At February 29, 2020, the investor has advanced $50,000 with the remainder to be advanced no later than June 30, 2020. If the total investor advances turns out to be less than $100,000, this would not constitute a breach of the agreement, rather the 1.00% rate would be adjusted on a pro-rata basis.   On April 22, 2020, the Company entered into another similar arrangement with the (first May 9, 2019) investor above whereby the investor would advance up to $100,000 in exchange for a perpetual 1.00% rate Payment on the Company’s quarterly Revenues. At May 31, 2020, the investor has fully funded this commitment.   On July 1, 2020, the Company entered into a similar agreement with the first investor whereby the investor would pay up to $800,000 in exchange for a perpetual 2.75% rate payment (Payment) on the Company’s reported quarterly revenue. These Payments are to be made 90 days after the fiscal quarter with the first payment being due no later than May 31, 2021. If the Payments would deplete RAD’s available cash by more than 20%, the payment may be deferred. The investor had agreed to pay $100,000 per month over an 8 month period with the first payment due July 2020 and the final payment no later than February 28, 2021. As at August 31, 2020 the investor had fully funded the $800,000 commitment.   On August 27, 2020, the Company and the first investor referred to above consolidated the three separate agreements of February 1, 2019, for $900,000, November 18, 2019 for $225,000 and July 1, 2020 for $800,000 into a new agreement for a total of $1,925,000. This new agreement is for similar terms as the above agreements save for the following: the rate payment is revised to 14.25% payable on revenues commencing the quarter ended August 31, 2020. Upon an event of default that we are unable to cure in the time allotted under the agreements, these Payments may be secured with a priority lien by UCC filing against all of our assets but is subordinated to equipment financing or leasing agreements on the products the Company leases to its customers.   In summary of all agreements mentioned above if in the event that at least 10% of the assets of the Company are sold by the Company, the investors would be entitled to the fair market value (FMV) of all future Payments associated with the assets sold as determined by an independent valuator to be chosen by the investors. The FMV cannot exceed 43.77% of the total asset disposition price defined as the total price paid for the assets plus all future Payments associated with the assets sold. In the event that the common or preferred shares are sold by the Company to a third party as to effect a change in control, then the investors must be paid the FMV of all future Payments in one lump payment. The FMV cannot exceed 43.77% of the share disposition price defined as the total price the third party paid for the shares plus the total value of all future Payments. As of March 1, 2021, as a result of the amendment with the first investor noted below. This aggregate asset disposition % was reduced from 43.77 % to 33.77%.   The Payments first become payable on June 30, 2019 (unless otherwise indicated) based on the quarterly Revenues for the quarter ended May 31, 2019, and accrue every quarter thereafter. As of November 30, 2024, the Company has accrued $1,599,971 in Payments of which $764,702 are in arrears. As of February 29, 2024, the Company has accrued approximately $904,377 in Payments, of which $542,176 is in arrears. No notices have been sent to the Company.   On March 1, 2021, the first investor referred to above whose aggregate investment is $1,925,000 revised his agreements as follows:     1) The rate payment was reduced from 14.25 % to 9.65 %   2) The asset disposition % (see below) was reduced from 31 % to 21%     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)   In consideration for the above changes, the investor received 40 Series F Convertible Preferred Stock and a warrant to purchase 367 shares of its Series F Convertible Preferred Stock with a five-year term and an exercise price of $1.00. During the three months ended May 31, 2021, the warrant holder exercised warrants to acquire 38 shares of Series F Convertible Preferred Stock. The Company attributed a fair value based on recent transactions for the Series F Preferred stock and warrants of $33,015,214 and recorded a loss on settlement of debt with a corresponding adjustment to paid in capital.   The Company retains total involvement in the generation of cash flows from these revenue streams that form the basis of the payments to be made to the investors under this agreement. Because of this, the Company has determined that the agreements constitute debt agreements. As of November 30, 2024, and February 29, 2024, the long-term balances other than Payments already owed is the cash received of $2,525,000 and $2,525,000, respectively.   For both the three months and nine months ended November 30, 2024 and year ended February 29, 2024, the Company has received $0 related to the deferred payment obligation since there were no new agreements during this period. The balance remains $2,525,000 at both November 30, 2024 and February 29, 2024.

RELATED PARTY TRANSACTIONS	9 Months Ended
	Nov. 30, 2024
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	9. RELATED PARTY TRANSACTIONS   For both the three months ended November 30, 2024 and November 30, 2023, the Company had no repayments of net advances from its loan payable-related party. At November 30, 2024, the loan payable-related party was $297,414 and $257,438 at February 29, 2024. Included in the balance due to the related party at November 30, 2024 is $222,754 of deferred salary and interest, $183,625 of which bears interest at 12%. As of February 29, 2024, included in the balance due to the related party is $140,013 of deferred salary all of which bears interest at 12%. The accrued interest included in loan at November 30, 2024 and February 29, 2024 was $28,267 and $32,468 respectively.   Pursuant to the amended Employment Agreement with its Chief Executive Officer, for the three months and six ended November 30, 2024, the Company accrued $0 (2023-$62,000) and $0 (2023-$187,000) of incentive compensation plan payable with a corresponding recognition of stock based compensation due to the expectation of additional awards being met. This will be payable in Series G Preferred Shares which are redeemable at the Company’s option at $1,000 per share. At November 31, 2024 and February 29, 2024 there was $2,500,000 and $2,500,000 of incentive compensation payable.   At November 30, 2024 deferred compensation for CEO was $598,635. For the nine months ended November 30, 2024, the net change was an increase of $59,868 comprising of net cash repayments and adjustments of $195,000offset by accruals of $700,082. At February 29, 2024 deferred compensation for CEO was $538,767.   During the three months ended November 30, 2024, and 2023, the Company was charged $556,175 and $526,723, respectively for fees for research and development from a company partially owned by a principal shareholder.   During the nine months ended November 30, 2024, and 2023, the Company was charged $1,846,005 and $2,185,998, respectively for fees for research and development from a company partially owned by a principal shareholder.

OTHER DEBT – VEHICLE LOAN	9 Months Ended
	Nov. 30, 2024
Other Debt Vehicle Loan
OTHER DEBT – VEHICLE LOAN	10. OTHER DEBT – VEHICLE LOAN   In December 2016, RAD entered into a vehicle loan for $47,704 secured by the vehicle. The loan is repayable over 5 years maturing November 9, 2021, and repayable $1,019 per month including interest and principal. In November 2017, RAD entered into another vehicle loan secured by the vehicle for $47,661. The loan is repayable over 5 years, maturing October 24, 2022 and repayable at $923 per month including interest and principal. The principal repayments made were $0 for both the year ended February 28, 2022 and February 28, 2021. Regarding the second vehicle loan, the vehicle was returned at the end of fiscal 2019 and the car was subsequently sold by the lender for proceeds of $21,907 which went to reduce the outstanding balance of the loan. A loss of $3,257 was recorded as well. A balance of $21,578 remains on this vehicle loan at both February 28, 2021 and February 29, 2020. For the first vehicle loan, the vehicle was retired in 2020, the proceeds of the disposal of $18,766 was applied against the balance of the loan with a $5,515 gain on the remaining asset value of $13,251. A balance of $16,944 remains on this vehicle loan at both February 28, 2022 and February 28, 2021. The remaining total balances of the amounts owed on the vehicle loans were $38,522 and $38,522 as of November 30, 2024 and February 29, 2024, respectively, of which all were classified as current.     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

LOANS PAYABLE	9 Months Ended
	Nov. 30, 2024
Debt Disclosure [Abstract]
LOANS PAYABLE	11. LOANS PAYABLE   Loans payable at November 30, 2024 consisted of the following:                          Annual   Date   Maturity   Description       Principal     Interest Rate   July 18, 2016   July 18, 2017   Promissory note   (1)*   $ 3,500       22 % December 10, 2020   March 1, 2025   Promissory note   (2)     3,921,168       12 % December 10, 2020   March 1, 2025   Promissory note   (3)     2,754,338       12 % December 10, 2020   December 10, 2024   Promissory note   (4)     165,605       12 % December 14, 2020   March 1, 2027   Promissory note   (5)     310,375       12 % December 30, 2020   March 1, 2025   Promissory note   (6)     350,000       12 % January 1, 2021   March 1, 2025   Promissory note   (7)     25,000       12 % January 1, 2021   March 1, 2025   Promissory note   (8)     145,000       12 % January 14, 2021   March 1, 2025   Promissory note   (9)     550,000       12 % February 22, 2021   March 1, 2025   Promissory note   (10)     1,650,000       12 % March 1, 2021   March 1, 2025   Promissory note   (11)     6,000,000       12 % June 8, 2021   June 8, 2025   Promissory note   (12)     2,750,000       12 % July 12, 2021   July 26, 2026   Promissory note   (13)     3,740,360       7 % September 14, 2021   September 14, 2025   Promissory note   (14)     1,650,000       12 % July 28, 2022   March 1, 2025   Promissory note   (15)     170,000       15 % August 30, 2022   August 30,2025   Promissory note   (16)     3,000,000       15 % September 7, 2022   March 1, 2025   Promissory note   (17)     400,000       15 % September 8, 2022   March 1, 2025   Promissory note   (18)     475,000       15 % October 13, 2022   March 1, 2025   Promissory note   (19)     350,000       15 % October 28, 2022   October 31, 2026   Promissory note   (20)     400,000       15 % November 9, 2022   October 31, 2026   Promissory note   (20)     400,000       15 % November 10, 2022   October 31, 2026   Promissory note   (20)     400,000       15 % November 15, 2022   October 31, 2026   Promissory note   (20)     400,000       15 % January 11, 2023   October 31, 2026   Promissory note   (20)     400,000       15 % February 6, 2023   October 31, 2026   Promissory note   (20)     400,000       15 % April 5. 2023   October 31, 2026   Promissory note   (20)     400,000       15 % April 20, 23   October 31, 2026   Promissory note   (20)     400,000       15 % May 11, 2023   October 31, 2026   Promissory note   (20)     400,000       15 % October 27, 2023   October 31, 2026   Promissory note   (20)     400,000       15 % November 30, 2023   April 30, 2025   Purchase Agreement   (21)     203,000       35 % March 8, 2024   August 8, 2025   Purchase Agreement   (22)     350,000       35 % August 8, 2024   August 8, 2025   Exchange Agreement   (23)     200,000       12 %                 $ 33,163,346                                         Less: current portion of loans payable         (25,112,611 )         Less: discount on non-current loans payable         (374,081 )         Non-current loans payable, net of discount       $ 7,676,654                                         Current portion of loans payable       $ 25,112,611           Less: discount on current portion of loans payable         (58,620 )         Current portion of loans payable, net of discount       $ 25,053,991             * In default     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)   (1) This note was transferred from convertible notes payable because in August 2022 it was no longer convertible due to restrictions placed on the lender.     (2) This promissory note was issued as part of a debt settlement whereby $2,683,357 in convertible notes and associated accrued interest of $1,237,811 totaling $3,921,168 was exchanged for this promissory note of $3,921,168, and a warrant to purchase 450,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a relative fair value of $990,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from December 10, 2023 to March 1, 2025 with all other terms and conditions remaining the same.     (3) This promissory note was issued as part of a debt settlement whereby $1,460,794 in convertible notes and associated accrued interest of $1,593,544 totaling $3,054,338 was exchanged for this promissory note of $3,054,338, and a warrant to purchase 250,000,000 shares at an exercise price of $0.002 per share and a three-year maturity having a relative fair value of $550,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. $300,000 has been repaid during the year ended February 29, 2024. On November 28, 2023, the parties extended the maturity date from December 10, 2023 to March 1, 2025 with all other terms and conditions remaining the same.     (4) This promissory note was issued as part of a debt settlement whereby $103,180 in convertible notes and associated accrued interest of $62,425 totaling $165,605 was exchanged for this promissory note of $165,605, and a warrant to purchase 80,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a fair value of $176,000.The maturity date was extended from December 10, 2023 to December 10, 2024 on February 29, 2024 and a fee of $22,958 was paid and charged to interest expense.     (5) This promissory note was issued as part of a debt settlement whereby $235,000 in convertible notes and associated accrued interest of $75,375 totaling $310,375 was exchanged for this promissory note of $310,375, and a warrant to purchase 25,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a fair value of $182,500.     (6) The note, with an original principal amount of $350,000, may be pre-payable at any time. The note balance includes an original issue discount of $35,000 and was issued with a warrant to purchase 50,000,000 shares at an exercise price of $0.025 per share with a 3-year term and having a relative fair value of $271,250. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $271,250 with a corresponding adjustment to paid in capital for the relative fair value of the warrant. On March 1, 2024, the unamortized relative fair value discount of $65,092 was removed with a corresponding adjustment to accumulated deficit. A $8,399 unamortized discount remained. On November 28, 2023, the parties extended the maturity date from December 10, 2023 to March 1, 2025 with all other terms and conditions remaining the same. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $2,115 and $6,069, respectively, with an unamortized discount of $2,330 at November 30, 2024.     (7) This promissory note was issued as part of a debt settlement whereby $9,200 in convertible notes and associated accrued interest of $6,944 totaling $16,144 was exchanged for this promissory note of $25,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from January 1, 2024 to March 1, 2025 with all other terms and conditions remaining the same.     (8) This promissory note was issued as part of a debt settlement whereby $79,500 in convertible notes and associated accrued interest of $28,925 totaling $108,425 was exchanged for this promissory note of $145,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from January 1, 2024 to March 1, 2025 with all other terms and conditions remaining the same.     (9) The note, with an original principal amount of $550,000, may be pre-payable at any time. The note balance includes an original issue discount of $250,000 and was issued with a warrant to purchase 50,000,000 shares at an exercise price of $0.025 per share with a 3-year term and having a relative fair value of $380,174. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $380,174 with a corresponding adjustment to paid in capital. On March 1, 2024, the unamortized relative fair value discount of $80,284 was removed with a corresponding adjustment to accumulated deficit. A $10,559 unamortized discount remained. On November 28, 2023, the parties extended the maturity date from January 14, 2024 to March 1, 2025 with all other terms and Conditions remaining the same. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $2,649 and $7,702, respectively, with an unamortized discount of $2,857 at November 30, 2024     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)   (10) The note, with an original principal balance of $1,650,000, may be pre-payable at any time. The note balance includes an original issue discount of $150,000 and was issued with a warrant to purchase 100,000,000 shares at an exercise price of $0.135 per share with a 3-year term and having a relative fair value of $1,342,857. The discount and warrant are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $1,342,857 with a corresponding adjustment to paid in capital for the relative fair value of the warrant. The maturity date was extended from February 22, 2022 to February 22, 2024 on February 28, 2022 in exchange for warrants to purchase 50,000,000 at an exercise price of $.0164 and a 3-year term. These warrants have a fair value of $950,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. On November 28, 2023, the parties extended the maturity date from February 22, 2024 to March 1, 2025 with all other terms and conditions remaining the same. On March 1, 2024, the unamortized relative fair value discount of $497,614 was removed with a corresponding adjustment to accumulated deficit. A $55,585 unamortized discount remained. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $14,046 and $40,289 respectively, with an unamortized discount of $15,296 at November 30, 2024.     (11) The unsecured note may be pre-payable at any time. Cash proceeds of $5,400,000 were received. The note balance of $6,000,000 includes an original issue discount of $600,000 and was issued with a warrant to purchase 300,000,000 shares at an exercise price of $0.135 per share with a 3-year term and having a relative fair value of $4,749,005 using Black-Scholes with assumptions described in note 13. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $4,749,005 with a corresponding adjustment to paid in capital for the relative value of the warrant. The maturity was extended from March 1, 2022 to March 1, 2024 on February 28, 2022 in exchange for warrants to purchase 150,000,000 shares of common stock at an exercise price of $.0164 and a 3 year term. These warrants have a fair value of $2,850,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. This note has been fully amortized. This note was again extended to March 1, 2025.     (12)  The note, with an original principal balance of $2,750,000, may be pre-payable at any time. The note balance includes an original issue discount of $50,000 and was issued with a warrant to purchase 170,000,000 shares at an exercise price of $0.064 per share with a 3-year term and having a relative fair value of $2,035,033. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $2,035,033 with a corresponding adjustment to paid in capital. The maturity date was extended from June 8, 2022 to June 8, 2024 on February 28, 2022 in exchange for warrants to purchase 85,000,000 at an exercise price of $.0164 and a 3 year term. These warrants have a fair value of $1,615,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. This note was extended to June 8, 2025. On March 1, 2024, the unamortized relative fair value discount of $33,547 was removed with a corresponding adjustment to accumulated deficit. A $4,121 unamortized discount remained. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $895 and $2,234, respectively, with an unamortized discount of $1,887 at November 30, 2024.     (13) This loan, with an original principal balance of $4,000,160, was in exchange for 184 Series F preferred shares from a former director. The interest and principal are payable at maturity. The loan is unsecured. For the three and nine months ended November 30, 2024 there were repayments of $9,000 and $36,000 , respectively on the note.     (14) The note, with an original principal balance of $1,650,000, may be pre-payable at any time. The note balance includes an original issue discount of $150,000 and was issued with a warrant to purchase 250,000,000 shares at an exercise price of $0.037 per share with a 3-year term and having a relative fair value of $1,284,783, The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $1,284,783 with a corresponding adjustment to paid in capital. On March 1, 2024, the unamortized relative fair value discount of $572,549 was removed with a corresponding adjustment to accumulated deficit. A $66,846 unamortized discount remained. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $10,668 and $30,659 respectively, with an unamortized discount of 36,250 at November 30, 2024. This note was extended to September 14, 2025.     (15) Original $170,000 note may be pre-payable at any time. The note balance includes an original issue discount of $20,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from July 28, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized..     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)   (16) A warrant holder exchanged 955,000,000 warrants for a promissory note of $3,000,000, bearing interest at 15% with a two year maturity. The fair value of the warrants was determined to be $2,960,500 with a corresponding adjustment to paid-in capital and a debt discount of $39,500 which will be amortized over the term of the loan. Principal and interest due at maturity. On March 1, 2024, the unamortized relative fair value discount of $11,535 was removed with a corresponding adjustment to accumulated deficit. This note has been fully amortized. This note was extended to August 30, 2025.     (17) Original $400,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from September 7, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized.     (18) Original $475,000 note may be pre-payable at any time. The note balance includes an original issue discount of $75,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from September 8, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized.     (19) Original $350,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of the Company’s s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from October 13, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized.   (20) On October 28, 2022 the Company entered into an loan facility with a lender for up to $4,000,000 including an original issue discount of $500,000. In exchange the Company will issue one series F Preferred Share, extended 329 series F warrants with a March 1, 2026 maturity to a new October 31, 2033 maturity, and issue up to 10 tranches with each tranche of $400,000, with cash proceeds of $350,000 an original issue discount of $50,000, October 31, 2026 maturity, and 61 Series F warrants with a October 31, 2033 maturity. Secured by a general security charging all of the Company’s present and after-acquired property. At February 29, 2024 the Company has issued all 10 tranches totaling $ 4,000,000 as follows:       October 28, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants and 1 Series F Preferred Share having a relative fair value of $299,399. On March 1, 2024, the unamortized relative fair value discount of $286,775 was removed with a corresponding adjustment to accumulated deficit. A $47,892 unamortized discount remained. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $3,857 and $10,922, respectively, with an unamortized discount of $36,970 at November 30, 2024.     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)   (20) November 9, 2022, $400,000 loan, original issue discount of $50,000 , 61 Series F Preferred Share warrants having a relative fair value of $299,750. On March 1, 2024, the unamortized relative fair value discount of $288,513 was removed with a corresponding adjustment to accumulated deficit. A $48,126 unamortized discount remained. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $3,875 and $10,972, respectively, with an unamortized discount of $37,154 at November 30, 2024.   November 10, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $302,020. On March 1, 2024, the unamortized relative fair value discount of $291,694 was removed with a corresponding adjustment to accumulated deficit. A $48,290 unamortized discount remained. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $3,887 and $11,006, respectively, with an unamortized discount of $37,284 at November 30, 2024.   November 15, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. On March 1, 2024, the unamortized relative fair value discount of $287,814 was removed with a corresponding adjustment to accumulated deficit. A $47,976 unamortized discount remained. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $3,863 and $10,939, respectively, with an unamortized discount of $37,037 at November 30, 2024.   January 11, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. On March 1, 2024, the unamortized relative fair value discount of $286,813 was removed with a corresponding adjustment to accumulated deficit. A $48,124 unamortized discount remained. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $3,874 and $10,970, respectively, with an unamortized discount of $37,154 at November 30, 2024.   February 6, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. On March 1, 2024, the unamortized relative fair value discount of $288,342 was removed with a corresponding adjustment to accumulated deficit. A $48,294 unamortized discount remained. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $3,887 and $11,007, respectively, with an unamortized discount of $37,287 at November 30, 2024.   April 5, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $296,245. On March 1, 2024, the unamortized relative fair value discount of $286,821 was removed with a corresponding adjustment to accumulated deficit. A $48,409 unamortized discount remained. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $3,896 and $11,031, respectively, with an unamortized discount of $37,378 at November 30, 2024.   April 20, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $302,219. On March 1, 2024, the unamortized relative fair value discount of $294,824 was removed with a corresponding adjustment to accumulated deficit. A $48,777 unamortized discount remained. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $3,924 and $11,110, respectively, with an unamortized discount of $37,667 at November 30, 2024.   May 11, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $348,983. On March 1, 2024, the unamortized relative fair value discount of $348,831 was removed with a corresponding adjustment to accumulated deficit. A $49,978 unamortized discount remained. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $4,015 and $11,365, respectively, with an unamortized discount of $38,613 at November 30, 2024.   October 27 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $261,759. On March 1, 2024, the unamortized relative fair value discount of $254,487 was removed with a corresponding adjustment to accumulated deficit. A $48,611 unamortized discount remained. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $3,912 and $11,075, respectively, with an unamortized discount of $37,536 at November 30, 2024.     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)   (21) On November 30, 2023, the Company entered into an agreement where the lender will pay the Company $350,000 in exchange for thirteen future monthly payments of $36,750 commencing on April 30,2024 through to April 30, 2025 totaling $477,750. The effective interest rate is 35% per annum. Secured by a general security charging all of RAD’s present and after-acquired property. Default rate of 15% per annum calculated daily on any missed monthly payment. The Company has repaid $147,000 and $53,000 in accrued interest in July to account for the missed the April and August 2024 payments not made in agreement with the lender. No notices have been sent.     (22) On March 8, 2024, the Company entered into another agreement where the lender will pay the Company $350,000 in exchange for thirteen future monthly payments of $36,750 commencing on August 8, 2024 through to August 80, 2025 totaling $477,750. The effective interest rate is 35% per annum. Secured by a general security charging all of RAD’s present and after- acquired property. Default rate of 15% per annum calculated daily on any missed monthly payment. The August 2024 payment has not been made but will be resolved with the lender. No notices have been sent.     (23) On August 8, 2024, a Series F preferred shareholder exchanged 20 Series F the preferred shares for a $400,000 note payable. On August 22, 2022 the lender exchanged $200,000 of note principal for 57,142,857 common shares. The common shares were issued in September 2024. The note balance at November 30, 2024 is $200,000.

STOCKHOLDERS’ EQUITY (DEFICIT)	9 Months Ended
	Nov. 30, 2024
Equity [Abstract]
STOCKHOLDERS’ EQUITY (DEFICIT)	12. STOCKHOLDERS’ EQUITY (DEFICIT)   Summary or Preferred Stock Activity   During the nine months ended November 30, 2024, a Series F preferred shareholder exchanged 20 Series F preferred shares for a $400,000 note payable. (see Note 12). The Company recorded an adjustment to the par value of the shares of $20, paid -in capital for the carrying value of the shares of $65,793 with the remaining amount of $334,187 a deemed dividend.   Summary of Preferred Stock Warrant Activity       Number of Series F Preferred Warrants     Weighted Average Exercise Price     Weighted Average Remaining Years   Outstanding at March 1, 2023     939     $ 1.00       9.50   Issued     —       —       —   Exercised     —       —       —   Forfeited and cancelled     —       —       —   Outstanding at November 30, 2024     939     $ 1.00       9.20     Series B Convertible, Redeemable Preferred Stock (Temporary Equity)   On April 27, 2024, in connection with a Share Purchase Agreement the Company created a new class Of Series B Convertible Redeemable Preferred Shares with 5,000 authorized shares. The Company received gross proceeds of $300,000 with net proceeds of $278,000 less $10,000 in legal fees and 12,000 in broker fees both charged against paid in capital. In addition, as a commitment fee the Company issued an additional 20 Series B Convertible Redeemable Preferred Shares, with a fair value of $24,000 charged to paid in capital. The shares have a redemption value of $1,200 per share. The Company must redeem one third of these shares in 30, days and each 30 days thereafter until all the shares are redeemed at 90 days. The Company must also pay an 8% dividend from issue date to redemption date. On May 30, June 28 and July 28, 2024 the Company then issued total dividends of 4.32 shares of Series B Convertible Redeemable Preferred Shares having a value of $5,188 and fully redeemed the outstanding 324 Series B shares for $389,189 including deemed dividends of $89,189 which represents the redemption value over the purchase cost of the shares.   At November 30, 2024 there are 0 Series B Convertible Redeemable Preferred Shares outstanding.     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) Series F Convertible Preferred Shares   During the nine months ended November 30, 2024, a Series F preferred shareholder exchanged 20 Series F preferred shares for a $400,000 note payable. (see Note 12). The Company record an adjustment to the par value of the shares of $20, paid -in capital for the carrying value of the shares of $65,793 with the remaining amount of $334,187 a deemed dividend.   Summary of Common Stock Activity   The Company increased authorized common shares from 12,500,000,000 to 15,000,000,000 on October 4, 2024.   For the three months ended November 30, 2024, the Company issued 875,000,000 common shares with gross proceeds of $2,468,477 and net proceeds of $2,073,393 after issuance costs of $93,885.   For the nine months ended November 30, 2024, the Company issued 3,285,777,227 common shares with gross proceeds of 9,652,914 and net proceeds of $9,247,248 after issuance costs of $406,566. Included in the net proceeds are $352,701 in share proceeds receivable received after quarter end. In addition, for the nine months ended November 30, 2024, the Company issued 57,142,857 issuable shares as payment for $200,000 of principle on a note payable. (see Note 12)   Summary of Common Stock Warrant Activity   For the three months and nine months ended November 30, 2024 and November 30, 2023, the Company recorded a total of $83,323 and $47,462, and $249,969 and $150,896 respectively, to stock-based compensation for options and warrants with a corresponding adjustment to additional paid-in capital.       Number of Warrants     Weighted Average Exercise Price     Weighted Average Remaining Years   Outstanding at March 1, 2024     300,595,661     $ 0.003       1.00   Issued     —       —       —   Exercised     —       —       —   Forfeited and cancelled     (253,324,212 )     0.003       —   Outstanding at November 30, 2024     47,271,449     $ 0.003       2.68     Summary of Common Stock Option Activity -Employee Stock Options       Number of Options     Weighted Average Exercise Price     Weighted Average Remaining Years   Outstanding at March 1, 2024     188,667,035     $ 0.02       4.10   Issued     —       —       —   Exercised     —       —       —   Forfeited, extinguished and cancelled     (3,011,029 )   $ 0.02       (4.60 ) Outstanding at November 30, 2024     185,656,006     $ 0.02       3.75       ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

COMMITMENTS AND CONTINGENCIES	9 Months Ended
	Nov. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	13. COMMITMENTS AND CONTINGENCIES   Litigation   Occasionally, the Company may be involved in claims and legal proceedings arising from the ordinary course of its business. The Company records a provision for a liability when it believes that is both probable that a liability has been incurred, and the amount can be reasonably estimated. If these estimates and assumptions change or prove to be incorrect, it could have a material impact on the Company’s condensed consolidated financial statements. Contingencies are inherently unpredictable, and the assessments of the value can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions.   The related legal costs are expensed as incurred.   On September 24, 2024 a prospective lender filed a claim against the Company for an alleged breach of a non-binding term sheet made on June 7, 2024. This claim is an example of predatory lending practices for which the Company has filed a notice of dismissal in the relevant jurisdiction. The Company and its counsel believe the claim is without merit and will contest it vigorously. Accordingly, the Company has made no accruals.   Operating Lease   On March 10, 2021, the Company entered into a 10 year lease agreement for q manufacturing facility at 10800 Galaxie Avenue, Ferndale, Michigan, 48220, commencing on May 1, 2021 through to April 30, 2031 with a minimum base rent of $15,880 per month. The base rent increase by 3% per annum commencing May 1, 2024. The Company paid a security deposit of $15,880.   On September 30, 2021, the Company entered into a 3-year lease agreement for a vehicle commencing September 30, 2021 through to April 30, 2031 with a minimum base rent of $1,538 per month. The Company paid a down payment of $18,462.   On January 28, 2022, the Company entered into a 2-year lease agreement for office space at 1516 E Edinger, Santa Ana, California, 92705, commencing on February 1, 2022 through to January 31, 2024 with a minimum base rent of $1,500 per month. The Company paid a security deposit of $1,500.   On February 5, 2024, the Company entered into a 3-year lease agreement for a vehicle commencing February 5, 2024 through to February 5, 2027 with a minimum base rent of $1,223 per month. The Company paid a down payment of $9,357.   The Company’s leases are accounted for as operating leases. Rent expense and operating lease cost are recorded over the lease terms on a straight-line basis. Rent expense and operating lease cost was $57,875 and $182,855 for the three and nine months ended November 30, 2024, respectively, and $64,081 and $189,164 for the three and nine months ended November 30, 2023 respectively.   Summary of rent expense and operating lease cost are recorded over the lease terms on a straight-line basis.   Maturity of Lease Liabilities   Operating Leases   November 30, 2025   $ 225,348   November 30, 2026     225,348   November 30, 2027     210,523   November 30, 2028     207,558   November 30, 2029     207,558   November 30, 2030 and after     294,041   Total lease payments     1,370,376   Less: Interest     (334,514 ) Present value of lease liabilities   $ 1,035,861       ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

EARNINGS (LOSS) PER SHARE	9 Months Ended
	Nov. 30, 2024
Earnings Per Share [Abstract]
EARNINGS (LOSS) PER SHARE	14. EARNINGS (LOSS) PER SHARE   The net income (loss) per common share amounts were determined as follows:       For the Three Months Ended     For the Nine Months Ended       November 30,     November 30,       2024     2023     2024     2023   Numerator:                                 Net income (loss) available to common shareholders   $ (3,703,974 )   $ (3,966,484 )   $ (11,828,656 )   $ (13,281,405 )                                   Effect of common stock equivalents                                 Deduct : Dividend on Series B shares     —       —       (89,189 )     —   Deduct: Deemed dividend on redemption of Series F shares     —       —       (334,187 )     —   Net income (loss) adjusted for common stock equivalents     (3,703,974 )     (3,966,484 )     (12,252,032 )     (13,281,405 )                                   Denominator:                                 Weighted average shares – basic     12,161,286,427       7,294,775,879       11,071,139,695       6,606,988,956                                     Net income (loss) per share – basic   $ (0.00 )   $ (0.00 )   $ (0.00 )   $ (0.00 )                                   Dilutive effect of common stock equivalents:                                 Convertible Debt     —       —       —       —   Preferred shares     —       —       —       —   Warrants     —       —       —       —         —       —       —       —   Denominator:                                 Weighted average shares – diluted     12,161,286,427       7,294,775,879       11,071,139,695       6,606,988,956                                     Net income (loss) per share – diluted   $ (0.00 )   $ (0.00 )   $ (0.00 )   $ (0.00 )   The anti-dilutive shares of common stock equivalents for the three and nine months ended November 30, 2024 and 2023 were as follows:       For the Three Months Ended     For the Nine Months Ended       November 30,     November 30,       2024     2023     2024     2023                             Convertible Series F Preferred Shares*     43,406,765,095       26,617,244,133       43,406,765,095       26,617,244,133   Stock options and warrants     232,927,455       428,667,451       232,927,455       428,667,451   Total     43,639,692,550       27,045,911,584       43,639,692,550       27,045,911,584

SUBSEQUENT EVENTS	9 Months Ended
	Nov. 30, 2024
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	15. SUBSEQUENT EVENTS   Subsequent to November 30, 2024 through to January 14, 2025:   — The Company issued 650,000,000 common shares pursuant to a share purchase agreement : 450,000,000 common shares for gross proceeds of $1,026,407, issuance costs of $44,131 and net proceeds of $982,236. The remaining 200,000,000 common shares were issued for estimated gross proceeds of $620,000 as the pricing on these common shares have not yet been determined at time of filing.   — The Company repaid the remaining $200,000 on a loan payable through the issuance of 76,923,076 common shares on December 16, 2024.

ACCOUNTING POLICIES (Policies)	9 Months Ended
	Nov. 30, 2024
Accounting Policies [Abstract]
Basis of Presentation and Consolidation	Basis of Presentation and Consolidation   The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and in conformity with the condensing instructions on Form 10-Q and Rule 8-03 of Regulation S-X and the related rules and regulations of the Securities and Exchange Commission (“SEC”) and should be read in conjunction with the audited financial statements and notes thereto in the Company’s latest Annual Report filed with the SEC on Form 10-K as filed on May 29, 2024. The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Robotic Assistance Devices, Inc., Robotic Assistance Devices Group , Inc, Robotic Assistance Devices Mobile, Inc., On the Move Experience, LLC and On the OMV Transports, LLC. All significant intercompany accounts and transactions have been eliminated in consolidation. The unaudited consolidated financial statements reflect all adjustments, consisting of normal recurring accruals, which are, in the opinion of management, necessary for a fair presentation of such statements. The results of operations for the nine months ended November 30, 2024 are not necessarily indicative of the results that may be expected for the entire year.
Use of Estimates	Use of Estimates   In order to prepare financial statements in conformity with accounting principles generally accepted in the United States, management must make estimates, judgements and assumptions that affect the amounts reported in the financial statements and determine whether contingent assets and liabilities, if any, are disclosed in the financial statements. The ultimate resolution of issues requiring these estimates and assumptions could differ significantly from resolution currently anticipated by management and on which the financial statements are based. The most significant estimates included in these consolidated financial statements are those associated with the assumptions used to value preferred stock and derivative liabilities.
Reclassifications	Reclassifications   Certain amounts in the Company’s consolidated financial statements for prior periods have been reclassified to conform to the current period presentation. These reclassifications have not changed the results of operations of prior periods.
Concentrations	Concentrations   Loans payable   At November 30, 2024 there were $33,163,345 of loans payable, $28,743,506 or 87% of these loans to companies controlled by one individual. At February 29, 2024 there were $32,796,345 of loans payable, $28,540,506 or 87% of these loans to companies controlled by the same individual.
Cash	Cash   The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Cash and cash equivalents consist of cash on deposit with banks and money market instruments. The Company places its cash and cash equivalents with high-quality, U.S. financial institutions and, to date has not experienced losses on any of its balances.
Accounts Receivable	Accounts Receivable   Accounts receivable are comprised of balances due from customers, net of estimated allowances for uncollectible accounts. In determining collectability, historical trends are evaluated, and specific customer issues are reviewed on a periodic basis to arrive at appropriate allowances. There was an allowance of $74,000 and $68,000 provided as of November 30, 2024 and February 29, 2024, respectively. For the three months ended November 30, 2024, one customer accounted for 61% of total accounts receivable. For the three months ended November 30, 2023, two customers account for 61% of total accounts receivable.
Device Parts Inventory	Device Parts Inventory   Device parts inventory is stated at the lower of cost or net realizable value using the weighted average cost method. The Company records a valuation reserve for obsolete and slow-moving inventory, relying principally on specific identification of such inventory. The Company uses these device parts in the assembly of revenue earning devices (and demo devices) as well as research and development. Depending on use, the Company will transfer the parts to the corresponding asset or expense if used in research and development. A charge to income is taken when factors that would result in a need for an increase in the valuation, such as excess or obsolete inventory, are noted. As of November 30, 2024 and February 29, 2024 there was a valuation reserve of $1,109,000 and $959,000, respectively.     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
Revenue Earning Devices	Revenue Earning Devices   Revenue earning devices are stated at cost. Depreciation is provided on a straight-line basis over the estimated useful life of 48 months. The Company continually evaluates revenue earning devices to determine whether events or changes in circumstances have occurred that may warrant revision of the estimated useful life or whether the devices should be evaluated for possible impairment. The Company uses a combination of undiscounted cash flows and market approaches in assessing whether an asset has been impaired. The Company measures impairment losses based upon the amount by which the carrying amount of the asset exceeds the fair value.
Fixed Assets	Fixed Assets   Fixed assets are stated at cost. Depreciation is provided on the straight-line method based on the estimated useful lives of the respective assets which range from two to five years. Major repairs or improvements are capitalized. Minor replacements and maintenance and repairs which do not improve or extend asset lives are expensed currently.    Computer equipment and software   2 or 3 years Office equipment   4 years Manufacturing equipment   7 years Warehouse equipment   5 years Tooling   2 years Demo Devices   4 years Vehicles   3 years Leasehold improvements   5 years, the life of the lease   The Company periodically evaluates the fair value of fixed assets whenever events or changes in circumstances indicate that its carrying amounts may not be recoverable. Upon retirement or other disposition of fixed assets, the cost and related accumulated depreciation are removed from the accounts and the resulting gain or loss, if any, is recognized in income.
Research and Development	Research and Development   Research and development costs are expensed in the period they are incurred in accordance with ASC 730, Research and Development unless they meet specific criteria related to technical, market and financial feasibility, as determined by Management, including but not limited to the establishment of a clearly defined future market for the product, and the availability of adequate resources to complete the project. If all criteria are met, the costs are deferred and amortized over the expected useful life or written off if a product is abandoned. At November 30, 2024 and February 29, 2024, the Company had no deferred development costs.
Contingencies	Contingencies   Occasionally, the Company may be involved in claims and legal proceedings arising from the ordinary course of its business. The Company records a provision for a liability when it believes that it is both probable that a liability has been incurred, and the amount can be reasonably estimated. If these estimates and assumptions change or prove to be incorrect, it could have a material impact on the Company’s consolidated financial statements. Contingencies are inherently unpredictable, and the assessments of the value can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions.
Sales of Future Revenues	Sales of Future Revenues   The Company has entered into transactions, as more fully described in footnote 8, in which it has received funding from investors in exchange for which it will make payments to those investors based on the level of sales of certain revenue categories, generally based on a percentage of sales for those certain revenues. The Company determines whether these agreements constitute sales of future revenues or are in substance debt based on the facts and circumstances of each agreement, with the following primary criteria determinative of whether the agreement constitutes a sale of future revenues or debt:     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)     ● Does the agreement purport, in substance, to be a sale   ● Does the Company have continuing involvement in the generation of cash flows due the investor   ● Is the transaction cancellable by either party through payment of a lump sum or other transfer of assets   ● Is the investors rate of return is implicitly limited by the terms of the agreement   ● Does the Company’s revenue for a reporting period underlying the agreement have only a minimal impact on the investor’s rate of return   ● Does the investor have recourse relating to payments due   In the event a transaction is determined to be a sale of future revenues, it is recorded as deferred revenue and amortized using the sum-of-the-revenue method. In the event a transaction is determined to be debt, it is recorded as debt and amortized using the effective interest method. As of the date of these financial statements, the Company has determined that all such agreements are debt.
Revenue Recognition	Revenue Recognition   ASU 2014-09, “Revenue from Contracts with Customers (Topic 606)”, supersedes the revenue recognition requirements and industry specific guidance under Revenue Recognition (Topic 605). Topic 606 requires an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration the entity expects to be entitled to in exchange for those goods or services. Topic 606 defines a five-step process that must be evaluated and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing accounting principles generally accepted in the United States of America (“U.S. GAAP”) including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. The Company adopted Topic 606 on March 1, 2018, using the modified retrospective method. Under the modified retrospective method, prior period financial positions and results will not be adjusted. There was no cumulative effect adjustment recognized as a result of this adoption. Refer to Note 4 – Revenue from Contracts with Customers for additional information. For the nine months ended November 30, 2024, one customer accounted for 57% of total revenue and for the nine months ended November 30, 2023, four customers accounted for 58% of total revenue.
Income Taxes	Income Taxes   Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized when items of income and expense are recognized in the financial statements in different periods than when recognized in the tax return. Deferred tax assets arise when expenses are recognized in the financial statements before the tax returns or when income items are recognized in the tax return prior to the financial statements. Deferred tax assets also arise when operating losses or tax credits are available to offset tax payments due in future years. Deferred tax liabilities arise when income items are recognized in the financial statements before the tax returns or when expenses are recognized in the tax return prior to the financial statements. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.   On December 22, 2017, the Tax Cuts and Jobs Act (“Tax Act”) was signed into law. ASC 740, Accounting for Income Taxes requires companies to recognize the effects of changes in tax laws and rates on deferred tax assets and liabilities and the retroactive effects of changes in tax laws in the period in which the new legislation is enacted. The Company’s gross deferred tax assets were revalued based on the reduction in the federal statutory tax rate from 35% to 21%. A corresponding offset has been made to the valuation allowance, and any potential other taxes arising due to the Tax Act will result in reductions to the Company’s net operating loss carryforward and valuation allowance. The Company will continue to analyze the Tax Act to assess its full effects on the Company’s financial results, including disclosures, for the Company’s fiscal year ending February 28, 2024, but the Company does not expect the Tax Act to have a material impact on the Company’s consolidated financial statements.
Leases	Leases   Lease agreements are evaluated to determine if they are sales/finance leases meeting any of the following criteria at inception: (a) transfer of ownership of the underlying asset; (b) purchase option that is reasonably certain of being exercised; (c) the lease term is greater than a major part of the remaining estimated economic life of the underlying asset; or (d) if the present value of the sum of lease payments and any residual value guaranteed by the lessee that has not already been included in lease payments in accordance with ASC 842-10-30-5(f) equals or exceeds substantially all of the fair value of the underlying asset.     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)   If at its inception, a lease meets any of the four lease criteria above, the lease is classified by the Company as a sales/finance; and if none of the four criteria are met, the lease is classified by the Company as an operating lease.   Operating lease payments are recognized as an expense in the income statement on a straight-line basis over the lease term, whereby an equal amount of rent expense is attributed to each period during the term of the lease, regardless of when actual payments are made. This generally results in rent expense in excess of cash payments during the early years of a lease and rent expense less than cash payments in the later years. The difference between rent expense recognized and actual rental payments is recorded as deferred rent and included in liabilities.
Distinguishing Liabilities from Equity	Distinguishing Liabilities from Equity   The Company relies on the guidance provided by ASC Topic 480, Distinguishing Liabilities from Equity, to classify certain redeemable and/or convertible instruments. The Company first determines whether a financial instrument should be classified as a liability. The Company will determine the liability classification if the financial instrument is mandatorily redeemable, or if the financial instrument, other than outstanding shares, embodies a conditional obligation that the Company must or may settle by issuing a variable number of its equity shares.   Once the Company determines that a financial instrument should not be classified as a liability, the Company determines whether the financial instrument should be presented between the liability section and the equity section of the balance sheet (“temporary equity”). The Company will determine temporary equity classification if the redemption of the financial instrument is outside the control of the Company (i.e. at the option of the holder). Otherwise, the Company accounts for the financial instrument as permanent equity.   Our Chief Executive Officer/ Chairman holds sufficient shares of the Company’s voting preferred stock that give sufficient voting rights under the articles of incorporation and bylaws of the Company such that the CEO/ Chairman can at any time unilaterally vote to increase the number of authorized shares of common stock of the Company, without the need to call a general meeting of common shareholders of the Company.   Initial Measurement   The Company records its financial instruments classified as liability, temporary equity or permanent equity at issuance at the fair value, or cash received.   Subsequent Measurement – Financial Instruments Classified as Liabilities   The Company records the fair value of its financial instruments classified as liabilities at each subsequent measurement date. The changes in fair value of its financial instruments classified as liabilities are recorded as other income (expenses).
Fair Value of Financial Instruments	Fair Value of Financial Instruments   ASC Topic 820, Fair Value Measurements and Disclosures (“ASC Topic 820”) provides a framework for measuring fair value in accordance with generally accepted accounting principles.   ASC Topic 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs).   The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy under ASC Topic 820 are described as follows:     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)     ● Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities that are accessible at the measurement date.         ● Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data by correlation or other means.         ● Level 3 – Inputs that are unobservable for the asset or liability.   Measured on a Recurring Basis   The following table presents information about our liabilities measured at fair value on a recurring basis, aggregated by the level in the fair value hierarchy within which those measurements fell:       Amount at     Fair Value Measurement Using       Fair Value     Level 1     Level 2     Level 3   November 30, 2024                                 Liabilities                                 Incentive compensation plan payable- revaluation of equity awards payable in Series G shares   $ 2,500,000     $ —     $ —     $ 2,500,000                                     February 29, 2024                                 Liabilities                                 Incentive compensation plan payable- revaluation of equity awards payable in Series G shares   $ 2,500,000     $ —     $ —     $ 2,500,000     The carrying amounts of the Company’s financial assets and liabilities, such as cash, accounts receivable, prepaid expenses and advances, accounts payable and accrued expenses, approximate their fair values because of the short maturity of these instruments.
Earnings (Loss) per Share	Earnings (Loss) per Share   Basic earnings (loss) per share (“EPS”) is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS give effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used to determine the number of shares assumed to be purchased from the exercise of stock options and/or warrants. Diluted EPS excluded all dilutive potential shares if their effect is anti-dilutive.   Basic loss per common share is computed based on the weighted average number of shares outstanding during the period. Diluted loss per share is computed in a manner similar to the basic loss per share, except the weighted-average number of shares outstanding is increased to include all common shares, including those with the potential to be issued by virtue of convertible debt and other such convertible instruments. Diluted loss per share contemplates a complete conversion to common shares of all convertible instruments only if they are dilutive in nature with regards to earnings per share.     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements   Recently Issued Accounting Standards During the Year   In August 2020, the FASB issued ASU 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. Under ASU 2020-06, the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives under Topic 815, or that do not result in substantial premiums accounted for as paid-in capital. Consequently, a convertible debt instrument will be accounted for as a single liability measured at its amortized cost, as long as no other features require bifurcation and recognition as derivatives. The new guidance also requires the if-converted method to be applied for all convertible instruments. The amendments in ASU 2020-06 are effective for public entities, excluding smaller reporting companies as defined, for fiscal years beginning after December 15, 2021. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023. Early adoption is permitted. A reporting entity is not permitted to adopt the guidance in an interim period, other than the first interim period of its fiscal year. The Company adopted the standard using a modified retrospective approach. The adjustment to the Company’s accumulated deficit at March 1, 2024 was $4,175,535 with a corresponding adjustment to loans payable.

ACCOUNTING POLICIES (Tables)	9 Months Ended
	Nov. 30, 2024
Accounting Policies [Abstract]
SCHEDULE OF FIXED ASSETS STATED AT COST	Computer equipment and software   2 or 3 years Office equipment   4 years Manufacturing equipment   7 years Warehouse equipment   5 years Tooling   2 years Demo Devices   4 years Vehicles   3 years Leasehold improvements   5 years, the life of the lease
SCHEDULE OF LIABILITIES MEASURED AT FAIR VALUE	The following table presents information about our liabilities measured at fair value on a recurring basis, aggregated by the level in the fair value hierarchy within which those measurements fell:       Amount at     Fair Value Measurement Using       Fair Value     Level 1     Level 2     Level 3   November 30, 2024                                 Liabilities                                 Incentive compensation plan payable- revaluation of equity awards payable in Series G shares   $ 2,500,000     $ —     $ —     $ 2,500,000                                     February 29, 2024                                 Liabilities                                 Incentive compensation plan payable- revaluation of equity awards payable in Series G shares   $ 2,500,000     $ —     $ —     $ 2,500,000

REVENUE FROM CONTRACTS WITH CUSTOMERS (Tables)	9 Months Ended
	Nov. 30, 2024
Revenue from Contract with Customer [Abstract]
SCHEDULE OF REVENUES FROM CONTRACTS WITH CUSTOMERS	The following table presents revenues from contracts with customers disaggregated by product/service:       Three Months Ended November 30, 2024     Three Months Ended November 30, 2023     Nine Months Ended November 30, 2024     Nine Months Ended November 30, 2023   Device rental activities   $ 1,429,112     $ 416,062     $ 3,475,546     $ 997,754   Direct sales of goods and services     321,856       180,918       802,405       370,797     $ 1,750,968     $ 596,980     $ 4,277,951     $ 1,368,551

LEASES (Tables)	9 Months Ended
	Nov. 30, 2024
Leases [Abstract]
SCHEDULE OF LEASE ASSETS AND LIABILITIES	Below is a summary of our lease assets and liabilities at November 30, 2024 and February 29, 2024.   Leases   Classification   November 30, 2024     February 29, 2024   Assets                     Operating   Operating Lease Assets   $ 1,040,862     $ 1,139,188   Liabilities                     Current                     Operating   Current Operating Lease Liability   $ 225,348     $ 237,653   Noncurrent                     Operating   Noncurrent Operating Lease Liabilities     810,513       889,360   Total lease liabilities       $ 1,035,861     $ 1,127,013

REVENUE EARNING DEVICES (Tables)	9 Months Ended
	Nov. 30, 2024
Revenue Earning Devices
SCHEDULE OF REVENUE EARNING DEVICES	Revenue earning devices consisted of the following:       November 30, 2024     February 29, 2024   Revenue earning devices   $ 6,233,201     $ 3,432,846   Less: Accumulated depreciation     (1,881,451 )     (952,844 )   $ 4,351,750     $ 2,480,002
SCHEDULE OF DEPRECIATION AND AMORTIZATION	Depreciation and amortization for the three and nine months ended November 30, 2024 and 2023 are as follows:   Depreciation and Amortization   Three Months Ended November 30, 2024     Three Months Ended November 30, 2023     Nine Months Ended November 30, 2024     Nine Months Ended November 30, 2023                             Cost of Goods Sold   $ 287,799     $ 113,830     $ 729,672     $ 322,369   Operating expenses     79,662       51,540       198,935       107,456   Total Depreciation and Amortization   $ 367,461     $ 165,370     $ 928,607     $ 429,825

FIXED ASSETS (Tables)	9 Months Ended
	Nov. 30, 2024
Property, Plant and Equipment [Abstract]
SCHEDULE OF FIXED ASSETS	Fixed assets consisted of the following:       November 30, 2024     February 29, 2024   Automobile   $ 74,237     $ 74,237   Demo devices     270,502       194,352   Tooling     107,020       107,020   Machinery and equipment     8,825       8,825   Computer equipment     157,448       150,387   Office equipment     15,312       15,312   Furniture and fixtures     21,225       21,225   Warehouse equipment     36,305       19,639   Leasehold improvements     26,956       26,956       717,830       617,953   Less: Accumulated depreciation     (460,641 )     (349,878 )   $ 257,189     $ 268,075
SCHEDULE OF DEPRECIATION AND AMORTIZATION IN OPERATING EXPENSES	Depreciation and Amortization   Three Months Ended November 30, 2024     Three Months Ended November 30, 2023     Nine Months Ended November 30, 2024     Nine Months Ended November 30, 2023                             Fixed assets   $ 26,599     $ 50,393     $ 110,764     $ 144,921   Revenue earning devices     79,662       51,540       198,935       107,456   Total Depreciation and Amortization included in operating expenses   $ 106,261     $ 101,933     $ 309,699     $ 252,377

LOANS PAYABLE (Tables)	9 Months Ended
	Nov. 30, 2024
Debt Disclosure [Abstract]
SCHEDULE OF LOANS PAYABLE	Loans payable at November 30, 2024 consisted of the following:                          Annual   Date   Maturity   Description       Principal     Interest Rate   July 18, 2016   July 18, 2017   Promissory note   (1)*   $ 3,500       22 % December 10, 2020   March 1, 2025   Promissory note   (2)     3,921,168       12 % December 10, 2020   March 1, 2025   Promissory note   (3)     2,754,338       12 % December 10, 2020   December 10, 2024   Promissory note   (4)     165,605       12 % December 14, 2020   March 1, 2027   Promissory note   (5)     310,375       12 % December 30, 2020   March 1, 2025   Promissory note   (6)     350,000       12 % January 1, 2021   March 1, 2025   Promissory note   (7)     25,000       12 % January 1, 2021   March 1, 2025   Promissory note   (8)     145,000       12 % January 14, 2021   March 1, 2025   Promissory note   (9)     550,000       12 % February 22, 2021   March 1, 2025   Promissory note   (10)     1,650,000       12 % March 1, 2021   March 1, 2025   Promissory note   (11)     6,000,000       12 % June 8, 2021   June 8, 2025   Promissory note   (12)     2,750,000       12 % July 12, 2021   July 26, 2026   Promissory note   (13)     3,740,360       7 % September 14, 2021   September 14, 2025   Promissory note   (14)     1,650,000       12 % July 28, 2022   March 1, 2025   Promissory note   (15)     170,000       15 % August 30, 2022   August 30,2025   Promissory note   (16)     3,000,000       15 % September 7, 2022   March 1, 2025   Promissory note   (17)     400,000       15 % September 8, 2022   March 1, 2025   Promissory note   (18)     475,000       15 % October 13, 2022   March 1, 2025   Promissory note   (19)     350,000       15 % October 28, 2022   October 31, 2026   Promissory note   (20)     400,000       15 % November 9, 2022   October 31, 2026   Promissory note   (20)     400,000       15 % November 10, 2022   October 31, 2026   Promissory note   (20)     400,000       15 % November 15, 2022   October 31, 2026   Promissory note   (20)     400,000       15 % January 11, 2023   October 31, 2026   Promissory note   (20)     400,000       15 % February 6, 2023   October 31, 2026   Promissory note   (20)     400,000       15 % April 5. 2023   October 31, 2026   Promissory note   (20)     400,000       15 % April 20, 23   October 31, 2026   Promissory note   (20)     400,000       15 % May 11, 2023   October 31, 2026   Promissory note   (20)     400,000       15 % October 27, 2023   October 31, 2026   Promissory note   (20)     400,000       15 % November 30, 2023   April 30, 2025   Purchase Agreement   (21)     203,000       35 % March 8, 2024   August 8, 2025   Purchase Agreement   (22)     350,000       35 % August 8, 2024   August 8, 2025   Exchange Agreement   (23)     200,000       12 %                 $ 33,163,346                                         Less: current portion of loans payable         (25,112,611 )         Less: discount on non-current loans payable         (374,081 )         Non-current loans payable, net of discount       $ 7,676,654                                         Current portion of loans payable       $ 25,112,611           Less: discount on current portion of loans payable         (58,620 )         Current portion of loans payable, net of discount       $ 25,053,991             * In default     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)   (1) This note was transferred from convertible notes payable because in August 2022 it was no longer convertible due to restrictions placed on the lender.     (2) This promissory note was issued as part of a debt settlement whereby $2,683,357 in convertible notes and associated accrued interest of $1,237,811 totaling $3,921,168 was exchanged for this promissory note of $3,921,168, and a warrant to purchase 450,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a relative fair value of $990,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from December 10, 2023 to March 1, 2025 with all other terms and conditions remaining the same.     (3) This promissory note was issued as part of a debt settlement whereby $1,460,794 in convertible notes and associated accrued interest of $1,593,544 totaling $3,054,338 was exchanged for this promissory note of $3,054,338, and a warrant to purchase 250,000,000 shares at an exercise price of $0.002 per share and a three-year maturity having a relative fair value of $550,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. $300,000 has been repaid during the year ended February 29, 2024. On November 28, 2023, the parties extended the maturity date from December 10, 2023 to March 1, 2025 with all other terms and conditions remaining the same.     (4) This promissory note was issued as part of a debt settlement whereby $103,180 in convertible notes and associated accrued interest of $62,425 totaling $165,605 was exchanged for this promissory note of $165,605, and a warrant to purchase 80,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a fair value of $176,000.The maturity date was extended from December 10, 2023 to December 10, 2024 on February 29, 2024 and a fee of $22,958 was paid and charged to interest expense.     (5) This promissory note was issued as part of a debt settlement whereby $235,000 in convertible notes and associated accrued interest of $75,375 totaling $310,375 was exchanged for this promissory note of $310,375, and a warrant to purchase 25,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a fair value of $182,500.     (6) The note, with an original principal amount of $350,000, may be pre-payable at any time. The note balance includes an original issue discount of $35,000 and was issued with a warrant to purchase 50,000,000 shares at an exercise price of $0.025 per share with a 3-year term and having a relative fair value of $271,250. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $271,250 with a corresponding adjustment to paid in capital for the relative fair value of the warrant. On March 1, 2024, the unamortized relative fair value discount of $65,092 was removed with a corresponding adjustment to accumulated deficit. A $8,399 unamortized discount remained. On November 28, 2023, the parties extended the maturity date from December 10, 2023 to March 1, 2025 with all other terms and conditions remaining the same. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $2,115 and $6,069, respectively, with an unamortized discount of $2,330 at November 30, 2024.     (7) This promissory note was issued as part of a debt settlement whereby $9,200 in convertible notes and associated accrued interest of $6,944 totaling $16,144 was exchanged for this promissory note of $25,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from January 1, 2024 to March 1, 2025 with all other terms and conditions remaining the same.     (8) This promissory note was issued as part of a debt settlement whereby $79,500 in convertible notes and associated accrued interest of $28,925 totaling $108,425 was exchanged for this promissory note of $145,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from January 1, 2024 to March 1, 2025 with all other terms and conditions remaining the same.     (9) The note, with an original principal amount of $550,000, may be pre-payable at any time. The note balance includes an original issue discount of $250,000 and was issued with a warrant to purchase 50,000,000 shares at an exercise price of $0.025 per share with a 3-year term and having a relative fair value of $380,174. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $380,174 with a corresponding adjustment to paid in capital. On March 1, 2024, the unamortized relative fair value discount of $80,284 was removed with a corresponding adjustment to accumulated deficit. A $10,559 unamortized discount remained. On November 28, 2023, the parties extended the maturity date from January 14, 2024 to March 1, 2025 with all other terms and Conditions remaining the same. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $2,649 and $7,702, respectively, with an unamortized discount of $2,857 at November 30, 2024     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)   (10) The note, with an original principal balance of $1,650,000, may be pre-payable at any time. The note balance includes an original issue discount of $150,000 and was issued with a warrant to purchase 100,000,000 shares at an exercise price of $0.135 per share with a 3-year term and having a relative fair value of $1,342,857. The discount and warrant are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $1,342,857 with a corresponding adjustment to paid in capital for the relative fair value of the warrant. The maturity date was extended from February 22, 2022 to February 22, 2024 on February 28, 2022 in exchange for warrants to purchase 50,000,000 at an exercise price of $.0164 and a 3-year term. These warrants have a fair value of $950,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. On November 28, 2023, the parties extended the maturity date from February 22, 2024 to March 1, 2025 with all other terms and conditions remaining the same. On March 1, 2024, the unamortized relative fair value discount of $497,614 was removed with a corresponding adjustment to accumulated deficit. A $55,585 unamortized discount remained. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $14,046 and $40,289 respectively, with an unamortized discount of $15,296 at November 30, 2024.     (11) The unsecured note may be pre-payable at any time. Cash proceeds of $5,400,000 were received. The note balance of $6,000,000 includes an original issue discount of $600,000 and was issued with a warrant to purchase 300,000,000 shares at an exercise price of $0.135 per share with a 3-year term and having a relative fair value of $4,749,005 using Black-Scholes with assumptions described in note 13. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $4,749,005 with a corresponding adjustment to paid in capital for the relative value of the warrant. The maturity was extended from March 1, 2022 to March 1, 2024 on February 28, 2022 in exchange for warrants to purchase 150,000,000 shares of common stock at an exercise price of $.0164 and a 3 year term. These warrants have a fair value of $2,850,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. This note has been fully amortized. This note was again extended to March 1, 2025.     (12)  The note, with an original principal balance of $2,750,000, may be pre-payable at any time. The note balance includes an original issue discount of $50,000 and was issued with a warrant to purchase 170,000,000 shares at an exercise price of $0.064 per share with a 3-year term and having a relative fair value of $2,035,033. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $2,035,033 with a corresponding adjustment to paid in capital. The maturity date was extended from June 8, 2022 to June 8, 2024 on February 28, 2022 in exchange for warrants to purchase 85,000,000 at an exercise price of $.0164 and a 3 year term. These warrants have a fair value of $1,615,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. This note was extended to June 8, 2025. On March 1, 2024, the unamortized relative fair value discount of $33,547 was removed with a corresponding adjustment to accumulated deficit. A $4,121 unamortized discount remained. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $895 and $2,234, respectively, with an unamortized discount of $1,887 at November 30, 2024.     (13) This loan, with an original principal balance of $4,000,160, was in exchange for 184 Series F preferred shares from a former director. The interest and principal are payable at maturity. The loan is unsecured. For the three and nine months ended November 30, 2024 there were repayments of $9,000 and $36,000 , respectively on the note.     (14) The note, with an original principal balance of $1,650,000, may be pre-payable at any time. The note balance includes an original issue discount of $150,000 and was issued with a warrant to purchase 250,000,000 shares at an exercise price of $0.037 per share with a 3-year term and having a relative fair value of $1,284,783, The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $1,284,783 with a corresponding adjustment to paid in capital. On March 1, 2024, the unamortized relative fair value discount of $572,549 was removed with a corresponding adjustment to accumulated deficit. A $66,846 unamortized discount remained. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $10,668 and $30,659 respectively, with an unamortized discount of 36,250 at November 30, 2024. This note was extended to September 14, 2025.     (15) Original $170,000 note may be pre-payable at any time. The note balance includes an original issue discount of $20,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from July 28, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized..     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)   (16) A warrant holder exchanged 955,000,000 warrants for a promissory note of $3,000,000, bearing interest at 15% with a two year maturity. The fair value of the warrants was determined to be $2,960,500 with a corresponding adjustment to paid-in capital and a debt discount of $39,500 which will be amortized over the term of the loan. Principal and interest due at maturity. On March 1, 2024, the unamortized relative fair value discount of $11,535 was removed with a corresponding adjustment to accumulated deficit. This note has been fully amortized. This note was extended to August 30, 2025.     (17) Original $400,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from September 7, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized.     (18) Original $475,000 note may be pre-payable at any time. The note balance includes an original issue discount of $75,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from September 8, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized.     (19) Original $350,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of the Company’s s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from October 13, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized.   (20) On October 28, 2022 the Company entered into an loan facility with a lender for up to $4,000,000 including an original issue discount of $500,000. In exchange the Company will issue one series F Preferred Share, extended 329 series F warrants with a March 1, 2026 maturity to a new October 31, 2033 maturity, and issue up to 10 tranches with each tranche of $400,000, with cash proceeds of $350,000 an original issue discount of $50,000, October 31, 2026 maturity, and 61 Series F warrants with a October 31, 2033 maturity. Secured by a general security charging all of the Company’s present and after-acquired property. At February 29, 2024 the Company has issued all 10 tranches totaling $ 4,000,000 as follows:       October 28, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants and 1 Series F Preferred Share having a relative fair value of $299,399. On March 1, 2024, the unamortized relative fair value discount of $286,775 was removed with a corresponding adjustment to accumulated deficit. A $47,892 unamortized discount remained. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $3,857 and $10,922, respectively, with an unamortized discount of $36,970 at November 30, 2024.     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)   (20) November 9, 2022, $400,000 loan, original issue discount of $50,000 , 61 Series F Preferred Share warrants having a relative fair value of $299,750. On March 1, 2024, the unamortized relative fair value discount of $288,513 was removed with a corresponding adjustment to accumulated deficit. A $48,126 unamortized discount remained. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $3,875 and $10,972, respectively, with an unamortized discount of $37,154 at November 30, 2024.   November 10, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $302,020. On March 1, 2024, the unamortized relative fair value discount of $291,694 was removed with a corresponding adjustment to accumulated deficit. A $48,290 unamortized discount remained. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $3,887 and $11,006, respectively, with an unamortized discount of $37,284 at November 30, 2024.   November 15, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. On March 1, 2024, the unamortized relative fair value discount of $287,814 was removed with a corresponding adjustment to accumulated deficit. A $47,976 unamortized discount remained. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $3,863 and $10,939, respectively, with an unamortized discount of $37,037 at November 30, 2024.   January 11, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. On March 1, 2024, the unamortized relative fair value discount of $286,813 was removed with a corresponding adjustment to accumulated deficit. A $48,124 unamortized discount remained. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $3,874 and $10,970, respectively, with an unamortized discount of $37,154 at November 30, 2024.   February 6, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. On March 1, 2024, the unamortized relative fair value discount of $288,342 was removed with a corresponding adjustment to accumulated deficit. A $48,294 unamortized discount remained. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $3,887 and $11,007, respectively, with an unamortized discount of $37,287 at November 30, 2024.   April 5, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $296,245. On March 1, 2024, the unamortized relative fair value discount of $286,821 was removed with a corresponding adjustment to accumulated deficit. A $48,409 unamortized discount remained. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $3,896 and $11,031, respectively, with an unamortized discount of $37,378 at November 30, 2024.   April 20, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $302,219. On March 1, 2024, the unamortized relative fair value discount of $294,824 was removed with a corresponding adjustment to accumulated deficit. A $48,777 unamortized discount remained. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $3,924 and $11,110, respectively, with an unamortized discount of $37,667 at November 30, 2024.   May 11, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $348,983. On March 1, 2024, the unamortized relative fair value discount of $348,831 was removed with a corresponding adjustment to accumulated deficit. A $49,978 unamortized discount remained. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $4,015 and $11,365, respectively, with an unamortized discount of $38,613 at November 30, 2024.   October 27 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $261,759. On March 1, 2024, the unamortized relative fair value discount of $254,487 was removed with a corresponding adjustment to accumulated deficit. A $48,611 unamortized discount remained. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $3,912 and $11,075, respectively, with an unamortized discount of $37,536 at November 30, 2024.     ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)   (21) On November 30, 2023, the Company entered into an agreement where the lender will pay the Company $350,000 in exchange for thirteen future monthly payments of $36,750 commencing on April 30,2024 through to April 30, 2025 totaling $477,750. The effective interest rate is 35% per annum. Secured by a general security charging all of RAD’s present and after-acquired property. Default rate of 15% per annum calculated daily on any missed monthly payment. The Company has repaid $147,000 and $53,000 in accrued interest in July to account for the missed the April and August 2024 payments not made in agreement with the lender. No notices have been sent.     (22) On March 8, 2024, the Company entered into another agreement where the lender will pay the Company $350,000 in exchange for thirteen future monthly payments of $36,750 commencing on August 8, 2024 through to August 80, 2025 totaling $477,750. The effective interest rate is 35% per annum. Secured by a general security charging all of RAD’s present and after- acquired property. Default rate of 15% per annum calculated daily on any missed monthly payment. The August 2024 payment has not been made but will be resolved with the lender. No notices have been sent.     (23) On August 8, 2024, a Series F preferred shareholder exchanged 20 Series F the preferred shares for a $400,000 note payable. On August 22, 2022 the lender exchanged $200,000 of note principal for 57,142,857 common shares. The common shares were issued in September 2024. The note balance at November 30, 2024 is $200,000.

STOCKHOLDERS’ EQUITY (DEFICIT) (Tables)	9 Months Ended
	Nov. 30, 2024
Equity [Abstract]
SUMMARY OF PREFERRED STOCK WARRANT ACTIVITY	Summary of Preferred Stock Warrant Activity       Number of Series F Preferred Warrants     Weighted Average Exercise Price     Weighted Average Remaining Years   Outstanding at March 1, 2023     939     $ 1.00       9.50   Issued     —       —       —   Exercised     —       —       —   Forfeited and cancelled     —       —       —   Outstanding at November 30, 2024     939     $ 1.00       9.20
SUMMARY OF COMMON STOCK WARRANT ACTIVITY	Number of Warrants     Weighted Average Exercise Price     Weighted Average Remaining Years   Outstanding at March 1, 2024     300,595,661     $ 0.003       1.00   Issued     —       —       —   Exercised     —       —       —   Forfeited and cancelled     (253,324,212 )     0.003       —   Outstanding at November 30, 2024     47,271,449     $ 0.003       2.68
SUMMARY OF COMMON STOCK OPTION ACTIVITY	Summary of Common Stock Option Activity -Employee Stock Options       Number of Options     Weighted Average Exercise Price     Weighted Average Remaining Years   Outstanding at March 1, 2024     188,667,035     $ 0.02       4.10   Issued     —       —       —   Exercised     —       —       —   Forfeited, extinguished and cancelled     (3,011,029 )   $ 0.02       (4.60 ) Outstanding at November 30, 2024     185,656,006     $ 0.02       3.75

COMMITMENTS AND CONTINGENCIES (Tables)	9 Months Ended
	Nov. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
SCHEDULE OF MATURITY OF OPERATING LEASE LIABILITIES	Summary of rent expense and operating lease cost are recorded over the lease terms on a straight-line basis.   Maturity of Lease Liabilities   Operating Leases   November 30, 2025   $ 225,348   November 30, 2026     225,348   November 30, 2027     210,523   November 30, 2028     207,558   November 30, 2029     207,558   November 30, 2030 and after     294,041   Total lease payments     1,370,376   Less: Interest     (334,514 ) Present value of lease liabilities   $ 1,035,861

EARNINGS (LOSS) PER SHARE (Tables)	9 Months Ended
	Nov. 30, 2024
Earnings Per Share [Abstract]
SCHEDULE OF NET INCOME (LOSS) PER COMMON SHARE	The net income (loss) per common share amounts were determined as follows:       For the Three Months Ended     For the Nine Months Ended       November 30,     November 30,       2024     2023     2024     2023   Numerator:                                 Net income (loss) available to common shareholders   $ (3,703,974 )   $ (3,966,484 )   $ (11,828,656 )   $ (13,281,405 )                                   Effect of common stock equivalents                                 Deduct : Dividend on Series B shares     —       —       (89,189 )     —   Deduct: Deemed dividend on redemption of Series F shares     —       —       (334,187 )     —   Net income (loss) adjusted for common stock equivalents     (3,703,974 )     (3,966,484 )     (12,252,032 )     (13,281,405 )                                   Denominator:                                 Weighted average shares – basic     12,161,286,427       7,294,775,879       11,071,139,695       6,606,988,956                                     Net income (loss) per share – basic   $ (0.00 )   $ (0.00 )   $ (0.00 )   $ (0.00 )                                   Dilutive effect of common stock equivalents:                                 Convertible Debt     —       —       —       —   Preferred shares     —       —       —       —   Warrants     —       —       —       —         —       —       —       —   Denominator:                                 Weighted average shares – diluted     12,161,286,427       7,294,775,879       11,071,139,695       6,606,988,956                                     Net income (loss) per share – diluted   $ (0.00 )   $ (0.00 )   $ (0.00 )   $ (0.00 )
SCHEDULE OF ANTI-DILUTIVE SHARES OF COMMON STOCK EQUIVALENTS	The anti-dilutive shares of common stock equivalents for the three and nine months ended November 30, 2024 and 2023 were as follows:       For the Three Months Ended     For the Nine Months Ended       November 30,     November 30,       2024     2023     2024     2023                             Convertible Series F Preferred Shares*     43,406,765,095       26,617,244,133       43,406,765,095       26,617,244,133   Stock options and warrants     232,927,455       428,667,451       232,927,455       428,667,451   Total     43,639,692,550       27,045,911,584       43,639,692,550       27,045,911,584

GENERAL INFORMATION (Details Narrative) - shares	Aug. 28, 2017	Nov. 30, 2024	Feb. 29, 2024	Jul. 25, 2017
Restructuring Cost and Reserve [Line Items]
Common stock, issued		12,581,671,042	9,238,750,958
Robotic Assistance Devices LLC [Member]
Restructuring Cost and Reserve [Line Items]
Common stock, issued				10,000
Robotic Assistance Devices LLC [Member] | Series E Preferred Stock [Member]
Restructuring Cost and Reserve [Line Items]
Number of shares isuued under acquisition	3,350,000
Robotic Assistance Devices LLC [Member] | Series F Preferred Stock [Member]
Restructuring Cost and Reserve [Line Items]
Number of shares isuued under acquisition	2,450

GOING CONCERN (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended						9 Months Ended
	Jul. 31, 2024	Nov. 30, 2024	Aug. 31, 2024	May 31, 2024	Nov. 30, 2023	Aug. 31, 2023	May 31, 2023	Nov. 30, 2024	Nov. 30, 2023	Mar. 01, 2024	Feb. 29, 2024	[1]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Cash flow from operating activities								$ 8,894,284	$ 9,378,427
Accumulated deficit		$ 149,389,994						149,389,994		$ (4,175,535)	$ 132,962,427
Negetive working capital		(37,294,051)						(37,294,051)
Purchase of common stock		93,885	$ 195,656	$ 116,046	$ 56,320	$ 176,672	$ 81,285
Common stock net of discount		26,000,000						26,000,000
Common Stock [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Purchase of common stock		$ 93,885						$ 406,566
Common Stock [Member] | Equity Financing Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Purchase of common stock	$ 30,000,000
[1] Derived from audited information

SCHEDULE OF FIXED ASSETS STATED AT COST (Details)	Nov. 30, 2024
Computer Equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	2 years
Computer Equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	3 years
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	4 years
Manufacturing Equipment [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	7 years
Warehouse Equipment [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	5 years
Tooling [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	2 years
Demo Devices [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	4 years
Vehicles [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	3 years
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	5 years

SCHEDULE OF LIABILITIES MEASURED AT FAIR VALUE (Details) - USD ($)	Nov. 30, 2024	Feb. 29, 2024
Platform Operator, Crypto Asset [Line Items]
Incentive compensation plan payable revaluation of equity awards payable in Series G shares	$ 2,500,000	$ 2,500,000
Fair Value, Inputs, Level 1 [Member]
Platform Operator, Crypto Asset [Line Items]
Incentive compensation plan payable revaluation of equity awards payable in Series G shares
Fair Value, Inputs, Level 2 [Member]
Platform Operator, Crypto Asset [Line Items]
Incentive compensation plan payable revaluation of equity awards payable in Series G shares
Fair Value, Inputs, Level 3 [Member]
Platform Operator, Crypto Asset [Line Items]
Incentive compensation plan payable revaluation of equity awards payable in Series G shares	$ 2,500,000	$ 2,500,000

ACCOUNTING POLICIES (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended	12 Months Ended
	Nov. 30, 2024	Nov. 30, 2023	Nov. 30, 2024	Feb. 29, 2024		Mar. 01, 2024
Product Information [Line Items]
Loans payable	$ 33,163,345		$ 33,163,345	$ 32,796,345
Allowance for doubtful accounts receivable	74,000		74,000	68,000
Inventory valuation reserves	$ 1,109,000		$ 1,109,000	959,000
Depreciation life	48 months		48 months
Deferred development costs	$ 0		$ 0	0
Description of deferred tax assets and liabilities			The Company’s gross deferred tax assets were revalued based on the reduction in the federal statutory tax rate from 35% to 21%.
Accumulated deficit	$ (149,389,994)		$ (149,389,994)	(132,962,427)	[1]	$ 4,175,535
One Customer [Member]
Product Information [Line Items]
Percentage of revenue	57.00%		57.00%
Four Customer [Member]
Product Information [Line Items]
Percentage of revenue		58.00%
Accounts Receivable [Member] | Customer Concentration Risk [Member] | One Customer [Member]
Product Information [Line Items]
Percentage of accounts receivable	61.00%
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Two Customer [Member]
Product Information [Line Items]
Percentage of accounts receivable		61.00%
Controller [Member]
Product Information [Line Items]
Loans additions			$ 28,743,506	$ 28,540,506
Loans percentage	87.00%		87.00%	87.00%
[1] Derived from audited information

SCHEDULE OF REVENUES FROM CONTRACTS WITH CUSTOMERS (Details) - USD ($)	3 Months Ended		9 Months Ended
	Nov. 30, 2024	Nov. 30, 2023	Nov. 30, 2024	Nov. 30, 2023
Revenue from Contract with Customer [Abstract]
Device rental activities	$ 1,429,112	$ 416,062	$ 3,475,546	$ 997,754
Direct sales of goods and services	321,856	180,918	802,405	370,797
Revenue	$ 1,750,968	$ 596,980	$ 4,277,951	$ 1,368,551

SCHEDULE OF LEASE ASSETS AND LIABILITIES (Details) - USD ($)	Nov. 30, 2024	Feb. 29, 2024
Leases [Abstract]
Operating Lease Assets	$ 1,040,862	$ 1,139,188
Current Operating Lease Liability	225,348	237,653	[1]
Noncurrent Operating Lease Liabilities	810,513	889,360	[1]
Total lease liabilities	$ 1,035,861	$ 1,127,013
[1] Derived from audited information

LEASES (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Nov. 30, 2024	Nov. 30, 2023	Nov. 30, 2024	Nov. 30, 2023
Leases [Abstract]
Initial lease term	12 months		12 months
Incremental borrowing rate	10.00%		10.00%
Rent expense	$ 57,875	$ 64,081	$ 182,855	$ 189,164

SCHEDULE OF REVENUE EARNING DEVICES (Details) - USD ($)	Nov. 30, 2024	Feb. 29, 2024
Revenue Earning Devices
Revenue earning devices	$ 6,233,201	$ 3,432,846
Less: Accumulated depreciation	(1,881,451)	(952,844)
Total	$ 4,351,750	$ 2,480,002

SCHEDULE OF DEPRECIATION AND AMORTIZATION (Details) - USD ($)	3 Months Ended		9 Months Ended
	Nov. 30, 2024	Nov. 30, 2023	Nov. 30, 2024	Nov. 30, 2023
Revenue Earning Devices
Cost of Goods Sold	$ 287,799	$ 113,830	$ 729,672	$ 322,369
Operating expenses	79,662	51,540	198,935	107,456
Total Depreciation and Amortization	$ 367,461	$ 165,370	$ 928,607	$ 429,825

REVENUE EARNING DEVICES (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Nov. 30, 2024	Nov. 30, 2023	Nov. 30, 2024	Nov. 30, 2023
Robotic Assistance Devices LLC [Member]
Restructuring Cost and Reserve [Line Items]
Revenue earning	$ 1,069,822	$ 521,037	$ 2,800,355	$ 1,306,501

SCHEDULE OF FIXED ASSETS (Details) - USD ($)	Nov. 30, 2024	Feb. 29, 2024
Property, Plant and Equipment [Line Items]
Fixed assets gross	$ 717,830	$ 617,953
Less: Accumulated depreciation	(460,641)	(349,878)
Fixed assets, net of accumulated depreciation	257,189	268,075	[1]
Automobiles [Member]
Property, Plant and Equipment [Line Items]
Fixed assets gross	74,237	74,237
Demo Devices [Member]
Property, Plant and Equipment [Line Items]
Fixed assets gross	270,502	194,352
Tools, Dies and Molds [Member]
Property, Plant and Equipment [Line Items]
Fixed assets gross	107,020	107,020
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Fixed assets gross	8,825	8,825
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Fixed assets gross	157,448	150,387
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Fixed assets gross	15,312	15,312
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Fixed assets gross	21,225	21,225
Warehouse Equipment [Member]
Property, Plant and Equipment [Line Items]
Fixed assets gross	36,305	19,639
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Fixed assets gross	$ 26,956	$ 26,956
[1] Derived from audited information

SCHEDULE OF DEPRECIATION AND AMORTIZATION IN OPERATING EXPENSES (Details) - USD ($)	3 Months Ended		9 Months Ended
	Nov. 30, 2024	Nov. 30, 2023	Nov. 30, 2024	Nov. 30, 2023
Property, Plant and Equipment [Line Items]
Total Depreciation and Amortization included in operating expenses	$ 106,261	$ 101,933	$ 309,699	$ 252,377
Fixed Assets [Member]
Property, Plant and Equipment [Line Items]
Total Depreciation and Amortization included in operating expenses	26,599	50,393	110,764	144,921
Revenue Earning Devices [Member]
Property, Plant and Equipment [Line Items]
Total Depreciation and Amortization included in operating expenses	$ 79,662	$ 51,540	$ 198,935	$ 107,456

FIXED ASSETS (Details Narrative) - Robotic Assistance Devices LLC [Member] - USD ($)	3 Months Ended		9 Months Ended
	Nov. 30, 2024	Nov. 30, 2023	Nov. 30, 2024	Nov. 30, 2023
Restructuring Cost and Reserve [Line Items]
Additions to fixed assets	$ 25,603	$ 22,101	$ 99,877	$ 129,331
Assets transfers from inventory		11,661	76,153	115,428
Remaining additions to fixed assets		$ 10,440	$ 23,724	$ 13,903

DEFERRED VARIABLE PAYMENT OBLIGATION (Details Narrative) - USD ($)										3 Months Ended		9 Months Ended	12 Months Ended
	Mar. 01, 2021	Aug. 27, 2020	Jul. 01, 2020	Apr. 22, 2020	Feb. 29, 2020	Dec. 30, 2019	Nov. 18, 2019	May 09, 2019	Feb. 01, 2019	Nov. 30, 2024	May 31, 2021	Nov. 30, 2024	Feb. 29, 2024		May 31, 2020
Maximum amount of debt										$ 33,163,346		$ 33,163,346
Accrued payment										1,599,971		1,599,971	$ 904,377
Default on payments										764,702		764,702	542,176
Aggregate investment	$ 1,925,000
Total payment obligation										2,525,000		2,525,000	2,525,000	[1]
Payment receive										0		$ 0	0
Investors [Member]
Maximum amount of debt									$ 900,000
Percentage of exchange rate									9.00%
Debt instrument, date of first required payment					Feb. 29, 2020
Maximum amount of debt					$ 900,000
Investor One [Member]
Maximum amount of debt					400,000			$ 400,000
Percentage of exchange rate								4.00%
Investor Two [Member]
Maximum amount of debt					50,000			$ 50,000
Percentage of exchange rate								1.11%
Investor [Member]
Maximum amount of debt			$ 800,000	$ 100,000		$ 100,000
Percentage of exchange rate		14.25%	2.75%	1.00%		1.00%	2.25%
Maximum amount of debt		$ 1,925,000			109,000		$ 225,000
Description of variable payments terms			If the Payments would deplete RAD’s available cash by more than 20%, the payment may be deferred. The investor had agreed to pay $100,000 per month over an 8 month period with the first payment due July 2020 and the final payment no later than February 28, 2021. As at August 31, 2020 the investor had fully funded the $800,000 commitment.									These variable payments (Payments) are to be made 30 days after the end of each fiscal quarter. If the Payments would deplete RAD’s available cash by more than 30%, the Payments may be deferred for up to 12 months after the quarterly report at an interest rate of 6% per annum on the unpaid amount.
Description of disposition price		The FMV cannot exceed 43.77% of the share disposition price defined as the total price the third party paid for the shares plus the total value of all future Payments. As of March 1, 2021, as a result of the amendment with the first investor noted below. This aggregate asset disposition % was reduced from 43.77 % to 33.77%.										the FMV of all future Payments in one lump payment. The FMV cannot exceed 30% of the share disposition price defined as the total price the third party paid for the shares plus the total value of all future Payments.
Advance amount															$ 116,000
Investor received advanced					$ 50,000
Percentage of exchange rate		10.00%
Total payment obligation										$ 2,525,000		$ 2,525,000	$ 2,525,000
Investor [Member] | Series F Preferred Stock [Member]
Shares issued	40
Warrants issued	367
Warrants term	5 years
Exercise price	$ 1.00
Warrants exercised											38
Fair value of warrants											$ 33,015,214
Investor [Member] | Maximum [Member]
Percentage of exchange rate	14.25%
Percentage of total asset disposition price	31.00%
Investor [Member] | Minimum [Member]
Percentage of exchange rate	9.65%
Percentage of total asset disposition price	21.00%
Investor [Member] | Agreement One [Member]
Maximum amount of debt		$ 900,000
Investor [Member] | Agreement Two [Member]
Maximum amount of debt		225,000
Investor [Member] | Agreement Three [Member]
Maximum amount of debt		$ 800,000
[1] Derived from audited information

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Nov. 30, 2024	Nov. 30, 2023	Nov. 30, 2024	Nov. 30, 2023	Feb. 29, 2024
Related Party Transaction [Line Items]
Loan payable-related party	$ 33,163,345		$ 33,163,345		$ 32,796,345
Interest accrued related party			28,267		32,468
Deferred compensation	598,635		598,635		538,767	[1]
Decrease of deferred compensation			(195,000)
Consulting fees for research and development	556,175	$ 526,723	1,846,005	2,185,998
Chief Executive Officer [Member]
Related Party Transaction [Line Items]
Incentive compensation plan payable			2,500,000		2,500,000
Deferred compensation	$ 598,635		598,635		538,767
Decrease of deferred compensation			59,868
Repayment of deferred compensation			195,000
Accruals and adjustments of deferred compensation			$ 700,082
Chief Executive Officer [Member] | Series G Preferred Stock [Member]
Related Party Transaction [Line Items]
Share price	$ 1,000		$ 1,000
Chief Executive Officer [Member] | Employment Agreement [Member]
Related Party Transaction [Line Items]
Incentive compensation plan payable	$ 0	$ 62,000	$ 0	$ 187,000
Related Party [Member]
Related Party Transaction [Line Items]
Loan payable-related party	297,414		297,414		257,438
Balance due to related party	$ 222,754		222,754		$ 140,013
Interest expenses			$ 183,625
Percentage of interest expense due to related party			12.00%		12.00%
[1] Derived from audited information

OTHER DEBT – VEHICLE LOAN (Details Narrative) - USD ($)		1 Months Ended		9 Months Ended
	Feb. 29, 2020	Nov. 30, 2017	Dec. 31, 2016	Nov. 30, 2024	Feb. 29, 2024	Feb. 28, 2022	Feb. 28, 2021
Restructuring Cost and Reserve [Line Items]
Vehicle loan secured by automobile				$ 33,163,346
Fair value of warrants						$ 0	$ 0
Robotic Assistance Devices LLC [Member] | Secured Debt [Member]
Restructuring Cost and Reserve [Line Items]
Vehicle loan secured by automobile		$ 47,661	$ 47,704
Term of debt		5 years	5 years
Maturity date		Oct. 24, 2022	Nov. 09, 2021
Payment of debt interest and principal		$ 923	$ 1,019
Outstanding balance of the loan		$ 21,907
Loss on sale of vehicle				3,257
Current portion vehicle loan	$ 21,578						21,578
Proceeds of disposal of vehicle offset against vehicle loan	18,766
Remaining asset value	5,515
Reclassification of fixed assets to vehicle for disposal	$ 13,251
Long-term vehicle loan						$ 16,944	$ 16,944
Total vehicle loan				$ 38,522	$ 38,522

SCHEDULE OF LOANS PAYABLE (Details)	9 Months Ended
	Nov. 30, 2024 USD ($)
Short-Term Debt [Line Items]
Debt instrument, face amount	$ 33,163,346
Less: current portion of loans payable	(25,112,611)
Less: discount on non-current loans payable	(374,081)
Non-current loans payable, net of discount	7,676,654
Current portion of loans payable	25,112,611
Less: discount on current portion of loans payable	(58,620)
Current portion of loans payable, net of discount	$ 25,053,991
Promissory Note Payable One [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Jul. 18, 2016	[1],[2]
Debt Instrument, Maturity Date	Jul. 18, 2017	[1],[2]
Debt instrument, face amount	$ 3,500	[1],[2]
Annual interest rate	22.00%	[1],[2]
Promissory Note Payable Two [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Dec. 10, 2020	[3]
Debt Instrument, Maturity Date	Mar. 01, 2025	[3]
Debt instrument, face amount	$ 3,921,168	[3]
Annual interest rate	12.00%	[3]
Promissory Note Payable Three [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Dec. 10, 2020	[4]
Debt Instrument, Maturity Date	Mar. 01, 2025	[4]
Debt instrument, face amount	$ 2,754,338	[4]
Annual interest rate	12.00%	[4]
Promissory Note Payable Four [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Dec. 10, 2020	[5]
Debt Instrument, Maturity Date	Dec. 10, 2024	[5]
Debt instrument, face amount	$ 165,605	[5]
Annual interest rate	12.00%	[5]
Promissory Note Payable Five [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Dec. 14, 2020	[6]
Debt Instrument, Maturity Date	Mar. 01, 2027	[6]
Debt instrument, face amount	$ 310,375	[6]
Annual interest rate	12.00%	[6]
Promissory Note Payable Six [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Dec. 30, 2020	[7]
Debt Instrument, Maturity Date	Mar. 01, 2025	[7]
Debt instrument, face amount	$ 350,000	[7]
Annual interest rate	12.00%	[7]
Promissory Note Payable Seven [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Jan. 01, 2021	[8]
Debt Instrument, Maturity Date	Mar. 01, 2025	[8]
Debt instrument, face amount	$ 25,000	[8]
Annual interest rate	12.00%	[8]
Promissory Note Payable Eight [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Jan. 01, 2021	[9]
Debt Instrument, Maturity Date	Mar. 01, 2025	[9]
Debt instrument, face amount	$ 145,000	[9]
Annual interest rate	12.00%	[9]
Promissory Note Payable Nine [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Jan. 14, 2021	[10]
Debt Instrument, Maturity Date	Mar. 01, 2025	[10]
Debt instrument, face amount	$ 550,000	[10]
Annual interest rate	12.00%	[10]
Promissory Note Payable Ten [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Feb. 22, 2021	[11]
Debt Instrument, Maturity Date	Mar. 01, 2025	[11]
Debt instrument, face amount	$ 1,650,000	[11]
Annual interest rate	12.00%	[11]
Promissory Note Payable Eleven [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Mar. 01, 2021	[12]
Debt Instrument, Maturity Date	Mar. 01, 2025	[12]
Debt instrument, face amount	$ 6,000,000	[12]
Annual interest rate	12.00%	[12]
Promissory Note Payable Twelve [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Jun. 08, 2021	[13]
Debt Instrument, Maturity Date	Jun. 08, 2025	[13]
Debt instrument, face amount	$ 2,750,000	[13]
Annual interest rate	12.00%	[13]
Promissory Note Payable Thirteen [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Jul. 12, 2021	[14]
Debt Instrument, Maturity Date	Jul. 26, 2026	[14]
Debt instrument, face amount	$ 3,740,360	[14]
Annual interest rate	7.00%	[14]
Promissory Note Payable Fourteen [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Sep. 14, 2021	[15]
Debt Instrument, Maturity Date	Sep. 14, 2025	[15]
Debt instrument, face amount	$ 1,650,000	[15]
Annual interest rate	12.00%	[15]
Promissory Note Payable Fifteen [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Jul. 28, 2022	[16]
Debt Instrument, Maturity Date	Mar. 01, 2025	[16]
Debt instrument, face amount	$ 170,000	[16]
Annual interest rate	15.00%	[16]
Promissory Note Payable Sixteen [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Aug. 30, 2022	[17]
Debt Instrument, Maturity Date	Aug. 30, 2025	[17]
Debt instrument, face amount	$ 3,000,000	[17]
Annual interest rate	15.00%	[17]
Promissory Note Payable Seventeen [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Sep. 07, 2022	[18]
Debt Instrument, Maturity Date	Mar. 01, 2025	[18]
Debt instrument, face amount	$ 400,000	[18]
Annual interest rate	15.00%	[18]
Promissory Note Payable Eighteen [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Sep. 08, 2022	[19]
Debt Instrument, Maturity Date	Mar. 01, 2025	[19]
Debt instrument, face amount	$ 475,000	[19]
Annual interest rate	15.00%	[19]
Promissory Note Payable Nineteen [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Oct. 13, 2022	[20]
Debt Instrument, Maturity Date	Mar. 01, 2025	[20]
Debt instrument, face amount	$ 350,000	[20]
Annual interest rate	15.00%	[20]
Promissory Note Payable Twenty [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Oct. 28, 2022	[21],[22]
Debt Instrument, Maturity Date	Oct. 31, 2026	[21],[22]
Debt instrument, face amount	$ 400,000	[21],[22]
Annual interest rate	15.00%	[21],[22]
Promissory Note Payable Twenty One [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Nov. 09, 2022	[21],[22]
Debt Instrument, Maturity Date	Oct. 31, 2026	[21],[22]
Debt instrument, face amount	$ 400,000	[21],[22]
Annual interest rate	15.00%	[21],[22]
Promissory Note Payable Twenty Two [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Nov. 10, 2022	[21],[22]
Debt Instrument, Maturity Date	Oct. 31, 2026	[21],[22]
Debt instrument, face amount	$ 400,000	[21],[22]
Annual interest rate	15.00%	[21],[22]
Promissory Note Payable Twenty Three [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Nov. 15, 2022	[21],[22]
Debt Instrument, Maturity Date	Oct. 31, 2026	[21],[22]
Debt instrument, face amount	$ 400,000	[21],[22]
Annual interest rate	15.00%	[21],[22]
Promissory Note Payable Twenty Four [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Jan. 11, 2023	[21],[22]
Debt Instrument, Maturity Date	Oct. 31, 2026	[21],[22]
Debt instrument, face amount	$ 400,000	[21],[22]
Annual interest rate	15.00%	[21],[22]
Promissory Note Payable Twenty Five [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Feb. 06, 2023	[21],[22]
Debt Instrument, Maturity Date	Oct. 31, 2026	[21],[22]
Debt instrument, face amount	$ 400,000	[21],[22]
Annual interest rate	15.00%	[21],[22]
Promissory Note Payable Twenty Six [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Apr. 05, 2023	[21],[22]
Debt Instrument, Maturity Date	Oct. 31, 2026	[21],[22]
Debt instrument, face amount	$ 400,000	[21],[22]
Annual interest rate	15.00%	[21],[22]
Promissory Note Payable Twenty Seven [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Apr. 20, 2023	[21],[22]
Debt Instrument, Maturity Date	Oct. 31, 2026	[21],[22]
Debt instrument, face amount	$ 400,000	[21],[22]
Annual interest rate	15.00%	[21],[22]
Promissory Note Payable Twenty Eight [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	May 11, 2023	[21],[22]
Debt Instrument, Maturity Date	Oct. 31, 2026	[21],[22]
Debt instrument, face amount	$ 400,000	[21],[22]
Annual interest rate	15.00%	[21],[22]
Promissory Note Payable Twenty Nine [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Oct. 27, 2023	[21],[22]
Debt Instrument, Maturity Date	Oct. 31, 2026	[21],[22]
Debt instrument, face amount	$ 400,000	[21],[22]
Annual interest rate	15.00%	[21],[22]
Promissory Note Payable Thirty [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Nov. 30, 2023	[23]
Debt Instrument, Maturity Date	Apr. 30, 2025	[23]
Debt instrument, face amount	$ 203,000	[23]
Annual interest rate	35.00%	[23]
Promissory Note Payable Thirty One [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Mar. 08, 2024	[24]
Debt Instrument, Maturity Date	Aug. 08, 2025	[24]
Debt instrument, face amount	$ 350,000	[24]
Annual interest rate	35.00%	[24]
Promissory Note Payable Thirty Two [Member]
Short-Term Debt [Line Items]
Debt Instrument, Issuance Date	Aug. 08, 2024	[25]
Debt Instrument, Maturity Date	Aug. 08, 2025	[25]
Debt instrument, face amount	$ 200,000	[25]
Annual interest rate	12.00%	[25]
[1] In default [2] This note was transferred from convertible notes payable because in August 2022 it was no longer convertible due to restrictions placed on the lender. [3] This promissory note was issued as part of a debt settlement whereby $2,683,357 in convertible notes and associated accrued interest of $1,237,811 totaling $3,921,168 was exchanged for this promissory note of $3,921,168, and a warrant to purchase 450,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a relative fair value of $990,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from December 10, 2023 to March 1, 2025 with all other terms and conditions remaining the same. [4] This promissory note was issued as part of a debt settlement whereby $1,460,794 in convertible notes and associated accrued interest of $1,593,544 totaling $3,054,338 was exchanged for this promissory note of $3,054,338, and a warrant to purchase 250,000,000 shares at an exercise price of $0.002 per share and a three-year maturity having a relative fair value of $550,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. $300,000 has been repaid during the year ended February 29, 2024. On November 28, 2023, the parties extended the maturity date from December 10, 2023 to March 1, 2025 with all other terms and conditions remaining the same. [5] This promissory note was issued as part of a debt settlement whereby $103,180 in convertible notes and associated accrued interest of $62,425 totaling $165,605 was exchanged for this promissory note of $165,605, and a warrant to purchase 80,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a fair value of $176,000.The maturity date was extended from December 10, 2023 to December 10, 2024 on February 29, 2024 and a fee of $22,958 was paid and charged to interest expense. [6] This promissory note was issued as part of a debt settlement whereby $235,000 in convertible notes and associated accrued interest of $75,375 totaling $310,375 was exchanged for this promissory note of $310,375, and a warrant to purchase 25,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a fair value of $182,500. [7] The note, with an original principal amount of $350,000, may be pre-payable at any time. The note balance includes an original issue discount of $35,000 and was issued with a warrant to purchase 50,000,000 shares at an exercise price of $0.025 per share with a 3-year term and having a relative fair value of $271,250. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $271,250 with a corresponding adjustment to paid in capital for the relative fair value of the warrant. On March 1, 2024, the unamortized relative fair value discount of $65,092 was removed with a corresponding adjustment to accumulated deficit. A $8,399 unamortized discount remained. On November 28, 2023, the parties extended the maturity date from December 10, 2023 to March 1, 2025 with all other terms and conditions remaining the same. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $2,115 and $6,069, respectively, with an unamortized discount of $2,330 at November 30, 2024. [8] This promissory note was issued as part of a debt settlement whereby $9,200 in convertible notes and associated accrued interest of $6,944 totaling $16,144 was exchanged for this promissory note of $25,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from January 1, 2024 to March 1, 2025 with all other terms and conditions remaining the same. [9] This promissory note was issued as part of a debt settlement whereby $79,500 in convertible notes and associated accrued interest of $28,925 totaling $108,425 was exchanged for this promissory note of $145,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from January 1, 2024 to March 1, 2025 with all other terms and conditions remaining the same. [10] The note, with an original principal amount of $550,000, may be pre-payable at any time. The note balance includes an original issue discount of $250,000 and was issued with a warrant to purchase 50,000,000 shares at an exercise price of $0.025 per share with a 3-year term and having a relative fair value of $380,174. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $380,174 with a corresponding adjustment to paid in capital. On March 1, 2024, the unamortized relative fair value discount of $80,284 was removed with a corresponding adjustment to accumulated deficit. A $10,559 unamortized discount remained. On November 28, 2023, the parties extended the maturity date from January 14, 2024 to March 1, 2025 with all other terms and Conditions remaining the same. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $2,649 and $7,702, respectively, with an unamortized discount of $2,857 at November 30, 2024 [11] The note, with an original principal balance of $1,650,000, may be pre-payable at any time. The note balance includes an original issue discount of $150,000 and was issued with a warrant to purchase 100,000,000 shares at an exercise price of $0.135 per share with a 3-year term and having a relative fair value of $1,342,857. The discount and warrant are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $1,342,857 with a corresponding adjustment to paid in capital for the relative fair value of the warrant. The maturity date was extended from February 22, 2022 to February 22, 2024 on February 28, 2022 in exchange for warrants to purchase 50,000,000 at an exercise price of $.0164 and a 3-year term. These warrants have a fair value of $950,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. On November 28, 2023, the parties extended the maturity date from February 22, 2024 to March 1, 2025 with all other terms and conditions remaining the same. On March 1, 2024, the unamortized relative fair value discount of $497,614 was removed with a corresponding adjustment to accumulated deficit. A $55,585 unamortized discount remained. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $14,046 and $40,289 respectively, with an unamortized discount of $15,296 at November 30, 2024. [12] The unsecured note may be pre-payable at any time. Cash proceeds of $5,400,000 were received. The note balance of $6,000,000 includes an original issue discount of $600,000 and was issued with a warrant to purchase 300,000,000 shares at an exercise price of $0.135 per share with a 3-year term and having a relative fair value of $4,749,005 using Black-Scholes with assumptions described in note 13. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $4,749,005 with a corresponding adjustment to paid in capital for the relative value of the warrant. The maturity was extended from March 1, 2022 to March 1, 2024 on February 28, 2022 in exchange for warrants to purchase 150,000,000 shares of common stock at an exercise price of $.0164 and a 3 year term. These warrants have a fair value of $2,850,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. This note has been fully amortized. This note was again extended to March 1, 2025. [13]  The note, with an original principal balance of $2,750,000, may be pre-payable at any time. The note balance includes an original issue discount of $50,000 and was issued with a warrant to purchase 170,000,000 shares at an exercise price of $0.064 per share with a 3-year term and having a relative fair value of $2,035,033. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $2,035,033 with a corresponding adjustment to paid in capital. The maturity date was extended from June 8, 2022 to June 8, 2024 on February 28, 2022 in exchange for warrants to purchase 85,000,000 at an exercise price of $.0164 and a 3 year term. These warrants have a fair value of $1,615,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. This note was extended to June 8, 2025. On March 1, 2024, the unamortized relative fair value discount of $33,547 was removed with a corresponding adjustment to accumulated deficit. A $4,121 unamortized discount remained. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $895 and $2,234, respectively, with an unamortized discount of $1,887 at November 30, 2024. [14] This loan, with an original principal balance of $4,000,160, was in exchange for 184 Series F preferred shares from a former director. The interest and principal are payable at maturity. The loan is unsecured. For the three and nine months ended November 30, 2024 there were repayments of $9,000 and $36,000 , respectively on the note. [15] The note, with an original principal balance of $1,650,000, may be pre-payable at any time. The note balance includes an original issue discount of $150,000 and was issued with a warrant to purchase 250,000,000 shares at an exercise price of $0.037 per share with a 3-year term and having a relative fair value of $1,284,783, The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $1,284,783 with a corresponding adjustment to paid in capital. On March 1, 2024, the unamortized relative fair value discount of $572,549 was removed with a corresponding adjustment to accumulated deficit. A $66,846 unamortized discount remained. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $10,668 and $30,659 respectively, with an unamortized discount of 36,250 at November 30, 2024. This note was extended to September 14, 2025. [16] Original $170,000 note may be pre-payable at any time. The note balance includes an original issue discount of $20,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from July 28, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized.. [17] A warrant holder exchanged 955,000,000 warrants for a promissory note of $3,000,000, bearing interest at 15% with a two year maturity. The fair value of the warrants was determined to be $2,960,500 with a corresponding adjustment to paid-in capital and a debt discount of $39,500 which will be amortized over the term of the loan. Principal and interest due at maturity. On March 1, 2024, the unamortized relative fair value discount of $11,535 was removed with a corresponding adjustment to accumulated deficit. This note has been fully amortized. This note was extended to August 30, 2025. [18] Original $400,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from September 7, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized. [19] Original $475,000 note may be pre-payable at any time. The note balance includes an original issue discount of $75,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from September 8, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized. [20] Original $350,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of the Company’s s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from October 13, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized. [21] November 9, 2022, $400,000 loan, original issue discount of $50,000 , 61 Series F Preferred Share warrants having a relative fair value of $299,750. On March 1, 2024, the unamortized relative fair value discount of $288,513 was removed with a corresponding adjustment to accumulated deficit. A $48,126 unamortized discount remained. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $3,875 and $10,972, respectively, with an unamortized discount of $37,154 at November 30, 2024. [22] On October 28, 2022 the Company entered into an loan facility with a lender for up to $4,000,000 including an original issue discount of $500,000. In exchange the Company will issue one series F Preferred Share, extended 329 series F warrants with a March 1, 2026 maturity to a new October 31, 2033 maturity, and issue up to 10 tranches with each tranche of $400,000, with cash proceeds of $350,000 an original issue discount of $50,000, October 31, 2026 maturity, and 61 Series F warrants with a October 31, 2033 maturity. Secured by a general security charging all of the Company’s present and after-acquired property. At February 29, 2024 the Company has issued all 10 tranches totaling $ 4,000,000 as follows: [23] On November 30, 2023, the Company entered into an agreement where the lender will pay the Company $350,000 in exchange for thirteen future monthly payments of $36,750 commencing on April 30,2024 through to April 30, 2025 totaling $477,750. The effective interest rate is 35% per annum. Secured by a general security charging all of RAD’s present and after-acquired property. Default rate of 15% per annum calculated daily on any missed monthly payment. The Company has repaid $147,000 and $53,000 in accrued interest in July to account for the missed the April and August 2024 payments not made in agreement with the lender. No notices have been sent. [24] On March 8, 2024, the Company entered into another agreement where the lender will pay the Company $350,000 in exchange for thirteen future monthly payments of $36,750 commencing on August 8, 2024 through to August 80, 2025 totaling $477,750. The effective interest rate is 35% per annum. Secured by a general security charging all of RAD’s present and after- acquired property. Default rate of 15% per annum calculated daily on any missed monthly payment. The August 2024 payment has not been made but will be resolved with the lender. No notices have been sent. [25] On August 8, 2024, a Series F preferred shareholder exchanged 20 Series F the preferred shares for a $400,000 note payable. On August 22, 2022 the lender exchanged $200,000 of note principal for 57,142,857 common shares. The common shares were issued in September 2024. The note balance at November 30, 2024 is $200,000.

SCHEDULE OF LOANS PAYABLE (Details) (Parenthetical) - USD ($)										1 Months Ended	3 Months Ended						9 Months Ended		12 Months Ended
		Aug. 22, 2024	Aug. 08, 2024	Mar. 08, 2024	Feb. 29, 2024	Nov. 30, 2023	Nov. 29, 2023	Nov. 28, 2023	Oct. 28, 2022	Jul. 31, 2024	Nov. 30, 2024	Aug. 31, 2024	May 31, 2024	Nov. 30, 2023	Aug. 31, 2023	May 31, 2023	Nov. 30, 2024	Nov. 30, 2023	Feb. 29, 2024	Feb. 28, 2022	Mar. 01, 2024	Oct. 27, 2023	May 11, 2023	Apr. 20, 2023	Apr. 05, 2023	Feb. 06, 2023	Jan. 11, 2023	Nov. 15, 2022	Nov. 10, 2022	Nov. 09, 2022
Short-Term Debt [Line Items]
Conversion of convertible securities												$ 200,000
Total payments
Amortization of debt expense																	198,696	$ 1,755,897
Loans payable					$ 32,796,345						$ 33,163,345						33,163,345		$ 32,796,345
Number of common stock issued, shares											2,073,393	$ 4,491,360	$ 2,682,593	$ 1,412,158	$ 4,796,123	$ 1,318,909
Promissory Note Payable Two [Member]
Short-Term Debt [Line Items]
Convertible notes payable											2,683,357						2,683,357
Accrued interest											1,237,811						1,237,811
Conversion of convertible securities																	3,921,168
Notes payable											$ 3,921,168						$ 3,921,168
Purchase of warrants											450,000,000						450,000,000
Exercise price											$ 0.002						$ 0.002
Fair value											$ 990,000						$ 990,000
Debt instrument maturity date description								On November 28, 2023, the parties extended the maturity date from December 10, 2023 to March 1, 2025 with all other terms and conditions remaining the same.
Annual interest rate	[1]										12.00%						12.00%
Promissory Note Payable Three [Member]
Short-Term Debt [Line Items]
Convertible notes payable											$ 1,460,794						$ 1,460,794
Accrued interest											1,593,544						1,593,544
Conversion of convertible securities																	3,054,338
Notes payable											$ 3,054,338						$ 3,054,338
Purchase of warrants											250,000,000						250,000,000
Exercise price											$ 0.002						$ 0.002
Fair value											$ 550,000						$ 550,000
Debt instrument maturity date description								On November 28, 2023, the parties extended the maturity date from December 10, 2023 to March 1, 2025 with all other terms and conditions remaining the same.
Total payments																			300,000
Annual interest rate	[2]										12.00%						12.00%
Promissory Note Payable Four [Member]
Short-Term Debt [Line Items]
Convertible notes payable											$ 103,180						$ 103,180
Accrued interest											62,425						62,425
Conversion of convertible securities																	165,605
Notes payable											$ 165,605						$ 165,605
Purchase of warrants											80,000,000						80,000,000
Exercise price											$ 0.002						$ 0.002
Fair value											$ 176,000						$ 176,000
Debt instrument maturity date description					The maturity date was extended from December 10, 2023 to December 10, 2024 on February 29, 2024 and a fee of $22,958 was paid and charged to interest expense.
Interest expenses					$ 22,958
Annual interest rate	[3]										12.00%						12.00%
Promissory Note Payable Five [Member]
Short-Term Debt [Line Items]
Convertible notes payable											$ 235,000						$ 235,000
Accrued interest											75,375						75,375
Conversion of convertible securities																	310,375
Notes payable											$ 310,375						$ 310,375
Purchase of warrants											25,000,000						25,000,000
Exercise price											$ 0.002						$ 0.002
Fair value											$ 182,500						$ 182,500
Annual interest rate	[4]										12.00%						12.00%
Promissory Note Payable Six [Member]
Short-Term Debt [Line Items]
Purchase of warrants											50,000,000						50,000,000
Exercise price											$ 0.025						$ 0.025
Fair value											$ 271,250						$ 271,250
Debt instrument maturity date description								On November 28, 2023, the parties extended the maturity date from December 10, 2023 to March 1, 2025 with all other terms and conditions remaining the same.
Prepaid expense											350,000						350,000
Original issue discount											$ 35,000						$ 35,000
Warrants term											3 years						3 years
Debt discount											$ 271,250						$ 271,250				$ 65,092
Unamortized discount											2,330						2,330				8,399
Amortization of debt expense											$ 2,115						$ 6,069
Annual interest rate	[5]										12.00%						12.00%
Promissory Note Payable Seven [Member]
Short-Term Debt [Line Items]
Convertible notes payable											$ 9,200						$ 9,200
Accrued interest											6,944						6,944
Conversion of convertible securities																	16,144
Notes payable											$ 25,000						$ 25,000
Debt instrument maturity date description								On November 28, 2023, the parties extended the maturity date from January 1, 2024 to March 1, 2025 with all other terms and conditions remaining the same.
Annual interest rate	[6]										12.00%						12.00%
Promissory Note Payable Eight [Member]
Short-Term Debt [Line Items]
Convertible notes payable											$ 79,500						$ 79,500
Accrued interest											28,925						28,925
Conversion of convertible securities																	108,425
Notes payable											$ 145,000						$ 145,000
Debt instrument maturity date description								On November 28, 2023, the parties extended the maturity date from January 1, 2024 to March 1, 2025 with all other terms and conditions remaining the same.
Annual interest rate	[7]										12.00%						12.00%
Promissory Note Payable Nine [Member]
Short-Term Debt [Line Items]
Purchase of warrants											50,000,000						50,000,000
Exercise price											$ 0.025						$ 0.025
Fair value											$ 380,174						$ 380,174
Debt instrument maturity date description								On November 28, 2023, the parties extended the maturity date from January 14, 2024 to March 1, 2025 with all other terms and Conditions remaining the same.
Prepaid expense											550,000						550,000
Original issue discount											$ 250,000						$ 250,000
Warrants term											3 years						3 years
Debt discount											$ 380,174						$ 380,174				80,284
Unamortized discount											2,857						2,857				10,559
Amortization of debt expense											$ 2,649						$ 7,702
Annual interest rate	[8]										12.00%						12.00%
Promissory Note Payable Ten [Member]
Short-Term Debt [Line Items]
Purchase of warrants											100,000,000						100,000,000			50,000,000
Exercise price											$ 0.135						$ 0.135			$ 0.0164
Fair value											$ 1,342,857						$ 1,342,857
Interest expenses																				$ 950,000
Prepaid expense											1,650,000						1,650,000
Original issue discount											$ 150,000						$ 150,000
Warrants term											3 years						3 years			3 years
Debt discount											$ 1,342,857						$ 1,342,857				497,614
Unamortized discount											15,296						15,296				55,585
Amortization of debt expense											$ 14,046						$ 40,289
Annual interest rate	[9]										12.00%						12.00%
Promissory Note Payable Eleven [Member]
Short-Term Debt [Line Items]
Notes payable											$ 6,000,000						$ 6,000,000
Purchase of warrants											300,000,000						300,000,000			150,000,000
Exercise price											$ 0.135						$ 0.135			$ 0.0164
Fair value											$ 4,749,005						$ 4,749,005
Interest expenses																				$ 2,850,000
Original issue discount											$ 600,000						$ 600,000
Warrants term											3 years						3 years			3 years
Debt discount											$ 4,749,005						$ 4,749,005
Cash proceeds																	$ 5,400,000
Annual interest rate	[10]										12.00%						12.00%
Promissory Note Payable Twelve [Member]
Short-Term Debt [Line Items]
Purchase of warrants											170,000,000						170,000,000			85,000,000
Exercise price											$ 0.064						$ 0.064			$ 0.0164
Fair value											$ 2,035,033						$ 2,035,033
Interest expenses																				$ 1,615,000
Original issue discount											$ 50,000						$ 50,000
Warrants term											3 years						3 years			3 years
Debt discount											$ 2,035,033						$ 2,035,033				33,547
Unamortized discount											1,887						1,887				4,121
Amortization of debt expense											$ 895						2,234
Cash proceeds																	$ 2,750,000
Annual interest rate	[11]										12.00%						12.00%
Promissory Note Payable Thirteen [Member]
Short-Term Debt [Line Items]
Prepaid expense											$ 4,000,160						$ 4,000,160
Repayment of notes											$ 9,000						$ 36,000
Annual interest rate	[12]										7.00%						7.00%
Promissory Note Payable Thirteen [Member] | Director [Member] | Series F Preferred Stock [Member]
Short-Term Debt [Line Items]
Conversion of convertible securities, shares																	184
Promissory Note Payable Fourteen [Member]
Short-Term Debt [Line Items]
Purchase of warrants											250,000,000						250,000,000
Exercise price											$ 0.037						$ 0.037
Fair value											$ 1,284,783						$ 1,284,783
Prepaid expense											1,650,000						1,650,000
Original issue discount											$ 150,000						$ 150,000
Warrants term											3 years						3 years
Debt discount											$ 1,284,783						$ 1,284,783				572,549
Unamortized discount											36,250						36,250				66,846
Amortization of debt expense											$ 10,668						$ 30,659
Annual interest rate	[13]										12.00%						12.00%
Promissory Note Payable Fifteen [Member]
Short-Term Debt [Line Items]
Debt instrument maturity date description							On November 29, 2023, the parties extended the maturity date from July 28, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized.
Prepaid expense											$ 170,000						$ 170,000
Unamortized discount											$ 20,000						$ 20,000
Annual interest rate	[14]										15.00%						15.00%
Promissory Note Payable Sixteen [Member]
Short-Term Debt [Line Items]
Notes payable											$ 3,000,000						$ 3,000,000
Fair value											2,960,500						2,960,500
Debt discount											$ 39,500						$ 39,500				11,535
Class of Warrant or Right, Outstanding											955,000,000						955,000,000
Annual interest rate	[15]										15.00%						15.00%
Promissory Note Payable Seventeen [Member]
Short-Term Debt [Line Items]
Debt instrument maturity date description							On November 29, 2023, the parties extended the maturity date from September 7, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized.
Prepaid expense											$ 400,000						$ 400,000
Unamortized discount											$ 50,000						$ 50,000
Annual interest rate	[16]										15.00%						15.00%
Promissory Note Payable Eighteen [Member]
Short-Term Debt [Line Items]
Debt instrument maturity date description							On November 29, 2023, the parties extended the maturity date from September 8, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized.
Prepaid expense											$ 475,000						$ 475,000
Unamortized discount											$ 75,000						$ 75,000
Annual interest rate	[17]										15.00%						15.00%
Promissory Note Payable Nineteen [Member]
Short-Term Debt [Line Items]
Debt instrument maturity date description							On November 29, 2023, the parties extended the maturity date from October 13, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized.
Prepaid expense											$ 350,000						$ 350,000
Unamortized discount											$ 50,000						$ 50,000
Annual interest rate	[18]										15.00%						15.00%
Promissory Note Payable Twenty [Member]
Short-Term Debt [Line Items]
Notes payable									$ 400,000
Original issue discount					$ 4,000,000				50,000										$ 4,000,000
Unamortized discount									500,000
Cash proceeds									$ 350,000
Annual interest rate	[19],[20]										15.00%						15.00%
Promissory Note Payable Twenty [Member] | Series F Warrants [Member] | October 31, 2033 [Member]
Short-Term Debt [Line Items]
Purchase of warrants									61
Promissory Note Payable Twenty [Member] | Lender [Member]
Short-Term Debt [Line Items]
Loans payable									$ 4,000,000
Promissory Note Payable Twenty [Member] | Lender [Member] | Series F Preferred Stock [Member]
Short-Term Debt [Line Items]
Shares issued									329
Promissory Note Payable Twenty One [Member]
Short-Term Debt [Line Items]
Fair value									$ 299,399
Original issue discount									50,000
Debt discount																					286,775
Unamortized discount											$ 36,970						$ 36,970				47,892
Amortization of debt expense											$ 3,857						$ 10,922
Annual interest rate	[19],[20]										15.00%						15.00%
Loans payable									$ 400,000
Promissory Note Payable Twenty One [Member] | Series F Preferred Share Warrants [Member]
Short-Term Debt [Line Items]
Purchase of warrants									61
Promissory Note Payable Twenty One [Member] | Series F Preferred Shares [Member]
Short-Term Debt [Line Items]
Conversion of convertible securities, shares									1
Promissory Note Payable Twenty Two [Member]
Short-Term Debt [Line Items]
Fair value																														$ 299,750
Original issue discount																														50,000
Debt discount																					288,513
Unamortized discount											$ 37,154						$ 37,154				48,126
Amortization of debt expense											$ 3,875						$ 10,972
Annual interest rate	[19],[20]										15.00%						15.00%
Loans payable																														$ 400,000
Promissory Note Payable Twenty Two [Member] | Series F Preferred Share Warrants [Member]
Short-Term Debt [Line Items]
Purchase of warrants																														61
Promissory Note Payable Twenty Three [Member]
Short-Term Debt [Line Items]
Fair value																													$ 302,020
Original issue discount																													50,000
Debt discount																					291,694
Unamortized discount											$ 37,284						$ 37,284				48,290
Amortization of debt expense											$ 3,887						$ 11,006
Annual interest rate	[19],[20]										15.00%						15.00%
Loans payable																													$ 400,000
Promissory Note Payable Twenty Three [Member] | Series F Preferred Share Warrants [Member]
Short-Term Debt [Line Items]
Purchase of warrants																													61
Promissory Note Payable Twenty Four [Member]
Short-Term Debt [Line Items]
Fair value																												$ 299,959
Original issue discount																												50,000
Debt discount																					287,814
Unamortized discount											$ 37,037						$ 37,037				47,976
Amortization of debt expense											$ 3,863						$ 10,939
Annual interest rate	[19],[20]										15.00%						15.00%
Loans payable																												$ 400,000
Promissory Note Payable Twenty Four [Member] | Series F Preferred Share Warrants [Member]
Short-Term Debt [Line Items]
Purchase of warrants																												61
Promissory Note Payable Twenty Five [Member]
Short-Term Debt [Line Items]
Fair value																											$ 299,959
Original issue discount																											50,000
Debt discount																					286,813
Unamortized discount											$ 37,154						$ 37,154				48,124
Amortization of debt expense											$ 3,874						$ 10,970
Annual interest rate	[19],[20]										15.00%						15.00%
Loans payable																											$ 400,000
Promissory Note Payable Twenty Five [Member] | Series F Preferred Share Warrants [Member]
Short-Term Debt [Line Items]
Purchase of warrants																											61
Promissory Note Payable Twenty Six [Member]
Short-Term Debt [Line Items]
Fair value																										$ 299,959
Original issue discount																										50,000
Debt discount																					288,342
Unamortized discount											$ 37,287						$ 37,287				48,294
Amortization of debt expense											$ 3,887						$ 11,007
Annual interest rate	[19],[20]										15.00%						15.00%
Loans payable																										$ 400,000
Promissory Note Payable Twenty Six [Member] | Series F Preferred Share Warrants [Member]
Short-Term Debt [Line Items]
Purchase of warrants																										61
Promissory Note Payable Twenty Seven [Member]
Short-Term Debt [Line Items]
Fair value																									$ 296,245
Original issue discount																									50,000
Debt discount																					286,821
Unamortized discount											$ 37,378						$ 37,378				48,409
Amortization of debt expense											$ 3,896						$ 11,031
Annual interest rate	[19],[20]										15.00%						15.00%
Loans payable																									$ 400,000
Promissory Note Payable Twenty Seven [Member] | Series F Preferred Share Warrants [Member]
Short-Term Debt [Line Items]
Purchase of warrants																									61
Promissory Note Payable Twenty Eight [Member]
Short-Term Debt [Line Items]
Fair value																								$ 302,219
Original issue discount																								50,000
Debt discount																					294,824
Unamortized discount											$ 37,667						$ 37,667				48,777
Amortization of debt expense											$ 3,924						$ 11,110
Annual interest rate	[19],[20]										15.00%						15.00%
Loans payable																								$ 400,000
Promissory Note Payable Twenty Nine [Member]
Short-Term Debt [Line Items]
Fair value																							$ 348,983
Original issue discount																							50,000
Debt discount																					348,831
Unamortized discount											$ 38,613						$ 38,613				49,978
Amortization of debt expense											$ 4,015						$ 11,365
Annual interest rate	[19],[20]										15.00%						15.00%
Loans payable																							$ 400,000
Promissory Note Payable Twenty Nine [Member] | Series F Preferred Share Warrants [Member]
Short-Term Debt [Line Items]
Purchase of warrants																							61	61
Promissory Note Payable Thirty [Member]
Short-Term Debt [Line Items]
Fair value																						$ 261,759
Original issue discount																						50,000
Debt discount																					254,487
Unamortized discount											$ 37,536						$ 37,536				$ 48,611
Amortization of debt expense											$ 3,912						$ 11,075
Annual interest rate	[21]										35.00%						35.00%
Loans payable																						$ 400,000
Promissory Note Payable Thirty [Member] | Series F Preferred Share Warrants [Member]
Short-Term Debt [Line Items]
Purchase of warrants																						61
Promissory Note Payable Thirty One [Member]
Short-Term Debt [Line Items]
Annual interest rate	[22]										35.00%						35.00%
Promissory Note Payable Thirty One [Member] | Lender [Member]
Short-Term Debt [Line Items]
Accrued interest										$ 53,000
Total payments						$ 477,750
Annual interest rate						35.00%								35.00%				35.00%
Loans payable						$ 350,000								$ 350,000				$ 350,000
Monthly payments						thirteen future monthly payments of $36,750 commencing on April 30,2024 through to April 30, 2025 totaling $477,750.
Default rate						15.00%
Repayment of debt										$ 147,000
Promissory Note Payable Thirty Two [Member]
Short-Term Debt [Line Items]
Annual interest rate	[23]										12.00%						12.00%
Promissory Note Payable Thirty Two [Member] | Lender [Member]
Short-Term Debt [Line Items]
Total payments				$ 477,750
Annual interest rate				35.00%
Loans payable				$ 350,000
Monthly payments				thirteen future monthly payments of $36,750 commencing on August 8, 2024 through to August 80, 2025 totaling $477,750
Default rate				15.00%
Promissory Note Payable Thirty Three [Member] | Lender [Member]
Short-Term Debt [Line Items]
Notes payable			$ 400,000								$ 200,000						$ 200,000
Conversion of convertible securities, shares			20
Outstanding payable		$ 200,000
Number of common stock issued, shares		$ 57,142,857
[1] This promissory note was issued as part of a debt settlement whereby $2,683,357 in convertible notes and associated accrued interest of $1,237,811 totaling $3,921,168 was exchanged for this promissory note of $3,921,168, and a warrant to purchase 450,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a relative fair value of $990,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from December 10, 2023 to March 1, 2025 with all other terms and conditions remaining the same. [2] This promissory note was issued as part of a debt settlement whereby $1,460,794 in convertible notes and associated accrued interest of $1,593,544 totaling $3,054,338 was exchanged for this promissory note of $3,054,338, and a warrant to purchase 250,000,000 shares at an exercise price of $0.002 per share and a three-year maturity having a relative fair value of $550,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. $300,000 has been repaid during the year ended February 29, 2024. On November 28, 2023, the parties extended the maturity date from December 10, 2023 to March 1, 2025 with all other terms and conditions remaining the same. [3] This promissory note was issued as part of a debt settlement whereby $103,180 in convertible notes and associated accrued interest of $62,425 totaling $165,605 was exchanged for this promissory note of $165,605, and a warrant to purchase 80,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a fair value of $176,000.The maturity date was extended from December 10, 2023 to December 10, 2024 on February 29, 2024 and a fee of $22,958 was paid and charged to interest expense. [4] This promissory note was issued as part of a debt settlement whereby $235,000 in convertible notes and associated accrued interest of $75,375 totaling $310,375 was exchanged for this promissory note of $310,375, and a warrant to purchase 25,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a fair value of $182,500. [5] The note, with an original principal amount of $350,000, may be pre-payable at any time. The note balance includes an original issue discount of $35,000 and was issued with a warrant to purchase 50,000,000 shares at an exercise price of $0.025 per share with a 3-year term and having a relative fair value of $271,250. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $271,250 with a corresponding adjustment to paid in capital for the relative fair value of the warrant. On March 1, 2024, the unamortized relative fair value discount of $65,092 was removed with a corresponding adjustment to accumulated deficit. A $8,399 unamortized discount remained. On November 28, 2023, the parties extended the maturity date from December 10, 2023 to March 1, 2025 with all other terms and conditions remaining the same. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $2,115 and $6,069, respectively, with an unamortized discount of $2,330 at November 30, 2024. [6] This promissory note was issued as part of a debt settlement whereby $9,200 in convertible notes and associated accrued interest of $6,944 totaling $16,144 was exchanged for this promissory note of $25,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from January 1, 2024 to March 1, 2025 with all other terms and conditions remaining the same. [7] This promissory note was issued as part of a debt settlement whereby $79,500 in convertible notes and associated accrued interest of $28,925 totaling $108,425 was exchanged for this promissory note of $145,000. This note is secured by a general security charging all of the Company’s present and after-acquired property. On November 28, 2023, the parties extended the maturity date from January 1, 2024 to March 1, 2025 with all other terms and conditions remaining the same. [8] The note, with an original principal amount of $550,000, may be pre-payable at any time. The note balance includes an original issue discount of $250,000 and was issued with a warrant to purchase 50,000,000 shares at an exercise price of $0.025 per share with a 3-year term and having a relative fair value of $380,174. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $380,174 with a corresponding adjustment to paid in capital. On March 1, 2024, the unamortized relative fair value discount of $80,284 was removed with a corresponding adjustment to accumulated deficit. A $10,559 unamortized discount remained. On November 28, 2023, the parties extended the maturity date from January 14, 2024 to March 1, 2025 with all other terms and Conditions remaining the same. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $2,649 and $7,702, respectively, with an unamortized discount of $2,857 at November 30, 2024 [9] The note, with an original principal balance of $1,650,000, may be pre-payable at any time. The note balance includes an original issue discount of $150,000 and was issued with a warrant to purchase 100,000,000 shares at an exercise price of $0.135 per share with a 3-year term and having a relative fair value of $1,342,857. The discount and warrant are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $1,342,857 with a corresponding adjustment to paid in capital for the relative fair value of the warrant. The maturity date was extended from February 22, 2022 to February 22, 2024 on February 28, 2022 in exchange for warrants to purchase 50,000,000 at an exercise price of $.0164 and a 3-year term. These warrants have a fair value of $950,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. On November 28, 2023, the parties extended the maturity date from February 22, 2024 to March 1, 2025 with all other terms and conditions remaining the same. On March 1, 2024, the unamortized relative fair value discount of $497,614 was removed with a corresponding adjustment to accumulated deficit. A $55,585 unamortized discount remained. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $14,046 and $40,289 respectively, with an unamortized discount of $15,296 at November 30, 2024. [10] The unsecured note may be pre-payable at any time. Cash proceeds of $5,400,000 were received. The note balance of $6,000,000 includes an original issue discount of $600,000 and was issued with a warrant to purchase 300,000,000 shares at an exercise price of $0.135 per share with a 3-year term and having a relative fair value of $4,749,005 using Black-Scholes with assumptions described in note 13. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $4,749,005 with a corresponding adjustment to paid in capital for the relative value of the warrant. The maturity was extended from March 1, 2022 to March 1, 2024 on February 28, 2022 in exchange for warrants to purchase 150,000,000 shares of common stock at an exercise price of $.0164 and a 3 year term. These warrants have a fair value of $2,850,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. This note has been fully amortized. This note was again extended to March 1, 2025. [11]  The note, with an original principal balance of $2,750,000, may be pre-payable at any time. The note balance includes an original issue discount of $50,000 and was issued with a warrant to purchase 170,000,000 shares at an exercise price of $0.064 per share with a 3-year term and having a relative fair value of $2,035,033. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $2,035,033 with a corresponding adjustment to paid in capital. The maturity date was extended from June 8, 2022 to June 8, 2024 on February 28, 2022 in exchange for warrants to purchase 85,000,000 at an exercise price of $.0164 and a 3 year term. These warrants have a fair value of $1,615,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. This note was extended to June 8, 2025. On March 1, 2024, the unamortized relative fair value discount of $33,547 was removed with a corresponding adjustment to accumulated deficit. A $4,121 unamortized discount remained. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $895 and $2,234, respectively, with an unamortized discount of $1,887 at November 30, 2024. [12] This loan, with an original principal balance of $4,000,160, was in exchange for 184 Series F preferred shares from a former director. The interest and principal are payable at maturity. The loan is unsecured. For the three and nine months ended November 30, 2024 there were repayments of $9,000 and $36,000 , respectively on the note. [13] The note, with an original principal balance of $1,650,000, may be pre-payable at any time. The note balance includes an original issue discount of $150,000 and was issued with a warrant to purchase 250,000,000 shares at an exercise price of $0.037 per share with a 3-year term and having a relative fair value of $1,284,783, The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $1,284,783 with a corresponding adjustment to paid in capital. On March 1, 2024, the unamortized relative fair value discount of $572,549 was removed with a corresponding adjustment to accumulated deficit. A $66,846 unamortized discount remained. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $10,668 and $30,659 respectively, with an unamortized discount of 36,250 at November 30, 2024. This note was extended to September 14, 2025. [14] Original $170,000 note may be pre-payable at any time. The note balance includes an original issue discount of $20,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from July 28, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized.. [15] A warrant holder exchanged 955,000,000 warrants for a promissory note of $3,000,000, bearing interest at 15% with a two year maturity. The fair value of the warrants was determined to be $2,960,500 with a corresponding adjustment to paid-in capital and a debt discount of $39,500 which will be amortized over the term of the loan. Principal and interest due at maturity. On March 1, 2024, the unamortized relative fair value discount of $11,535 was removed with a corresponding adjustment to accumulated deficit. This note has been fully amortized. This note was extended to August 30, 2025. [16] Original $400,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from September 7, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized. [17] Original $475,000 note may be pre-payable at any time. The note balance includes an original issue discount of $75,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from September 8, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized. [18] Original $350,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of the Company’s s present and after-acquired property. On November 29, 2023, the parties extended the maturity date from October 13, 2023 to March 1, 2025 with all other terms and conditions remaining the same. This note has been fully amortized. [19] November 9, 2022, $400,000 loan, original issue discount of $50,000 , 61 Series F Preferred Share warrants having a relative fair value of $299,750. On March 1, 2024, the unamortized relative fair value discount of $288,513 was removed with a corresponding adjustment to accumulated deficit. A $48,126 unamortized discount remained. For the three and nine months ended November 30, 2024, the Company recorded amortization expense of $3,875 and $10,972, respectively, with an unamortized discount of $37,154 at November 30, 2024. [20] On October 28, 2022 the Company entered into an loan facility with a lender for up to $4,000,000 including an original issue discount of $500,000. In exchange the Company will issue one series F Preferred Share, extended 329 series F warrants with a March 1, 2026 maturity to a new October 31, 2033 maturity, and issue up to 10 tranches with each tranche of $400,000, with cash proceeds of $350,000 an original issue discount of $50,000, October 31, 2026 maturity, and 61 Series F warrants with a October 31, 2033 maturity. Secured by a general security charging all of the Company’s present and after-acquired property. At February 29, 2024 the Company has issued all 10 tranches totaling $ 4,000,000 as follows: [21] On November 30, 2023, the Company entered into an agreement where the lender will pay the Company $350,000 in exchange for thirteen future monthly payments of $36,750 commencing on April 30,2024 through to April 30, 2025 totaling $477,750. The effective interest rate is 35% per annum. Secured by a general security charging all of RAD’s present and after-acquired property. Default rate of 15% per annum calculated daily on any missed monthly payment. The Company has repaid $147,000 and $53,000 in accrued interest in July to account for the missed the April and August 2024 payments not made in agreement with the lender. No notices have been sent. [22] On March 8, 2024, the Company entered into another agreement where the lender will pay the Company $350,000 in exchange for thirteen future monthly payments of $36,750 commencing on August 8, 2024 through to August 80, 2025 totaling $477,750. The effective interest rate is 35% per annum. Secured by a general security charging all of RAD’s present and after- acquired property. Default rate of 15% per annum calculated daily on any missed monthly payment. The August 2024 payment has not been made but will be resolved with the lender. No notices have been sent. [23] On August 8, 2024, a Series F preferred shareholder exchanged 20 Series F the preferred shares for a $400,000 note payable. On August 22, 2022 the lender exchanged $200,000 of note principal for 57,142,857 common shares. The common shares were issued in September 2024. The note balance at November 30, 2024 is $200,000.

SUMMARY OF PREFERRED STOCK WARRANT ACTIVITY (Details) - Series F Preferred Warrants [Member] - $ / shares	9 Months Ended	12 Months Ended
	Nov. 30, 2024	Feb. 29, 2024
Class of Stock [Line Items]
Number of Series F Preferred Warrants, Outstanding Beginning balance	939
Weighted Average Exercise Price, Oustanding Beginng balance	$ 1.00
Weighted Average Remaining Years, Outstanding	9 years 2 months 12 days	9 years 6 months
Number of Series F Preferred Warrants, Issued
Weighted Average Exercise Price, Issued
Number of Series F Preferred Warrants, Exercised
Weighted Average Exercise Price, Exercised
Number of Series F Preferred Warrants,Forfieted and cancelled
Weighted Average Exercise Price,Forfieted and cancelled
Number of Series F Preferred Warrants, Outstanding Beginning balance	939	939
Weighted Average Exercise Price, Oustanding ending balance	$ 1.00	$ 1.00

SUMMARY OF COMMON STOCK WARRANT ACTIVITY (Details) - Common Stock Warrant [Member] - $ / shares	9 Months Ended	12 Months Ended
	Nov. 30, 2024	Feb. 29, 2024
Class of Stock [Line Items]
Number of Series F Preferred Warrants, Outstanding Beginning balance	300,595,661
Weighted Average Exercise Price, Oustanding Beginng balance	$ 0.003
Weighted Average Remaining Years, Outstanding	2 years 8 months 4 days	1 year
Number of Series F Preferred Warrants, Issued
Weighted Average Exercise Price, Issued
Number of Series F Preferred Warrants, Exercised
Weighted Average Exercise Price, Exercised
Number of Series F Preferred Warrants, Forfeited and cancelled	(253,324,212)
Weighted Average Exercise Price,Forfieted and cancelled	$ 0.003
Number of Series F Preferred Warrants, Outstanding Beginning balance	47,271,449	300,595,661
Weighted Average Exercise Price, Oustanding ending balance	$ 0.003	$ 0.003

SUMMARY OF COMMON STOCK OPTION ACTIVITY (Details) - Share-Based Payment Arrangement, Option [Member] - $ / shares	9 Months Ended	12 Months Ended
	Nov. 30, 2024	Feb. 29, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Stock options, Outstanding, Beginning Balance	188,667,035
Weighted Average Exercise Price, Beginning Balance	$ 0.02
Weighted Average Remaining Years, Outstanding	3 years 9 months	4 years 1 month 6 days
Number of Stock Options, Issued
Weighted Average Exercise Price, Issued
Number of Stock Options, Exercised
Weighted Average Exercise Price, Exercised
Number of Stock Options, Forfeited, extinguished and cancelled	(3,011,029)
Weighted Average Exercise Price, Forfeited, extinguished and cancelled	$ 0.02
Weighted Average Remaining Contractual Term, Forfeited, extinguished and cancelled	4 years 7 months 6 days
Number of Stock Options, Outstanding, Ending Balance	185,656,006	188,667,035
Weighted Average Exercise Price, Ending Balance	$ 0.02	$ 0.02

STOCKHOLDERS’ EQUITY (DEFICIT) (Details Narrative) - USD ($)			3 Months Ended						9 Months Ended
	Jul. 28, 2024	Apr. 27, 2024	Nov. 30, 2024	Aug. 31, 2024	May 31, 2024	Nov. 30, 2023	Aug. 31, 2023	May 31, 2023	Nov. 30, 2024	Nov. 30, 2023	Oct. 04, 2024	Oct. 03, 2024	Feb. 29, 2024
Accumulated Other Comprehensive Income (Loss) [Line Items]
Deeemed dividend on redemption of Series F shares									$ 334,187
Preferred stock, shares authorized			15,535,000						15,535,000				15,535,000
Gross proceeds									$ 278,000
Preferred stock dividend	$ 5,188
Reedemable preferred stock dividend, shares	324
Reedemable preferred stock dividend	$ 389,189
Deemed dividends	$ 89,189
Common stock, authorized			15,000,000,000						15,000,000,000				15,000,000,000
Net proceeds from issuance of common stock									$ 8,894,645	7,527,190
Payments of stock issuance costs			$ 93,885	$ 195,656	$ 116,046	$ 56,320	$ 176,672	$ 81,285
Share based compensation									$ 249,969	337,896
Series B Convertible Redeemable Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock dividend rate percentage		8.00%
Preferred stock dividend	$ 4.32
Temporary shares outstanding			0						0
Preferred Stock [Member] | Series F Convertible Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Seies F convertible preferred share									20
Notes payable			$ 400,000						$ 400,000
Preferred stock par value shares			$ 20						$ 20
Seies F convertible preferred shares									$ 65,793
Preferred Stock [Member] | Series B Convertible Redeemable Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares authorized		5,000
Gross proceeds		$ 300,000
Net proceeds		278,000
Legal fees		10,000
Broker fees		$ 12,000
Shares issuable		20
Fair value charged in paid in capital		$ 24,000
Preferred stock redemption price per share		$ 1,200
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Shares issuable			875,000,000	1,330,610,802	1,080,166,425	675,336,434	903,636,004	280,929,190	3,285,777,227
Reedemable preferred stock dividend
Common stock, authorized											15,000,000,000	12,500,000,000
Gross proceeds from issuance of common stock			$ 2,468,477						$ 9,652,914
Net proceeds from issuance of common stock			2,073,393						9,247,248
Payments of stock issuance costs			93,885						406,566
Net proceeds from issuance of common stock									352,701
Debt instrument carrying amount			200,000						$ 200,000
Common Stock Issuable [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Shares issuable									57,142,857
Common Stock Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share based compensation			$ 83,323			$ 47,462			$ 249,969	$ 150,896

SCHEDULE OF MATURITY OF OPERATING LEASE LIABILITIES (Details) - USD ($)	Nov. 30, 2024	Feb. 29, 2024
Commitments and Contingencies Disclosure [Abstract]
November 30, 2025	$ 225,348
November 30, 2026	225,348
November 30, 2027	210,523
November 30, 2028	207,558
November 30, 2029	207,558
November 30, 2030 and after	294,041
Total lease payments	1,370,376
Less: Interest	(334,514)
Present value of lease liabilities	$ 1,035,861	$ 1,127,013

COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)					3 Months Ended		9 Months Ended
	Feb. 05, 2024	Jan. 28, 2022	Sep. 30, 2021	Mar. 10, 2021	Nov. 30, 2024	Nov. 30, 2023	Nov. 30, 2024	Nov. 30, 2023	Feb. 29, 2024	[1]
Product Liability Contingency [Line Items]
Rent expense and operating lease cost					$ 57,875	$ 64,081	$ 182,855	$ 189,164
Security deposit					$ 15,880		$ 15,880		$ 15,880
10 Years Lease Agreement [Member]
Product Liability Contingency [Line Items]
Description of operating lease				the Company entered into a 10 year lease agreement for q manufacturing facility at 10800 Galaxie Avenue, Ferndale, Michigan, 48220, commencing on May 1, 2021 through to April 30, 2031 with a minimum base rent of $15,880 per month.
10 Years Lease Agreement [Member] | Ferndale, Michigan [Member]
Product Liability Contingency [Line Items]
Rent expense and operating lease cost				$ 15,880
Security deposit				$ 15,880
3-Years Lease Agreement [Member]
Product Liability Contingency [Line Items]
Description of operating lease	On February 5, 2024, the Company entered into a 3-year lease agreement for a vehicle commencing February 5, 2024 through to February 5, 2027 with a minimum base rent of $1,223 per month.		On September 30, 2021, the Company entered into a 3-year lease agreement for a vehicle commencing September 30, 2021 through to April 30, 2031 with a minimum base rent of $1,538 per month.
Rent expense and operating lease cost	$ 1,223		$ 1,538
Rental down payment	$ 9,357		$ 18,462
2-Years Lease Agreement [Member] | Santa Ana, California [Member]
Product Liability Contingency [Line Items]
Description of operating lease		On January 28, 2022, the Company entered into a 2-year lease agreement for office space at 1516 E Edinger, Santa Ana, California, 92705, commencing on February 1, 2022 through to January 31, 2024 with a minimum base rent of $1,500 per month.
Rent expense and operating lease cost		$ 1,500
Security deposit		$ 1,500
[1] Derived from audited information

SCHEDULE OF NET INCOME (LOSS) PER COMMON SHARE (Details) - USD ($)	3 Months Ended						9 Months Ended
	Nov. 30, 2024	Aug. 31, 2024	May 31, 2024	Nov. 30, 2023	Aug. 31, 2023	May 31, 2023	Nov. 30, 2024	Nov. 30, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Net income (loss) available to common shareholders	$ (3,703,974)	$ (3,930,323)	$ (4,194,359)	$ (3,966,484)	$ (4,759,728)	$ (4,555,193)	$ (11,828,656)	$ (13,281,405)
Deduct : Dividend on Series B shares							(89,189)
Deduct: Deemed dividend on redemption of Series F shares							$ (334,187)
Net income (loss) adjusted for common stock equivalents	$ (3,703,974)			$ (3,966,484)			$ (12,252,032)	$ (13,281,405)
Weighted average shares – basic	12,161,286,427			7,294,775,879			11,071,139,695	6,606,988,956
Net income (loss) per share – basic	$ (0.00)			$ (0.00)			$ (0.00)	$ (0.00)
Weighted average shares – diluted	12,161,286,427			7,294,775,879			11,071,139,695	6,606,988,956
Net income (loss) per share – diluted	$ (0.00)			$ (0.00)			$ (0.00)	$ (0.00)
Convertible Debt [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Warrants
Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Warrants
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Warrants

SCHEDULE OF ANTI-DILUTIVE SHARES OF COMMON STOCK EQUIVALENTS (Details) - shares	3 Months Ended		9 Months Ended
	Nov. 30, 2024	Nov. 30, 2023	Nov. 30, 2024	Nov. 30, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	43,639,692,550	27,045,911,584	43,639,692,550	27,045,911,584
Convertible Notes And Accrued Interest [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	43,406,765,095	26,617,244,133	43,406,765,095	26,617,244,133
Share-Based Payment Arrangement, Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	232,927,455	428,667,451	232,927,455	428,667,451

SUBSEQUENT EVENTS (Details Narrative) - USD ($)		1 Months Ended	3 Months Ended						9 Months Ended
	Dec. 16, 2024	Jan. 14, 2025	Nov. 30, 2024	Aug. 31, 2024	May 31, 2024	Nov. 30, 2023	Aug. 31, 2023	May 31, 2023	Nov. 30, 2024	Nov. 30, 2023	Feb. 29, 2024
Subsequent Event [Line Items]
Proceeds from Issuance of Common Stock									$ 8,894,645	$ 7,527,190
Issuance cost of shares			$ 93,885	$ 195,656	$ 116,046	$ 56,320	$ 176,672	$ 81,285
Estimated gross proceeds			2,073,393	$ 4,491,360	$ 2,682,593	$ 1,412,158	$ 4,796,123	$ 1,318,909
Loans payable			$ 33,163,345						$ 33,163,345		$ 32,796,345
Common Stock [Member]
Subsequent Event [Line Items]
Number of shares issued			875,000,000	1,330,610,802	1,080,166,425	675,336,434	903,636,004	280,929,190	3,285,777,227
Proceeds from Issuance of Common Stock			$ 2,073,393						$ 9,247,248
Issuance cost of shares			93,885						406,566
Proceeds from Issuance or Sale of Equity									$ 352,701
Estimated gross proceeds			$ 8,750	$ 13,306	$ 10,802	$ 6,753	$ 9,036	$ 2,809
Subsequent Event [Member]
Subsequent Event [Line Items]
Loans payable	$ 200,000
Subsequent Event [Member] | Common Stock [Member]
Subsequent Event [Line Items]
Number of shares issued	76,923,076
Subsequent Event [Member] | Share Purchase Agreement [Member]
Subsequent Event [Line Items]
Number of shares issued		650,000,000
Proceeds from Issuance of Common Stock		$ 1,026,407
Issuance cost of shares		44,131
Proceeds from Issuance or Sale of Equity		982,236
Estimated gross proceeds		$ 620,000
Subsequent Event [Member] | Share Purchase Agreement [Member] | Common Stock [Member]
Subsequent Event [Line Items]
Number of shares issued		450,000,000
Remaining shares issued		200,000,000

---